0000081362-23-000071.txt : 20231102 0000081362-23-000071.hdr.sgml : 20231102 20231102164633 ACCESSION NUMBER: 0000081362-23-000071 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 231373217 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr-20230930.htm 10-Q kwr-20230930
000008136212/312023Q3falseP1Y24300000813622023-01-012023-09-3000000813622023-10-31xbrli:shares00000813622023-07-012023-09-30iso4217:USD00000813622022-07-012022-09-3000000813622022-01-012022-09-30iso4217:USDxbrli:shares00000813622023-09-3000000813622022-12-3100000813622021-12-3100000813622022-09-300000081362us-gaap:CommonStockMember2021-12-310000081362us-gaap:AdditionalPaidInCapitalMember2021-12-310000081362us-gaap:RetainedEarningsMember2021-12-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000081362us-gaap:NoncontrollingInterestMember2021-12-310000081362us-gaap:RetainedEarningsMember2022-01-012022-03-310000081362us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100000813622022-01-012022-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000081362us-gaap:CommonStockMember2022-01-012022-03-310000081362us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000081362us-gaap:CommonStockMember2022-03-310000081362us-gaap:AdditionalPaidInCapitalMember2022-03-310000081362us-gaap:RetainedEarningsMember2022-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000081362us-gaap:NoncontrollingInterestMember2022-03-3100000813622022-03-310000081362us-gaap:RetainedEarningsMember2022-04-012022-06-300000081362us-gaap:NoncontrollingInterestMember2022-04-012022-06-3000000813622022-04-012022-06-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000081362us-gaap:CommonStockMember2022-04-012022-06-300000081362us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000081362us-gaap:CommonStockMember2022-06-300000081362us-gaap:AdditionalPaidInCapitalMember2022-06-300000081362us-gaap:RetainedEarningsMember2022-06-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000081362us-gaap:NoncontrollingInterestMember2022-06-3000000813622022-06-300000081362us-gaap:RetainedEarningsMember2022-07-012022-09-300000081362us-gaap:NoncontrollingInterestMember2022-07-012022-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000081362us-gaap:CommonStockMember2022-07-012022-09-300000081362us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000081362us-gaap:CommonStockMember2022-09-300000081362us-gaap:AdditionalPaidInCapitalMember2022-09-300000081362us-gaap:RetainedEarningsMember2022-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000081362us-gaap:NoncontrollingInterestMember2022-09-300000081362us-gaap:CommonStockMember2022-12-310000081362us-gaap:AdditionalPaidInCapitalMember2022-12-310000081362us-gaap:RetainedEarningsMember2022-12-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000081362us-gaap:NoncontrollingInterestMember2022-12-310000081362us-gaap:RetainedEarningsMember2023-01-012023-03-310000081362us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100000813622023-01-012023-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000081362us-gaap:CommonStockMember2023-01-012023-03-310000081362us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000081362us-gaap:CommonStockMember2023-03-310000081362us-gaap:AdditionalPaidInCapitalMember2023-03-310000081362us-gaap:RetainedEarningsMember2023-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000081362us-gaap:NoncontrollingInterestMember2023-03-3100000813622023-03-310000081362us-gaap:RetainedEarningsMember2023-04-012023-06-300000081362us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000000813622023-04-012023-06-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000081362us-gaap:CommonStockMember2023-04-012023-06-300000081362us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000081362us-gaap:CommonStockMember2023-06-300000081362us-gaap:AdditionalPaidInCapitalMember2023-06-300000081362us-gaap:RetainedEarningsMember2023-06-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000081362us-gaap:NoncontrollingInterestMember2023-06-3000000813622023-06-300000081362us-gaap:RetainedEarningsMember2023-07-012023-09-300000081362us-gaap:NoncontrollingInterestMember2023-07-012023-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000081362us-gaap:CommonStockMember2023-07-012023-09-300000081362us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000081362us-gaap:CommonStockMember2023-09-300000081362us-gaap:AdditionalPaidInCapitalMember2023-09-300000081362us-gaap:RetainedEarningsMember2023-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000081362us-gaap:NoncontrollingInterestMember2023-09-30kwr:segmentkwr:country0000081362kwr:ArgentineAndTurkishSubsidiariesMembersrt:SubsidiariesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-09-30xbrli:pure0000081362kwr:ArgentineAndTurkishSubsidiariesMembersrt:SubsidiariesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-07-012023-09-300000081362kwr:ArgentineAndTurkishSubsidiariesMemberus-gaap:SalesRevenueNetMembersrt:SubsidiariesMemberus-gaap:GeographicConcentrationRiskMember2023-07-012023-09-300000081362kwr:ArgentineAndTurkishSubsidiariesMemberus-gaap:SalesRevenueNetMembersrt:SubsidiariesMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300000081362kwr:ArgentineAndTurkishSubsidiariesMembersrt:SubsidiariesMember2023-07-012023-09-300000081362kwr:ArgentineAndTurkishSubsidiariesMembersrt:SubsidiariesMember2023-01-012023-09-300000081362srt:SubsidiariesMembercountry:AR2022-07-012022-09-300000081362srt:SubsidiariesMembercountry:AR2022-01-012022-09-300000081362kwr:BusinessRelatedToPicklingAndRinsingProductsAndServicesMember2022-10-012022-10-31iso4217:EUR0000081362kwr:BusinessProvidingPicklingInhibitorTechnologiesMember2022-01-012022-01-310000081362kwr:BusinessProvidingPicklingInhibitorTechnologiesMember2022-07-012022-09-300000081362kwr:AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember2022-01-012022-01-310000081362kwr:BaronIndustriesMember2021-11-012021-11-3000000813622021-11-012021-11-300000081362srt:MaximumMember2021-11-300000081362kwr:BaronIndustriesMember2023-09-300000081362kwr:BaronIndustriesMember2022-07-012022-09-300000081362srt:MinimumMemberkwr:CoralChemicalCompanyMember2023-09-300000081362srt:MaximumMemberkwr:CoralChemicalCompanyMember2023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMember2022-01-012022-09-300000081362srt:AmericasMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300000081362srt:AmericasMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300000081362srt:AmericasMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300000081362srt:AmericasMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300000081362us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300000081362us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300000081362us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300000081362us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300000081362srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2023-07-012023-09-300000081362srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300000081362srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2023-01-012023-09-300000081362srt:AsiaPacificMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300000081362us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberkwr:TopFiveMember2022-01-012022-12-310000081362us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberkwr:LargestCustomerMember2022-01-012022-12-310000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalsMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalsMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalsMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalworkingAndOtherMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalworkingAndOtherMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalworkingAndOtherMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalworkingAndOtherMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberus-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:EMEAMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberus-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AmericasMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMemberus-gaap:EMEAMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AsiaPacificMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMember2023-07-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalsMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalsMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalsMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalworkingAndOtherMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalworkingAndOtherMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalworkingAndOtherMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalworkingAndOtherMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:EMEAMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AmericasMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMemberus-gaap:EMEAMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AsiaPacificMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalsMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalsMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalsMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalworkingAndOtherMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalworkingAndOtherMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalworkingAndOtherMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalworkingAndOtherMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberus-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:EMEAMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberus-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AmericasMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMemberus-gaap:EMEAMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AsiaPacificMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMember2022-07-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalsMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalsMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalsMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberkwr:MetalworkingAndOtherMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMemberkwr:MetalworkingAndOtherMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberkwr:MetalworkingAndOtherMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberkwr:MetalworkingAndOtherMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMemberus-gaap:EMEAMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AmericasMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMemberus-gaap:EMEAMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMembersrt:AsiaPacificMember2022-01-012022-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:TransferredOverTimeMember2022-01-012022-09-300000081362kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember2023-09-300000081362us-gaap:LandMember2023-09-30kwr:position0000081362us-gaap:RestructuringChargesMember2022-12-310000081362us-gaap:RestructuringChargesMember2023-01-012023-09-300000081362us-gaap:RestructuringChargesMember2023-09-300000081362kwr:StockOptionsCompensationExpenseMember2023-07-012023-09-300000081362kwr:StockOptionsCompensationExpenseMember2022-07-012022-09-300000081362kwr:StockOptionsCompensationExpenseMember2023-01-012023-09-300000081362kwr:StockOptionsCompensationExpenseMember2022-01-012022-09-300000081362kwr:NonvestedStockAwardsCompensationExpenseMember2023-07-012023-09-300000081362kwr:NonvestedStockAwardsCompensationExpenseMember2022-07-012022-09-300000081362kwr:NonvestedStockAwardsCompensationExpenseMember2023-01-012023-09-300000081362kwr:NonvestedStockAwardsCompensationExpenseMember2022-01-012022-09-300000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2023-07-012023-09-300000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2022-07-012022-09-300000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2023-01-012023-09-300000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2022-01-012022-09-300000081362us-gaap:PerformanceSharesMember2023-07-012023-09-300000081362us-gaap:PerformanceSharesMember2022-07-012022-09-300000081362us-gaap:PerformanceSharesMember2023-01-012023-09-300000081362us-gaap:PerformanceSharesMember2022-01-012022-09-300000081362kwr:CombinationAndOtherAcquisitionRelatedMember2022-07-012022-09-300000081362kwr:CombinationAndOtherAcquisitionRelatedMember2022-01-012022-09-300000081362us-gaap:EmployeeStockOptionMember2023-09-300000081362us-gaap:EmployeeStockOptionMember2023-01-012023-09-300000081362us-gaap:RestrictedStockMember2023-01-012023-09-300000081362us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300000081362us-gaap:RestrictedStockMembersrt:MinimumMember2023-01-012023-09-300000081362us-gaap:RestrictedStockMembersrt:MaximumMember2023-01-012023-09-300000081362us-gaap:RestrictedStockMember2023-09-300000081362us-gaap:RestrictedStockUnitsRSUMember2023-09-300000081362us-gaap:PerformanceSharesMembersrt:MaximumMember2023-01-012023-09-300000081362us-gaap:PerformanceSharesMember2023-09-300000081362us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300000081362us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300000081362us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300000081362us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300000081362us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-07-310000081362us-gaap:PensionPlansDefinedBenefitMember2023-09-300000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-09-300000081362country:ITus-gaap:ForeignCountryMemberkwr:HoughtonMember2022-03-310000081362country:ITus-gaap:ForeignCountryMemberkwr:HoughtonMember2023-09-300000081362country:ITus-gaap:ForeignCountryMemberkwr:HoughtonMember2023-07-012023-09-300000081362country:ITus-gaap:ForeignCountryMemberkwr:HoughtonMember2023-01-012023-09-300000081362srt:ScenarioPreviouslyReportedMemberus-gaap:OperatingSegmentsMembersrt:AmericasMember2022-12-310000081362srt:ScenarioPreviouslyReportedMemberus-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2022-12-310000081362srt:ScenarioPreviouslyReportedMemberus-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2022-12-310000081362srt:ScenarioPreviouslyReportedMemberus-gaap:OperatingSegmentsMemberkwr:GlobalSpecialtyBusinessesMember2022-12-310000081362srt:ScenarioPreviouslyReportedMember2022-12-310000081362us-gaap:OperatingSegmentsMembersrt:AmericasMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-12-312022-12-310000081362us-gaap:OperatingSegmentsMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMemberus-gaap:EMEAMember2022-12-312022-12-310000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-12-312022-12-310000081362us-gaap:OperatingSegmentsMemberkwr:GlobalSpecialtyBusinessesMembersrt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-12-312022-12-310000081362srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-12-312022-12-310000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2022-12-310000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2022-12-310000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2022-12-310000081362us-gaap:OperatingSegmentsMemberkwr:GlobalSpecialtyBusinessesMember2022-12-310000081362us-gaap:OperatingSegmentsMemberkwr:GlobalSpecialtyBusinessesMember2023-01-012023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AmericasMember2023-09-300000081362us-gaap:OperatingSegmentsMemberus-gaap:EMEAMember2023-09-300000081362us-gaap:OperatingSegmentsMembersrt:AsiaPacificMember2023-09-300000081362us-gaap:OperatingSegmentsMemberkwr:GlobalSpecialtyBusinessesMember2023-09-300000081362us-gaap:CustomerListsMember2023-09-300000081362us-gaap:CustomerListsMember2022-12-310000081362kwr:TrademarksFormulationsandproducttechnologymemberMember2023-09-300000081362kwr:TrademarksFormulationsandproducttechnologymemberMember2022-12-310000081362us-gaap:OtherIntangibleAssetsMember2023-09-300000081362us-gaap:OtherIntangibleAssetsMember2022-12-310000081362kwr:HoughtonCombinationMember2022-12-310000081362kwr:AmendedRevolverMember2023-09-300000081362kwr:AmendedRevolverMember2022-12-310000081362kwr:AmendedUsTermLoanMember2023-09-300000081362kwr:AmendedUsTermLoanMember2022-12-310000081362kwr:AmendedEuroTermLoanMember2023-09-300000081362kwr:AmendedEuroTermLoanMember2022-12-310000081362kwr:IndustrialDevelopmentBondsMember2023-09-300000081362kwr:IndustrialDevelopmentBondsMember2022-12-310000081362kwr:BankLinesOfCreditAndOtherDebtObligationsMember2023-09-300000081362kwr:BankLinesOfCreditAndOtherDebtObligationsMember2022-12-310000081362kwr:AmendedEuroTermLoanMember2022-06-300000081362kwr:AmendedUsTermLoanMember2022-06-300000081362kwr:AmendedRevolverMember2022-06-300000081362kwr:AmendedCreditFacilityMember2022-06-300000081362kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember2023-07-012023-09-300000081362kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember2023-01-012023-09-300000081362kwr:OldCreditFacilityMember2023-09-300000081362kwr:AmendedCreditFacilityMembersrt:MinimumMember2023-01-012023-09-300000081362kwr:AmendedCreditFacilityMembersrt:MaximumMember2023-01-012023-09-300000081362us-gaap:InterestRateSwapMember2023-03-310000081362us-gaap:InterestRateSwapMember2023-01-012023-03-310000081362us-gaap:InterestRateSwapMember2023-09-300000081362kwr:AmendedRevolverMemberus-gaap:OtherAssetsMember2022-06-300000081362us-gaap:OtherAssetsMember2023-09-300000081362us-gaap:OtherAssetsMember2022-12-310000081362us-gaap:CorporateBondSecuritiesMember2023-09-300000081362us-gaap:CorporateBondSecuritiesMember2022-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300000081362us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-3000000813622023-06-012023-06-300000081362us-gaap:FairValueInputsLevel1Member2023-09-300000081362us-gaap:FairValueInputsLevel2Member2023-09-300000081362us-gaap:FairValueInputsLevel3Member2023-09-300000081362us-gaap:FairValueInputsLevel1Member2022-12-310000081362us-gaap:FairValueInputsLevel2Member2022-12-310000081362us-gaap:FairValueInputsLevel3Member2022-12-310000081362currency:MXN2023-09-300000081362currency:JPY2023-09-300000081362us-gaap:ForeignExchangeForwardMember2023-01-012023-09-300000081362us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2023-01-012023-09-300000081362us-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2022-01-012022-12-310000081362us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMember2023-01-012023-09-300000081362us-gaap:ForeignExchangeForwardMemberus-gaap:AccruedLiabilitiesMember2023-01-012023-03-3100000813622022-01-012022-12-310000081362us-gaap:InterestRateSwapMember2023-01-012023-09-300000081362us-gaap:InterestRateSwapMember2022-01-012022-12-310000081362us-gaap:InterestExpenseMember2023-07-012023-09-300000081362us-gaap:InterestExpenseMember2022-07-012022-09-300000081362us-gaap:InterestExpenseMember2023-01-012023-09-300000081362us-gaap:InterestExpenseMember2022-01-012022-09-300000081362us-gaap:NonoperatingIncomeExpenseMember2023-07-012023-09-300000081362us-gaap:NonoperatingIncomeExpenseMember2022-07-012022-09-300000081362us-gaap:NonoperatingIncomeExpenseMember2023-01-012023-09-300000081362us-gaap:NonoperatingIncomeExpenseMember2022-01-012022-09-300000081362us-gaap:InsuranceClaimsMember2022-01-012022-12-31kwr:location0000081362us-gaap:InsuranceClaimsMember2023-01-012023-09-300000081362kwr:HoughtonEnvironmentalMattersMember2022-12-310000081362kwr:HoughtonEnvironmentalMattersMember2023-09-300000081362kwr:JeewatBijlaniMember2023-07-012023-09-300000081362kwr:JeewatBijlaniMemberkwr:MrBijlanisTradingArrangementCommonStockMember2023-09-300000081362kwr:JeewatBijlaniMemberkwr:MrBijlanisTradingArrangementStockOptionsMember2023-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 001-12019
QUAKER CHEMICAL CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania23-0993790
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
901 E. Hector Street,
Conshohocken, Pennsylvania
19428 – 2380
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: 610-832-4000
Not Applicable
Former name, former address and former fiscal year, if changed since last report.
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1 par valueKWR
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes    x     No    o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   x     No    o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerxAccelerated filero
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o   No  x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Number of Shares of Common Stock Outstanding on October 31, 2023
17,984,916

Quaker Chemical Corporation
Table of Contents
Page
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and September 30, 2022
Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and September 30, 2022
Item 5.
1
PART I
FINANCIAL INFORMATION
Item 1.    Financial Statements (Unaudited).
Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Unaudited; Dollars in thousands, except per share data)
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net sales$490,612 $492,218 $1,486,204 $1,458,777 
Cost of goods sold (excluding amortization expense -
   See Note 13)		307,265 331,469 951,716 1,002,393 
Gross profit183,347 160,749 534,488 456,384 
Selling, general and administrative expenses122,810 115,456 362,212 343,081 
Restructuring and related charges (credits), net1,019 (1,423)6,034 (604)
Combination, integration and other acquisition-related expenses— 2,107 — 7,992 
Operating income59,518 44,609 166,242 105,915 
Other (expense) income, net(2,713)85 (8,558)(10,520)
Interest expense, net(12,781)(8,389)(38,744)(20,228)
Income before taxes and equity in net income of associated companies44,024 36,305 118,940 75,167 
Taxes on income before equity in net income of associated companies13,593 10,185 36,956 14,425 
Income before equity in net income of associated companies30,431 26,120 81,984 60,742 
Equity in net income (loss) of associated companies3,279 (212)10,660 (642)
Net income33,710 25,908 92,644 60,100 
Less: Net income attributable to noncontrolling interest40 41 94 74 
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Per share data:
Net income attributable to Quaker Chemical Corporation common shareholders – basic$1.87 $1.44 $5.15 $3.35 
Net income attributable to Quaker Chemical Corporation common shareholders – diluted$1.87 $1.44 $5.14 $3.35 
Dividends declared$0.455 $0.435 $1.325 $1.265 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive Income
(Unaudited; Dollars in thousands)
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net income$33,710 $25,908 $92,644 $60,100 
Other comprehensive (loss) income, net of tax
Currency translation adjustments(25,504)(71,986)(24,116)(155,284)
Defined benefit retirement plans281 497 852 2,400 
Current period change in fair value of derivatives1,241 (140)5,804 1,535 
Unrealized (loss) gain on available-for-sale securities(637)(818)938 (2,385)
Other comprehensive loss(24,619)(72,447)(16,522)(153,734)
Comprehensive income (loss)9,091 (46,539)76,122 (93,634)
Less: Comprehensive loss attributable to noncontrolling interest(36)(3)(55)(5)
Comprehensive income (loss) attributable to Quaker Chemical Corporation$9,055 $(46,542)$76,067 $(93,639)
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Unaudited; Dollars in thousands, except par value)
September 30,
2023		December 31,
2022
ASSETS
Current assets
Cash and cash equivalents$198,358$180,963
Accounts receivable, net446,459472,888
Inventories
Raw materials and supplies129,204151,105
Work-in-process and finished goods121,566133,743
Prepaid expenses and other current assets70,72455,438
Total current assets966,311994,137
Property, plant and equipment, at cost431,565428,190
Less: Accumulated depreciation(235,125)(229,595)
Property, plant and equipment, net196,440198,595
Right of use lease assets38,59543,766
Goodwill504,457515,008
Other intangible assets, net890,464942,925
Investments in associated companies92,96588,234
Deferred tax assets9,56911,218
Other non-current assets33,70527,739
Total assets$2,732,506$2,821,622
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt$19,246$19,245
Accounts payable190,067193,983
Dividends payable8,1907,808
Accrued compensation43,64139,834
Accrued restructuring3,5905,483
Accrued pension and postretirement benefits1,5741,560
Other accrued liabilities85,79986,873
Total current liabilities352,107354,786
Long-term debt804,973933,561
Long-term lease liabilities22,16326,967
Deferred tax liabilities151,606160,294
Non-current accrued pension and postretirement benefits27,34428,765
Other non-current liabilities33,21238,664
Total liabilities1,391,4051,543,037
Commitments and contingencies (Note 18)
Equity
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding
September 30, 2023 – 18,000,855 shares; December 31, 2022 – 17,950,264 shares
18,00117,950
Capital in excess of par value938,473928,288
Retained earnings538,628469,920
Accumulated other comprehensive loss(154,724)(138,240)
Total Quaker shareholders’ equity1,340,3781,277,918
Noncontrolling interest723667
Total equity1,341,1011,278,585
Total liabilities and equity$2,732,506$2,821,622
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)
Nine Months Ended
September 30,
20232022
Cash flows from operating activities
Net income$92,644 $60,100 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of debt issuance costs1,059 2,589 
Depreciation and amortization61,434 60,692 
Equity in undistributed earnings of associated companies, net of dividends(7,486)3,612 
Deferred compensation, deferred taxes and other, net(515)(8,844)
Share-based compensation11,189 8,635 
Loss on extinguishment of debt— 5,246 
Combination and other acquisition-related expenses, net of payments— (4,265)
Restructuring and related charges (credits), net6,034 (604)
Pension and other postretirement benefits(2,000)(6,556)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable22,133 (65,256)
Inventories30,607 (72,386)
Prepaid expenses and other current assets(9,771)(11,081)
Change in restructuring liabilities(7,914)(1,234)
Accounts payable and accrued liabilities2,046 3,059 
Net cash provided by (used in) operating activities199,460 (26,293)
Cash flows from investing activities
Investments in property, plant and equipment(25,794)(20,230)
Payments related to acquisitions, net of cash acquired— (9,421)
Proceeds from disposition of assets— 65 
Net cash used in investing activities(25,794)(29,586)
Cash flows from financing activities
Payments of long-term debt(14,075)(668,500)
Proceeds from long-term debt— 750,000 
Payments on revolving credit facilities, net(112,835)(10,418)
Borrowings on other debt, net797 2,131 
Financing-related debt issuance costs— (3,734)
Dividends paid(23,459)(22,302)
Other stock related activity(953)(616)
Net cash (used in) provided by financing activities(150,525)46,561 
Effect of foreign exchange rate changes on cash(5,746)(16,967)
Net increase (decrease) in cash and cash equivalents17,395 (26,285)
Cash and cash equivalents at the beginning of the period180,963 165,176 
Cash and cash equivalents at the end of the period$198,358 $138,891 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Changes in Equity
(Unaudited; Dollars in thousands, except per share amounts)
Common
Stock		Capital in
Excess of
Par Value		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Noncontrolling
Interest		Total
Balance as of December 31, 2021$17,897 $917,053 $516,334 $(63,990)$628 $1,387,922 
Net income— — 19,816 — 5 19,821 
Amounts reported in other comprehensive (loss) income— — — (6,271)1 (6,270)
Dividends ($0.415 per share)
— — (7,434)— — (7,434)
Share issuance and equity-based compensation plans15 1,646 — — — 1,661 
Balance as of March 31, 2022$17,912 $918,699 $528,716 $(70,261)$634 $1,395,700 
Net income— — 14,343 — 28 14,371 
Amounts reported in other comprehensive loss— — — (74,985)(33)(75,018)
Dividends ($0.415 per share)
— — (7,438)— — (7,438)
Share issuance and equity-based compensation plans8 2,943 — — — 2,951 
Balance as of June 30, 2022$17,920 $921,642 $535,621 $(145,246)$629 $1,330,566 
Net income— — 25,867 — 41 25,908 
Amounts reported in other comprehensive loss— — — (72,409)(38)(72,447)
Dividends ($0.435 per share)
— — (7,803)— — (7,803)
Share issuance and equity-based compensation plans11 3,395 — — — 3,406 
Balance as of September 30, 2022$17,931 $925,037 $553,685 $(217,655)$632 $1,279,630 
Balance as of December 31, 2022$17,950 $928,288 $469,920 $(138,240)$667 $1,278,585 
Net income— — 29,534 — 7 29,541 
Amounts reported in other comprehensive income— — — 15,063 3 15,066 
Dividends ($0.435 per share)
— — (7,822)— — (7,822)
Share issuance and equity-based compensation plans32 1,386 — — — 1,418 
Balance as of March 31, 2023$17,982 $929,674 $491,632 $(123,177)$677 $1,316,788 
Net income— — 29,346 — 47 29,393 
Amounts reported in other comprehensive loss— — — (6,931)(38)(6,969)
Dividends ($0.435 per share)
— — (7,830)— — (7,830)
Share issuance and equity-based compensation plans17 5,267 — — — 5,284 
Balance as of June 30, 2023$17,999 $934,941 $513,148 $(130,108)$686 $1,336,666 
Net income— — 33,670 — 40 33,710 
Amounts reported in other comprehensive loss— — — (24,616)(3)(24,619)
Dividends ($0.455 per share)
— — (8,190)— — (8,190)
Share issuance and equity-based compensation plans2 3,532 — — — 3,534 
Balance as of September 30, 2023$18,001 $938,473 $538,628 $(154,724)$723 $1,341,101 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 1 – Basis of Presentation and Description of Business
As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires. The “Combination” refers to the legacy Quaker combination with Houghton International, Inc. (“Houghton”).
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments, which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company’s business structure as of January 1, 2023, including reportable segments and customer industry disaggregation. As a result of the Company’s new organizational structure effective January 1, 2023, the Company reallocated goodwill previously held by the former Global Specialty Businesses segment to the remaining business segments as of January 1, 2023. However, the Company did not recast the carrying amount of goodwill for the year ended December 31, 2022. See Notes 4, 5, and 13 of Notes to Condensed Consolidated Financial Statements.
Description of Business
The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as “FluidcareTM”, for various heavy industrial and manufacturing applications.
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three and nine months ended September 30, 2023, the Company's Argentine and Turkish subsidiaries represented a combined 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2023, the Company recorded $1.2 million and $2.9 million of remeasurement losses associated with the applicable currency conversions, respectively. Comparatively, during the three and nine months ended September 30, 2022, the Company recorded $1.0 million and $1.2 million of remeasurement losses associated with the applicable currency conversions, respectively. These losses were recorded within foreign exchange losses, net, which is a component of Other (expense) income, net, in the Company’s Condensed Consolidated Statements of Operations.
Note 2 – Business Acquisitions
Previous Acquisitions
In October 2022, the Company acquired a business that provides pickling and rinsing products and services, which is part of the EMEA reportable segment, for approximately 3.5 million EUR or approximately $3.5 million. This acquisition, along with the Company’s January 2022 acquisition in the Americas (described below), which had similar specializations and product offerings in pickling inhibitor technologies, strengthens Quaker Houghton’s position in pickling inhibitors and additives, enabling the Company to better support and optimize production processes for customers across the metals industry. As of September 30, 2023, the allocation of the purchase of this acquisition has been finalized.
7
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
In January 2022, the Company acquired a business that provides pickling inhibitor technologies, drawing lubricants and stamping oil, and various other lubrication, rust preventative, and cleaner applications, which is part of the Americas reportable segment, for approximately $8.0 million. This business broadens the Company’s product offerings within its existing metals and metalworking business in the Americas region. During the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company paying less than $0.1 million of additional purchase consideration. Also in January 2022, the Company acquired a business related to the sealing and impregnation of metal castings for the automotive sector, as well as impregnation resin and impregnation systems for metal parts, which is part of the EMEA reportable segment, for approximately 1.2 million EUR or approximately $1.4 million. This business broadens its product offerings and service capabilities within its existing impregnation business. The allocation of the purchase prices of both of these January 2022 acquisitions have been finalized.
In November 2021, the Company acquired Baron Industries, a privately held company that provides vacuum impregnation services of castings, powder metals and electrical components for its Americas reportable segment for $11.0 million, including an initial cash payment of $7.1 million, subject to post-closing adjustments, as well as certain earn-out provisions that are payable at various times from 2022 through 2025. The earn-out provisions could total a maximum of $4.5 million. As of September 30, 2023, the Company has remaining earn-out liabilities recorded on its Condensed Consolidated Balance Sheet of $1.1 million. Additionally, during the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company receiving a payment of less than $0.1 million.
In December 2020, the Company acquired Coral Chemical Company, LLC (“Coral”), a privately held U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. During the first nine months of 2023, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.
Note 3 – Recently Issued Accounting Standards
There have been no recently issued accounting standards that will have a material impact on the Company’s condensed consolidated financial statements and related footnote disclosures.
Note 4 – Business Segments
The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region. All prior period information has been recast to reflect the Company’s new reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.
Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”) and Selling, general and administrative expenses (“SG&A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges (credits), net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other (expense) income, net.
8
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
The following table presents information about the performance of the Company’s reportable segments:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net sales
Americas$245,899 $254,678 $750,531 $702,580 
EMEA139,620 134,386 435,602 426,739 
Asia/Pacific105,093 103,154 300,071 329,458 
Total net sales$490,612 $492,218 $1,486,204 $1,458,777 
Segment operating earnings
Americas$69,148 $66,749 $204,280 $164,065 
EMEA27,922 15,479 81,076 58,803 
Asia/Pacific30,963 26,723 86,604 76,146 
Total segment operating earnings128,033 108,951 371,960 299,014 
Combination, integration and other acquisition-related expenses— (2,107)— (7,992)
Restructuring and related (charges) credits, net(1,019)1,423 (6,034)604 
Non-operating and administrative expenses(52,280)(47,852)(154,001)(139,894)
Depreciation of corporate assets and amortization(15,216)(15,806)(45,683)(45,817)
Operating income59,518 44,609 166,242 105,915 
Other (expense) income, net(2,713)85 (8,558)(10,520)
Interest expense, net(12,781)(8,389)(38,744)(20,228)
Income before taxes and equity in net income of associated companies$44,024 $36,305 $118,940 $75,167 
The following table summarizes inter-segment revenues. All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Americas$1,772 $2,702 $6,778 $9,200 
EMEA5,161 9,448 18,718 37,259 
Asia/Pacific793 327 1,329 739 
Note 5 – Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s FluidcareTM business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $21.6 million and $63.2 million for the three and nine months ended September 30, 2023, respectively, and $21.4 million and $61.7 million for the three and nine months ended September 30, 2022, respectively.
Customer Concentration
A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2022 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 11% of consolidated net sales, with its largest customer accounting for approximately 3% of consolidated net sales.
9
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of September 30, 2023 or December 31, 2022.
The Company had approximately $2.8 million and $5.7 million of deferred revenue as of September 30, 2023 and December 31, 2022, respectively. For the nine months ended September 30, 2023, the Company satisfied all of the associated performance obligations and recognized into revenue the advance payments received and recorded as of December 31, 2022.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.
The following tables disaggregate the Company’s net sales by geographic region, customer industries, and timing of revenue recognized. Prior period information has been recast to reflect the Company’s current period customer industry disaggregation. See Note 1 of Notes to Condensed Consolidated Financial Statements.
Three Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,957 $32,630 $49,320 $149,907 
Metalworking and other177,942 106,990 55,773 340,705 
$245,899 $139,620 $105,093 $490,612 
Timing of Revenue Recognized
Product sales at a point in time$235,209 $128,586 $102,305 $466,100 
Services transferred over time10,690 11,034 2,788 24,512 
$245,899 $139,620 $105,093 $490,612 
Nine Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$204,834 $104,376 $144,109 $453,319 
Metalworking and other545,697 331,226 155,962 1,032,885 
$750,531 $435,602 $300,071 $1,486,204 
Timing of Revenue Recognized
Product sales at a point in time$718,187 $402,508 $291,740 $1,412,435 
Services transferred over time32,344 33,094 8,331 73,769 
$750,531 $435,602 $300,071 $1,486,204 
10
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Three Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,943 $32,748 $51,341 $152,032 
Metalworking and other186,735 101,638 51,813 340,186 
$254,678 $134,386 $103,154 $492,218 
Timing of Revenue Recognized
Product sales at a point in time$243,699 $124,566 $99,929 $468,194 
Services transferred over time10,979 9,820 3,225 24,024 
$254,678 $134,386 $103,154 $492,218 
Nine Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$185,784 $107,163 $163,239 $456,186 
Metalworking and other516,796 319,576 166,219 1,002,591 
$702,580 $426,739 $329,458 $1,458,777 
Timing of Revenue Recognized
Product sales at a point in time$669,945 $396,944 $321,031 $1,387,920 
Services transferred over time32,635 29,795 8,427 70,857 
$702,580 $426,739 $329,458 $1,458,777 
Note 6 - Leases
The Company has operating leases for certain facilities, vehicles and machinery and equipment with remaining lease terms up to 8 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 92 years.
The Company had no material variable lease costs, sublease income, or finance leases for the three and nine months ended September 30, 2023 and 2022. The components of the Company’s lease expense are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Operating lease expense$3,886 $3,664 $11,532 $10,592 
Short-term lease expense193 201 587 625 
11
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Supplemental cash flow information related to the Company’s leases is as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,917 $3,768 $11,547 $10,575 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities2,910 2,599 6,566 10,672 
Supplemental balance sheet information related to the Company’s leases is as follows:
September 30,
2023		December 31,
2022
Right of use lease assets$38,595 $43,766 
Other current liabilities12,113 12,024 
Long-term lease liabilities22,163 26,967 
Total operating lease liabilities$34,276 $38,991 
Weighted average remaining lease term (years)4.825.10
Weighted average discount rate4.67 %4.36 %
Maturities of operating lease liabilities were as follows:
September 30,
2023
For the remainder of 2023$3,691 
For the year ended December 31, 202412,589 
For the year ended December 31, 20258,417 
For the year ended December 31, 20266,286 
For the year ended December 31, 20273,051 
For the year ended December 31, 2028 and beyond5,614 
Total lease payments39,648 
Less: imputed interest(5,372)
Present value of lease liabilities$34,276 
Note 7 – Restructuring and Related Activities
In the third quarter of 2019, the Company’s management approved a global restructuring plan (the “QH Program”) as part of its initial plan to realize certain cost synergies associated with the Combination. As of December 31, 2022, the Company substantially completed all of the initiatives under the QH Program with only an immaterial amount of remaining severance still to be paid, which has been paid as of September 30, 2023.
In the fourth quarter of 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of September 30, 2023, the program included restructuring and associated severance costs to reduce headcount by approximately 100 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to continue throughout 2023. The exact timing to complete all actions and final costs associated will depend on a number of factors that are subject to change.
12
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. Restructuring costs include severance costs to reduce headcount, including customary and routine adjustments to initial estimates for employee separation costs, as well as costs to close certain facilities under the QH Program. These costs are recorded in Restructuring and related charges in the Company’s Consolidated Statements of Operations. As described in Note 4 of Notes to Consolidated Financial Statements, Restructuring and related charges are not included in the Company’s calculation of reportable segments’ measure of operating earnings and therefore these costs are not reviewed by or recorded to reportable segments.
In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. During the three months ended September 30, 2023, the Company classified certain properties with aggregate book value of approximately $6.9 million as held-for-sale that are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.
Changes in the Company’s accruals for its restructuring programs are as follows:
Restructuring Programs
Accrued restructuring as of December 31, 2022$5,483
Restructuring and related charges, net6,034 
Cash payments(7,914)
Currency translation adjustments(13)
Accrued restructuring as of September 30, 2023$3,590
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Stock options$203$533$837$1,269
Non-vested stock awards and restricted stock units2,4291,7837,1924,998
Director stock ownership plan3095653
Performance stock units1,1138753,1042,314
Total share-based compensation expense$3,775$3,200$11,189$8,634
Share-based compensation expense is recorded in SG&A, except for $0.1 million and $0.2 million for the three and nine months ended September 30, 2022, respectively, recorded within Combination, integration and other acquisition-related expenses.
Stock Options
As of September 30, 2023, unrecognized compensation expense related to unvested stock options was $0.5 million, to be recognized over a weighted average remaining period of 0.9 years.
Restricted Stock Awards and Restricted Stock Units
During the nine months ended September 30, 2023, the Company granted 38,894 non-vested restricted shares and 6,675 non-vested restricted stock units under its long-term incentive plan (“LTIP”), which are subject to time-based vesting, generally over one to three years. The fair value of these grants is based on the last sale price of the Company’s common stock on the date of grant. As of September 30, 2023, unrecognized compensation expense related to the non-vested restricted shares was $8.0 million, to be recognized over a weighted average remaining period of 1.4 years, and unrecognized compensation expense related to non-vested restricted stock units was $1.6 million, to be recognized over a weighted average remaining period of 1.5 years.
13
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Performance Stock Units
As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”), which will be settled in a certain number of shares subject to market-based or performance-based and time-based vesting conditions. The number of fully vested shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of the Company’s peer group, the S&P Midcap 400 Materials group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service period required for the PSUs is generally three years and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.
Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. The fair value of PSUs granted with a ROIC condition is based on the trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation, which included the following assumptions set forth in the table below:
2023
Grants
Number of PSUs granted16,861
Risk-free interest rate3.85%
Dividend yield0.96%
Expected term (years)3.0
Based on the conditions of the PSUs and performance to date for each of the outstanding PSU awards as of September 30, 2023, the Company estimates that it will issue 25,613 fully vested shares as of the applicable settlement date for such outstanding PSUs awards. As of September 30, 2023, there was approximately $8.0 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.2 years.
Note 9 – Pension and Other Postretirement Benefits
The components of net periodic benefit cost (income) are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Pension BenefitsOther Postretirement BenefitsPension BenefitsOther Postretirement Benefits
20232022202320222023202220232022
Service cost$109$166$—$1 $320$520$—$1
Interest cost2,4871,272148 7,4523,9495119
Expected return on plan assets(2,033)(1,942)——(6,056)(6,038)——
Actuarial loss (gain) amortization103238(36)(23)308743(95)(70)
Prior service cost (income) amortization183(4)(8)268(12)(17)
Net periodic benefit cost (income)$684 $(263)$(26)$(22)$2,050 $(818)$(56)$(67)
In July 2023, one of the Company’s pension plans in the U.K. liquidated approximately $50 million of its invested assets and subsequently funded and entered into an insurance annuity contract, which will provide for the pension plan’s defined benefit obligations to participants.
Employer Contributions
As of September 30, 2023, $3.4 million and $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.2 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2023.
14
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 10 – Other (expense) income, net
The components of Other (expense) income, net are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Income from third party license fees$245$253$891$906
Foreign exchange losses, net(2,498)(1,928)(10,049)(5,859)
(Loss) gain on disposals of property, plant, equipment and other assets, net(25)48 (91)33
Non-income tax refunds and other related credits (expense)911221,339 (1,617)
Pension and postretirement benefit (costs) income, non-service components(549)452(1,674)1,406
Facility remediation recoveries, net—1,1041,0141,104
Loss on extinguishment of debt——— (6,763)
Other non-operating income, net233412270
Total other (expense) income, net$(2,713)$85$(8,558)$(10,520)
Non-income tax refunds and other related credits (expense) during the nine months ended September 30, 2023 and nine months ended September 30, 2022 include adjustments to a Combination-related indemnification asset associated with the settlement of certain income tax audits for tax periods prior to August 1, 2019. See Note 11 of Notes to Condensed Consolidated Financial Statements.
Facility remediation recoveries, net, during the nine months ended September 30, 2023 and the three and nine months ended September 30, 2022, reflect gains recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage incurred during the three months ended September 30, 2021. See Note 18 of Notes to the Condensed Consolidated Financial Statements.
Loss on extinguishment of debt during the nine months ended September 30, 2022, represents a write-off of certain previously unamortized deferred financing costs as well as a portion of third party and creditor debt issuance costs incurred to execute an amendment to the Company’s primary credit facility. See Note 14 of Notes to Condensed Consolidated Financial Statements.
Note 11 – Income Taxes and Uncertain Income Tax Positions
The Company’s effective tax rates for the three and nine months ended September 30, 2023 were 30.9% and 31.1%, respectively, compared to 28.1% and 19.2% for the three and nine months ended September 30, 2022, respectively. The Company’s effective tax rate for the three months ended September 30, 2023 was primarily impacted by foreign tax inclusions, withholding taxes, return to provision adjustments, the impact of U.S. Department of Treasury guidance on the usage of foreign tax credits, and the mix of earnings. The effective tax rate for the first nine months of 2023 was further impacted by various other items including changes to the valuation allowance for and the usage of foreign tax credits due to an enacted law change in Brazil, and share-based compensation. Comparatively, the prior year effective tax rates were largely impacted by foreign tax inclusions, changes in the valuation allowance for foreign tax credits, the impact of audit settlements, a reduction in reserves for uncertain tax positions, withholding taxes, and the impact of forecasted earnings and the mix of such earnings. In addition, the Company’s effective tax rates for three and nine months ended September 30, 2022 were impacted by the Company recording earnings of one of its subsidiaries at a statutory tax rate of 25% while the recertification of its concessionary 15% tax rate was pending receipt.
As previously reported, Houghton Italia, S.r.l was involved in a corporate income tax audit with the Italian tax authorities covering tax years 2014 through 2018. The Company settled all years 2014 through 2018 for $3.7 million and, accordingly, released all reserves relating to this audit for the settled tax years during the first quarter of 2022. The settlement is to be paid via installments through 2026 and, through September 30, 2023, the Company has paid $1.5 million of such installments. Having received approximately $1.2 million from escrow during the quarter, the Company has a remaining indemnification receivable of $3.2 million in connection with its claim against the former owners of Houghton for any pre-Combination tax liabilities arising from this matter, as well as other audit settlements and tax matters.
15
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
In the first quarter of 2023, the Company was notified by the Spanish tax authorities of audits to commence for several of its legal entities operating in Spain and spanning tax years 2018 through 2021. In addition, in July 2023, the Company was notified by the Italian tax authorities of an audit to commence for one of the Company’s Italian subsidiaries for tax year 2019. Both of these audit proceedings are ongoing and the Company has been providing documentation in response to all of their inquiries. The Company has not established any reserves for these matters at this time.
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Basic earnings per common share$1.87 $1.44 $5.15 $3.35 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Effect of dilutive securities12,52012,56616,70915,465
Diluted weighted average common shares outstanding17,921,27417,859,87117,906,15317,851,441
Diluted earnings per common share$1.87 $1.44 $5.14 $3.35 
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 11,598 and 10,453 for the three and nine months ended September 30, 2023, respectively, and 25,896 and 24,618 for the three and nine months ended September 30, 2022, respectively.
Note 13 – Goodwill and Other Intangible Assets
The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment. The Company continually evaluates financial performance, economic conditions and other recent developments, including rising interest rates and the cost of capital among other factors, in assessing if a triggering event indicates that the carrying values of goodwill, indefinite-lived, or long-lived assets are impaired. The Company concluded that during the third quarter the ongoing financial, economic or geopolitical conditions did not represent a triggering event.
In connection with the Company’s reorganization and the associated change in reportable segments and reporting units during the first quarter of 2023, the Company performed the required impairment assessments directly before and immediately after the change in reporting units and concluded that it was not more likely than not that the fair values of any of the Company’s previous or new reporting units were less than their respective carrying amounts.
16
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Changes in the carrying amount of goodwill were as follows. Prior period information has been recast to reflect the Company’s current period reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.
AmericasEMEAAsia/PacificGlobal
Specialty
Businesses		Total
Balance as of December 31, 2022$215,899$34,567$150,375$114,167$515,008
Reallocation of reporting units63,697 31,711 18,759 (114,167)—
Balance as of January 1, 2023279,596 66,278 169,134 — 515,008 
Currency translation adjustments2,561 (805)(12,307)— (10,551)
Balance as of September 30, 2023$282,157$65,473$156,827$—$504,457
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
September 30, 2023December 31, 2022September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Customer lists and rights to sell$824,893$831,600$226,956$191,286$597,937$640,314
Trademarks, formulations and product technology157,362158,56452,53446,281104,828112,283
Other5,8547,5765,7346,3901201,186
Total definite-lived intangible assets$988,109$997,740$285,224$243,957$702,885$753,783
The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Amortization expense$14,529 $14,102 $43,734 $43,343 
Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows:
For the remainder of 2023$13,455
For the year ended December 31, 202456,630
For the year ended December 31, 202555,942
For the year ended December 31, 202655,650
For the year ended December 31, 202755,309
As of September 30, 2023 and December 31, 2022, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $187.6 million and $189.1 million, respectively.
17
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 14 – Debt
The following table sets forth the components of the Company’s debt:
As of September 30, 2023As of December 31, 2022
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver6.0%$82,838 5.2%$195,673 
U.S. Term Loan6.7%585,000 5.7%596,250 
Euro Term Loan5.0%146,918 3.1%151,572 
Industrial development bonds5.3%10,000 5.3%10,000 
Bank lines of credit and other debt obligationsVarious1,120 Various1,303 
Total debt$825,876 $954,798 
Less: debt issuance costs(1,657)(1,992)
Less: short-term and current portion of long-term debts(19,246)(19,245)
Total long-term debt$804,973 $933,561 
Credit facilities
During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.
As of September 30, 2023, the Company was in compliance with all of the Credit Facility covenants. See Note 20 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K.
The weighted average variable interest rates incurred on the outstanding borrowings under the Credit Facility during the three and nine months ended September 30, 2023 were approximately 6.4% and 6.1%, respectively. As of September 30, 2023, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.3%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $414 million, which is net of bank letters of credit of approximately $3 million, as of September 30, 2023.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of September 30, 2023, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of September 30, 2023, the Company had $1.7 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $3.6 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2022, the Company had $2.0 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $4.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet.
18
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Industrial development bonds
As of September 30, 2023 and December 31, 2022, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of September 30, 2023 was approximately $34 million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of September 30, 2023 were approximately $5 million.
Interest expense, net
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest expense$12,598 $9,465 $40,863 $20,339 
Amortization of debt issuance costs353 353 1,059 2,589 
Total$12,951 $9,818 $41,922 $22,928 
Based on the variable interest rates associated with the Credit Facility, as of September 30, 2023 and as of December 31, 2022, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.
Note 15 – Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance at June 30, 2023$(130,738)$(4,024)$91 $4,563 $(130,108)
Other comprehensive (loss) income before Reclassifications(25,501)304 (802)1,612 (24,387)
Amounts reclassified from AOCI— 71 (4)67 
Related tax amounts— (94)169 (371)(296)
Balance at September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance at June 30, 2022$(133,110)$(11,269)$(1,170)$303 $(145,246)
Other comprehensive (loss) income before Reclassifications(71,948)453 (1,006)(182)(72,683)
Amounts reclassified from AOCI— 210 (30)— 180 
Related tax amounts— (166)218 42 94 
Balance at September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
19
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before reclassifications(24,078)915 640 7,538 (14,985)
Amounts reclassified from AOCI— 225 547 772 
Related tax amounts— (288)(249)(1,734)(2,271)
Balance as of September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance as of December 31, 2021$(49,843)$(13,172)$397 $(1,372)$(63,990)
Other comprehensive (loss) income before reclassifications(155,215)2,535 (3,326)1,993 (154,013)
Amounts reclassified from AOCI— 657 306 — 963 
Related tax amounts— (792)635 (458)(615)
Balance as of September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
All reclassifications related to unrealized (loss) gain in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other comprehensive income for noncontrolling interest are related to currency translation adjustments.
Note 16 – Fair Value Measurements
The Company has valued its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. The fair values of Company-owned life insurance assets are based on quotes for like instruments with similar credit ratings and terms. These assets are subject to fair value measurement as follows:
Total
Fair Value		Fair Value Measurements as of September 30, 2023
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$285 $— $285 $— 
Total$285 $— $285 $— 
Total
Fair Value		Fair Value Measurements as of December 31, 2022
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$2,114 $— $2,114 $— 
Total$2,114 $— $2,114 $— 
Note 17 – Hedging Activities
The Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.
20
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Foreign Exchange Forward Contracts
A significant portion of the Company’s revenues and earnings are generated by its foreign operations. These foreign operations also represent a significant portion of the Company’s assets and liabilities. Generally, all of these foreign operations use the local currency as their functional currency and many have operations in currencies other than their functional currency, which creates foreign exchange risk. The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other (expense) income, net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments.
All open foreign exchange forward contracts as of September 30, 2023 were entered into as hedges against the U.S. dollar. As of September 30, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar value of the following:
CurrencySeptember 30,
2023
Mexican Peso$41,900 
Japanese Yen4,500 
$46,400 
Open foreign exchange forward contracts as of September 30, 2023 had maturities occurring over a period of one month.
Interest Rate Swaps
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements.
These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur. Interest rate swaps are entered into with a limited number of counterparties within several tranches, each of which allows for net settlement of all contracts through a single payment to participating counterparties in a single currency in the event of a default on or termination of any one contract. As such, in accordance with the Company’s accounting policy, these derivative instruments are recorded on a net basis within the Condensed Consolidated Balance Sheets.
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Fair Value
Condensed Consolidated
Balance Sheet Location		September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsOther non-current Assets$7,538 $— 
Foreign currency forward contractsOther current liabilities(564)$— 
$6,974 $— 
The following table presents the net unrealized (gain) loss deferred to AOCI:
September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsAOCI$5,804 $— 
21
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
The following table presents the net gain (loss) reclassified from AOCI to earnings:
Location and Amount of Gain (Loss) Recognized in
Statements of Operations
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest rate swapsInterest expense, net$1,198 $134 $2,259 $(882)
Foreign exchange forward contractsOther (expense) income, net(29)— 2,107 — 
$1,169 $134 $4,366 $(882)
Note 18 – Commitments and Contingencies
The Company previously disclosed in its 2022 Form 10-K that two of the Company’s locations suffered property damage as a result of flooding and electrical fire, respectively. The Company maintains property and flood insurance for all of its locations globally. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of this previously disclosed matter, other than ongoing work with the Company’s insurance adjuster and insurance carrier regarding the insurance claims submitted. Through September 30, 2023, the Company has received cumulative payments from its insurers of $5.9 million associated with these events. During the nine months ended September 30, 2023, the Company recognized a gain on insurance recoveries of $1.0 million. See Note 10 of Notes to the Condensed Consolidated Financial Statements.
As previously disclosed in its 2022 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 26 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. In addition, during the three and nine months ended September 30, 2023, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation the Company is party to, the Company believes that it has made adequate accruals for costs and liabilities associated with environmental matters or provisions for ongoing litigation for which it is aware. The Company has accrued approximately $6 million as of both September 30, 2023 and December 31, 2022, respectively, for these ongoing matters.
22
Quaker Chemical Corporation
Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
As used in this Report, the terms “Quaker Houghton,” the “Company,” “we” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires. The term the “Combination” refers to the legacy Quaker combination with Houghton International, Inc. (“Houghton”) on August 1, 2019.
Executive Summary
Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge, and customized services. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the U.S.
Despite a continued challenging economic environment, the Company delivered strong results in the third quarter of 2023. Net sales in the third quarter of 2023 were $490.6 million, a decrease of less than 1% compared to $492.2 million in the third quarter of 2022. This was primarily driven by an increase in selling price and product mix of approximately 2% and a favorable impact of foreign currency translation of 2%, offset by a 4% decrease in sales volumes. The increase in selling price and product mix was primarily the result of value-based pricing initiatives implemented, primarily in 2022, to offset ongoing inflationary pressures. The decline in sales volumes was primarily attributable to soft end market conditions, primarily in the Americas and EMEA segments, partially offset by new business wins.
The Company generated net income in the third quarter of 2023 of $33.7 million, or $1.87 per diluted share, compared to net income of $25.9 million, or $1.44 per diluted share in the third quarter of 2022. Excluding non-recurring and non-core items in each period, the Company’s third quarter of 2023 non-GAAP earnings per diluted share were $2.05 compared to $1.74 in the prior year quarter and the Company’s current quarter adjusted EBITDA was $84.4 million compared to $70.3 million in the third quarter of 2022. These current quarter earnings were primarily driven by a recovery in gross margins compared to the prior year quarter, partially offset by higher selling, general and administrative expenses (“SG&A”) as a result of year-over-year inflationary pressures and higher labor-related costs. See the Non-GAAP Measures section of this Item below, as well as other items discussed in the Company’s Consolidated Operations Review in the Operations section of this Item, below.
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. The Company’s third quarter of 2023 operating performance in each of its three reportable segments reflect similar drivers to that of its consolidated performance. Operating earnings for all segments increased compared to the prior year quarter, driven by an improvement in margins in all three segments. Additional details of each segment’s operating performance are further discussed in the Company’s Reportable Segments Review, in the Operations section of this Item, below.
Net cash flows provided by operating activities were $199.5 million in the first nine months of 2023 compared to net cash flows used in operating activities of $26.3 million in the first nine months of 2022. The net operating cash inflow year-over-year reflects higher operating performance in 2023 compared to 2022 as well as a favorable shift from a working capital investment in the prior year to positive cash flows from working capital in the first nine months of 2023. The key drivers of the Company’s operating cash flow and working capital are further discussed in the Company’s Liquidity and Capital Resources section of this Item, below.
Overall, the Company delivered strong results in the third quarter of 2023 including relatively stable net sales and an improvement in gross margins. These factors contributed to the Company’s current quarter earnings growth despite ongoing inflationary pressures, macroeconomic and geopolitical challenges, soft end market conditions and other factors that have impacted the Company’s customers and end markets. Looking at the remainder of 2023, the Company remains focused on executing on items within its control as it manages through a continued uneven and uncertain macroeconomic, geopolitical and end market environment, as well as the potential impact of the automotive industry labor dispute in the Americas segment. The Company is encouraged by its continued execution on its financial and operational priorities and the positive momentum built through the first nine months of 2023 and continues to expect to deliver higher earnings and cash flow in 2023 as compared to 2022.
Critical Accounting Policies and Estimates
Our significant accounting policies are described in “Management’s Discussion and Analysis” and “Note 1 – Significant Accounting Policies” to the Consolidated Financial Statements in our 2022 Form 10-K. There have been no material changes to the critical accounting policies and estimates previously disclosed in its 2022 Form 10-K remain materially consistent.
Recently Issued Accounting Standards
See Note 3 of Notes to Condensed Consolidated Financial Statements, in Part I, Item 1, of this Report for a discussion regarding recently issued accounting standards.
23
Quaker Chemical Corporation
Management’s Discussion and Analysis
Liquidity and Capital Resources
As of September 30, 2023, we had cash and cash equivalents of $198.4 million. Total cash and cash equivalents was $181.0 million as of December 31, 2022. The $17.4 million increase in cash and cash equivalents was the net result of $199.5 million of cash provided by operating activities partially offset by $150.5 million of cash used in financing activities, $25.8 million of cash used in investing activities and an unfavorable impact due to the effect of foreign currency translation of approximately $5.8 million.
Net cash flows provided by operating activities were $199.5 million in the first nine months of 2023 compared to net cash flows used in operating activities of $26.3 million in the first nine months of 2022. The increase in net operating cash flow year-over-year reflects higher year-over-year operating performance as well as a cash inflow from working capital, notably reductions in accounts receivable and inventory, in the current year, demonstrating the Company’s ongoing focus on cash conversion. Comparatively, during the first nine months of 2022, operating cash flow was negatively impacted by a significant working capital investment due to inflationary impacts on inventory and related pricing impacts on accounts receivable.
Net cash flows used in investing activities were $25.8 million in the first nine months of 2023 compared to $29.6 million in the first nine months of 2022. The lower level of cash used in investing activities year-over-year is the result of lower payments in the current year related to acquisitions which the Company had in the prior year, partially offset by higher capital expenditures in the current year. See Note 2 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report.
Net cash flows used in financing activities were $150.5 million in the first nine months of 2023 compared to net cash flows provided by financing activities of $46.6 million in the first nine months of 2022. The increase in net cash outflows was primarily related to net repayments of borrowings in the first nine months of 2023, primarily under the Company’s Credit Facility, described further below, as compared to net borrowings in the first nine months of 2022, which included the impact of new borrowings, net of repayments of old borrowings and debt issuance costs, related to the June 2022 credit facility amendment, described further below. In addition, the Company paid $23.5 million of cash dividends during the first nine months of 2023, a $1.2 million, or 5% increase, in cash dividends compared to the prior year quarter.
During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.
As of September 30, 2023, the Company had Credit Facility borrowings outstanding of $814.8 million. As of December 31, 2022, the Company had Credit Facility borrowings outstanding of $943.5 million. The Company’s other debt obligations are primarily industrial development bonds, bank lines of credit and municipality-related loans, which totaled $11.1 million as of September 30, 2023 and $11.3 million as of December 31, 2022. Total unused capacity under these arrangements as of September 30, 2023 was approximately $34 million. The Company’s total net debt as of September 30, 2023, which consists of total borrowings of $825.9 million less cash and cash equivalents of $198.4 million, was $627.5 million. The Credit Facility contains affirmative and negative covenants, financial covenants and events of default. Financial covenants contained in the Credit Facility include a consolidated interest coverage ratio test and a consolidated net leverage ratio test. As of September 30, 2023, the Company was in compliance with all of the Credit Facility covenants. Refer to the description of the Company’s primary Credit Facility in Note 20 of Notes to Consolidated Financial Statements in its 2022 Form 10-K and in Note 14 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for more information about the covenants and events of default.
The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the three and nine months ended September 30, 2023 was approximately 6.4% and 6.1%, respectively. As of September 30, 2023, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.3%. As part of the Credit Facility, in addition to paying interest on the outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $414 million, which is net of bank letters of credit of approximately $3 million, as of September 30, 2023.
24
Quaker Chemical Corporation
Management’s Discussion and Analysis
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as SOFR, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three-year interest rate swaps to convert a portion of the Company’s variable rate borrowings into an average fixed rate obligation of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of September 30, 2023, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized certain third-party and creditor debt issuance costs. Costs attributed to the Euro Term Loan and U.S. Term Loan were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Costs attributed to the Revolver were recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five-year term of the Credit Facility. As of September 30, 2023, the Company had $1.7 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $3.6 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2022, the Company had $2.0 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $4.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet.
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. During the first nine months ended 2023, the Company entered into and settled forward contracts resulting in cash proceeds of $2.1 million. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In the first nine months of 2022, the Company incurred $8.0 million of total Combination, integration and other acquisition-related expenses, described in the Non-GAAP Measures section of this Item below. The Company had net cash outflows related to the Combination, integration and other acquisition-related expenses during the first nine months of 2022 of $4.3 million. The Company had no Combination, integration and other acquisition-related expenses in the first nine months of 2023, except for $0.5 million in other income related to changes for an indemnification asset related to the Combination.
During the first nine months of 2023, the Company incurred $3.8 million of strategic planning expenses as compared to $4.5 million during the first nine months of 2022. The Company expects to incur additional operating costs and associated cash flows, as well as higher capital expenditures related to strategic planning, process optimization and the next phase of the Company’s long-term integration to further optimize its footprint, processes and other functions in 2023 and thereafter.
The Company’s management approved, and the Company initiated, a global restructuring plan (the “QH Program”) in 2019 as part of its planned cost synergies associated with the Combination. As of December 31, 2022, the Company had substantially completed all of the initiatives under the QH Program with only an immaterial amount of remaining severance still to be paid, which has been paid as of September 30, 2023. In the fourth quarter of 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. The exact timing to complete all actions and final costs associated will depend on a number of factors and are subject to change. The Company is continuing to evaluate and expects to implement further actions under this program, and as a result, additional headcount reductions and restructuring costs may be incurred in the future. The Company expects to generate full run-rate cost savings from the global cost and optimization program of approximately $20 million by the end of 2024. The Company expects total cash costs of this program to be approximately 1 to 1.5 times savings. The Company recognized Restructuring and related charges of $6.0 million and $0.6 million for the nine months ended September 30, 2023, and 2022, respectively, as a result of these programs. The Company made cash payments related to the settlement of restructuring liabilities under the restructuring programs during the first nine months of 2023 of approximately $7.9 million compared to $0.4 million in the first nine months of 2022. The Company has remaining restructuring accruals, as of September 30, 2023, for this program of $3.6 million, which the Company expects to settle over the next twelve months. See Note 7 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report.
As of September 30, 2023, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $20.4 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $6.5 million as a result of offsetting benefits in other tax jurisdictions.
25
Quaker Chemical Corporation
Management’s Discussion and Analysis
The Company previously disclosed in its 2022 Form 10-K that two of the Company’s locations suffered property damage as a result of flooding and electrical fire, respectively. The Company maintains property and flood insurance for all of its locations globally. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of this previously disclosed matter, other than ongoing work with the Company’s insurance adjuster and insurance carrier regarding the insurance claims submitted. Through September 30, 2023, the Company has received cumulative payments from its insurers of $5.9 million associated with these events. During the nine months ended September 30, 2023, the Company recognized a gain on insurance recoveries of $1.0 million. See Notes 10 and 18 of Notes to the Condensed Consolidated Financial Statements, in Item 1 of this report.
The Company believes that its existing cash, anticipated cash flows from operations and available liquidity will be sufficient to support its operating requirements and fund its business objectives for at least the next twelve months, including but not limited to, payments of dividends to shareholders, capital expenditures, other growth opportunities (including potential acquisitions), pension plan contributions, implementing actions to achieve the Company’s sustainability goals and other potential known or anticipated contingencies. The Company also believes it has sufficient additional liquidity to support its operating requirements and to fund its business obligations for the period beyond the next twelve months, including the aforementioned items which are expected to recur annually, as well as future principal and interest payments on the Company’s Credit Facility, tax obligations and other long-term liabilities. The Company’s liquidity is affected by many factors, some based on normal operations of our business and others related to the impact of the pandemic and other global events on our business and on global economic conditions as well as industry uncertainties, which we cannot predict. We also cannot predict economic conditions and industry downturns or the timing, strength or duration of recoveries. We may seek, as we believe appropriate, additional debt or equity financing that would provide capital for corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions and organic investments. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, specialty chemical industry conditions, competitive factors, and the condition of financial markets, among others.
Non-GAAP Measures
The information in this Form 10-Q includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered indicative of future operating performance or not considered core to the Company’s operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable respective GAAP measures, may not be comparable to similarly named measures reported by other companies.
The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company’s operations. In addition, the Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company’s operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the “two-class share method.” The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
26
Quaker Chemical Corporation
Management’s Discussion and Analysis
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company’s non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin ReconciliationsThree Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Operating income$59,518 $44,609 $166,242 $105,915 
Combination, integration and other acquisition-related expenses (a)— 2,107 — 7,992 
Restructuring and related charges (credits), net (b)1,019 (1,423)6,034 (609)
Strategic planning expenses (c)1,093 4,545 3,759 10,745 
Russia-Ukraine conflict related expenses (d)— 88 — 2,183 
Other charges (e)206 1,016 855 2,681 
Non-GAAP operating income$61,836 $50,942 $176,890 $128,907 
Non-GAAP operating margin (%) (l)12.6 %10.3 %11.9 %8.8 %
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income ReconciliationsThree Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Depreciation and amortization (j)20,866 19,908 62,210 61,491 
Interest expense, net12,781 8,389 38,744 20,228 
Taxes on income before equity in net income of associated companies (k)13,593 10,185 36,956 14,425 
EBITDA80,910 64,349 230,460 156,170 
Equity (income) loss in a captive insurance company (f)(756)174 (748)2,199 
Combination, integration and other acquisition-related expenses (credits) (a)— 2,107 (475)10,387 
Restructuring and related charges (credits), net (b)1,019 (1,423)6,034 (609)
Strategic planning expenses (c)1,093 4,545 3,759 10,745 
Russia-Ukraine conflict related expenses (d)— 88 — 2,183 
Currency conversion impacts of hyper-inflationary economies (g)1,229 991 2,869 1,216 
Loss on extinguishment of debt (i)— — — 6,763 
Other charges (credits) (e)886 (540)1,515 172 
Adjusted EBITDA$84,381 $70,291 $243,414 $189,226 
Adjusted EBITDA margin (%) (l)17.2 %14.3 %16.4 %13.0 %
Adjusted EBITDA$84,381 $70,291 $243,414 $189,226 
Less: Depreciation and amortization (j)20,866 19,908 62,210 61,491 
Less: Interest expense, net12,781 8,389 38,744 20,228 
Less: Taxes on income before equity in net income of associated companies - adjusted (a)(k)13,806 10,821 36,766 27,189 
Non-GAAP net income$36,928 $31,173 $105,694 $80,318 
27
Quaker Chemical Corporation
Management’s Discussion and Analysis
Non-GAAP Earnings per Diluted Share ReconciliationsThree Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders$1.87 $1.44 $5.14 $3.35 
Equity (income) loss in a captive insurance company per diluted share (f)(0.04)0.01 (0.04)0.12 
Combination, integration and other acquisition-related expenses (credits) per diluted share (a)— 0.09 (0.03)0.47 
Restructuring and related charges (credits), net per diluted share (b)0.04 (0.05)0.25 (0.02)
Strategic planning expenses per diluted share (c)0.04 0.19 0.17 0.46 
Russia-Ukraine conflict related expenses per diluted share (d)— 0.01 — 0.11 
Currency conversion impacts of hyper-inflationary economies per diluted share (g)0.07 0.060.16 0.07 
Loss on extinguishment of debt per diluted share (i)— — — 0.29 
Other charges (credits) per diluted share (e)0.04 (0.03)0.06 — 
Impact of certain discrete tax items per diluted share (h)0.03 0.02 0.16 (0.37)
Non-GAAP earnings per diluted share (m)$2.05 $1.74 $5.87 $4.48 
(a)Combination, integration and other acquisition-related expenses (credits) in 2022 included certain legal, financial, and other advisory and consultant costs incurred in connection with the Combination integration activities and similar expenses associated with the Company's other recent acquisitions. These costs are not indicative of the future operating performance of the Company. Approximately $0.3 million and $0.5 million for the three and nine months ended September 30, 2022 of these pre-tax costs were considered non-deductible for the purpose of determining the Company’s effective tax rate, and, therefore, taxes on income before equity in net income of associated companies - adjusted reflects the impact of these items. During the nine months ended September 30, 2023, the Company recorded $0.5 million of other income due to changes in an indemnification asset related to the Combination. Similarly, during the nine months ended September 30, 2022, the Company recorded $2.4 million, respectively, of other expense due to changes in a Combination-related indemnification asset. The amounts recorded that are related to the changes in indemnification assets are included in the caption “Combination, integration and other acquisition-related (credits) expenses” in the reconciliation of GAAP earnings per diluted share attributed to Quaker Chemical Corporation common shareholders to Non-GAAP earnings per diluted share as well as the reconciliation of net income attributable to Quaker Chemical Corporation to Adjusted EBITDA and Non-GAAP net income. See Notes 2, 10, and 11 of Notes to Condensed Consolidated Financial Statements, which appear in Item 1 of this Report.
(b)Restructuring and related charges (credits), net represent the costs (credits) incurred by the Company associated with the Company’s restructuring programs. These costs (credits) are not indicative of the future operating performance of the Company. See Note 7 of Notes to Condensed Consolidated Financial Statements, which appear in Item 1 of this Report.
(c)Strategic planning expenses include certain consultant and advisory expenses for the Company’s strategic planning phase of its long-term process optimization and integration projects to further optimize its footprint, processes and other functions. These planning phase costs are one-time in nature and not indicative of the future operating performance of the Company.
(d)Russia-Ukraine conflict related expenses represent the direct costs associated with the Company’s exit of operations in Russia during 2022, including costs for employee separation benefits, as well as costs associated with establishing specific reserves or changes to existing reserves for trade accounts receivable within the Company’s EMEA reportable segment for certain customers who filed for bankruptcy protection and were directly impacted by the conflict between Russia and Ukraine. These expenses are not indicative of the future operating performance of the Company.
(e)Other charges (credits) include executive transition costs, facility remediation insurance recoveries, net, charges incurred by an inactive subsidiary of the Company as a result of the termination of restrictions on insurance settlement reserves and non-service components of the Company’s pension and postretirement net periodic benefit income and expense. See Notes 9 and 18 of Notes to Condensed Consolidated Financial Statements, which appear in Item 1 of this Report.
28
Quaker Chemical Corporation
Management’s Discussion and Analysis
(f)Equity (income) loss in a captive insurance company represents the after-tax income attributable to the Company’s interest in Primex, Ltd. (“Primex”), a captive insurance company. The Company holds a 32% investment in and has significant influence over Primex, and therefore accounts for this interest under the equity method of accounting. The (income) loss attributable to Primex is not indicative of the future operating performance of the Company and is not considered core to the Company’s operations.
(g)Currency conversion impacts of hyper-inflationary economies represents the foreign currency remeasurement impacts associated with the Company’s affiliates whose local economies are designated as hyper-inflationary under U.S. GAAP. During both the three and nine months ended September 30, 2023 and 2022, the Company incurred non-deductible, pre-tax charges related to the Company’s Argentina and Türkiye affiliates. The charges incurred related to the immediate recognition of foreign currency remeasurement in the Consolidated Statements of Income associated with these entities are not indicative of the future operating performance of the Company. See Note 1 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(h)The impacts of certain discrete tax items include changes in valuation allowances recorded on certain Brazilian branch foreign tax credits and the related deferred taxes. These discrete items relate to tax law changes occurring in 2022 and 2023, both in the United States and Brazil which impacted the creditability of Brazilian foreign taxes in the U.S. Additionally, the Company has discrete items related to the remeasurement of deferred taxes on the transfer of intellectual property and the release of the reserves for uncertain tax positions. See Note 11 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(i)In connection with executing the Amended Credit Facility, the Company recorded a loss on extinguishment of debt of approximately $6.8 million during the period ended September 30, 2022 which includes the write-off of certain previously unamortized deferred financing costs as well as a portion of the third-party and creditor debt issuance costs incurred to execute the Amended Credit Facility. These expenses are not indicative of the future operating performance of the Company. See Note 14 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(j)Depreciation and amortization for both the three and nine months ended September 30, 2023 and September 30, 2022 includes approximately $0.3 million and $0.8 million, respectively, of amortization expense recorded within equity in net income of associated companies in the Company’s Condensed Consolidated Statements of Operations, which is attributable to the amortization of the fair value step up for the Company’s 50% interest in a joint venture in Korea as a result of required purchase accounting.
(k)Taxes on income before equity in net income of associated companies – adjusted presents the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net income attributable to Quaker Chemical Corporation to adjusted EBITDA and was determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. Combination, integration and other acquisition-related expenses (credits) described in (a) resulted in an incremental tax expense of $0.5 million and $1.9 million for the three and nine months ended September 30, 2022, respectively. Restructuring and related charges (credits), net described in (b) above resulted in incremental taxes of $0.2 million and $1.5 million for the three and nine months ended September 30, 2023, respectively, compared to an incremental benefit of $0.3 million and $0.1 million for the three and nine months ended September 30, 2022, respectively. Strategic planning expenses described in (c) above resulted in incremental taxes of $0.3 million and $0.9 million for the three and nine months ended September 30, 2023, respectively, compared to incremental taxes of $1.0 million and $2.5 million for the three and nine months ended September 30, 2022, respectively. Russia-Ukraine conflict related expenses described in (d) resulted in incremental taxes of less than $0.1 million and $0.5 million for the three and nine months ended September 30, 2022, respectively. Other charges described in (e) resulted in incremental taxes of $0.2 million and $0.4 million for the three and nine months ended September 30, 2023, compared to incremental taxes of $0.1 million and a tax benefit of $0.1 million for the three and nine months ended September 30, 2022, respectively. The impact of certain discrete items described in (h) resulted in a tax benefit of $0.5 million and $2.9 million for the three and nine months ended September 30, 2023, respectively, compared to a tax benefit of $0.5 million and incremental taxes of $6.4 million for the three and nine months ended September 30, 2022, respectively. Loss on extinguishment of debt described in (i) resulted in incremental taxes of $1.6 million during the nine months ended September 30, 2022.
(l)The Company calculates adjusted EBITDA margin and non-GAAP operating margin as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales.
(m)The Company calculates non-GAAP earnings per diluted share as non-GAAP net income attributable to the Company per weighted average diluted shares outstanding using the “two-class share method” to calculate such in each given period.
29
Quaker Chemical Corporation
Management’s Discussion and Analysis
Off-Balance Sheet Arrangements
The Company had no material off-balance sheet commitments or obligations as of September 30, 2023. The Company’s off-balance sheet items outstanding as of September 30, 2023 includes approximately $5 million of total bank letters of credit and guarantees. The bank letters of credit and guarantees are not significant to the Company’s liquidity or capital resources. See Note 14 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report.
Operations
Consolidated Operations Review – Comparison of the Third Quarter of 2023 with the Third Quarter of 2022
Net sales were $490.6 million in the third quarter of 2023 compared to $492.2 million in the third quarter of 2022. The net sales decrease of $1.6 million, or less than 1%, quarter-over-quarter reflects an increase in selling price and product mix of approximately 2% and a favorable impact of foreign currency translation of 2%, offset by a decline in sales volumes of approximately 4%. The increase in selling price and product mix was primarily driven by year-over-year impact of our value-based pricing initiatives. The decline in sales volumes was primarily attributable to softer end market conditions across the Company’s EMEA and Americas segments and the Company’s value-based pricing initiatives, partially offset by an increase in sales volumes in the Asia/Pacific segment and a positive contribution from new business wins in all segments.
COGS were $307.3 million in the third quarter of 2023 compared to $331.5 million in the third quarter of 2022, a decrease of $24.2 million. The decrease in COGS reflects lower spend on the decline in current year sales volumes and to a lesser extent softening in the Company’s global raw material costs.
Gross profit was $183.3 million in the third quarter of 2023 compared to $160.7 million in the third quarter of 2022, an increase of approximately $22.6 million or 14%. The Company’s reported gross margin in the third quarter of 2023 was 37.4% compared to 32.7% in the third quarter of 2022 primarily driven by the year-over-year impact of our value-based pricing initiatives, primarily implemented in 2022, which offset significant increases in raw material and other input costs.
SG&A was $122.8 million in the third quarter of 2023 compared to $115.5 million in the third quarter of 2022, an increase of approximately $7.3 million or 6%, driven by higher labor-related costs, including year-over-year inflationary increases, and higher levels of incentive compensation due to improved Company performance.
The Company incurred $2.1 million of Combination, integration and other acquisition-related operating expenses in the third quarter of 2022, primarily due to various professional fees related to legal, financial and other advisory and consultant expenses for Combination integration activities. There were no similar expenses incurred in the third quarter of 2023.
The Company incurred Restructuring and related charges of $1.0 million and a credit of $1.4 million during the third quarters of 2023 and 2022, respectively, related to reductions in headcount and site closures under the Company’s restructuring programs. See the Non-GAAP Measures section of this Item, above.
Operating income in the third quarter of 2023 was $59.5 million compared to $44.6 million in the third quarter of 2022. Excluding non-recurring and non-core expenses that are not indicative of the future operating performance of the Company described in the Non-GAAP Measures section of this Item, above, the Company’s non-GAAP operating income increased to $61.8 million in the third quarter of 2023 as compared to $50.9 million in the third quarter of 2022 primarily due to higher gross profit partially offset by higher SG&A, as described above.
The Company had Other expense, net of $2.7 million in the third quarter of 2023 as compared to other income, net of $0.1 million in the third quarter of 2022. Both the third quarter of 2023 and 2022 included foreign exchange transaction losses, which were higher in the current year. The third quarter of 2022 also included facility remediation recoveries, net of $1.1 million. The Company had no such facility remediation recoveries during the third quarter of 2023. See the Non-GAAP Measures section of this Item, above.
Interest expense, net, was $12.8 million in the third quarter of 2023 compared to $8.4 million in the third quarter of 2022, an increase of $4.4 million as a result of an increase in interest rates partially offset by a reduction in borrowings outstanding.
30
Quaker Chemical Corporation
Management’s Discussion and Analysis
The Company’s effective tax rates for the third quarters of 2023 and 2022 were 30.9% and 28.1%, respectively. The Company’s effective tax rate for the third quarter of 2023 was primarily impacted by foreign tax inclusions, withholding taxes, return to provision adjustments, the impact of U.S Department of Treasury guidance on the usage of foreign tax credits, and the impact of forecasted pre-tax earnings and the mix of such earnings. Comparatively, the effective tax rate for the third quarter of 2022 was largely driven by foreign tax inclusions, a reduction in reserves for uncertain tax positions, withholding taxes, and the impact of forecasted pre-tax earnings and the mix of such earnings. In addition, the effective tax rate for the third quarter of 2022 was impacted by the Company recording earnings of one of its subsidiaries at a statutory tax rate of 25% while the recertification of its concessionary 15% tax rate was pending receipt. Excluding the impact of non-core items in each quarter, described in the Non-GAAP Measures section of this Item, above, the Company estimates that its effective tax rates for the third quarters of 2023 and 2022 would have been approximately 28% and 26%, respectively. The Company expects continued volatility in its effective tax rates due to several factors, including the timing and scope of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, the unpredictability of the timing and amount of certain incentives in various tax jurisdictions, the treatment of certain acquisition-related costs and the timing and amount of certain share-based compensation-related tax benefits, among other factors.
Equity in net income of associated companies was $3.3 million in the third quarter of 2023 compared to a net loss of $0.2 million in the third quarter of 2022, an increase of $3.5 million, primarily due to higher current year income from the Company’s interest in a captive insurance company as well as from the Company’s 50% interest in a joint venture in Korea. See the Non-GAAP Measures section of this Item, above.
Net income attributable to noncontrolling interest was less than $0.1 million in both the third quarter of 2023 and 2022.
Foreign exchange negatively impacted the Company’s third quarter of 2023 results by approximately 1% compared to the third quarter of 2022 driven by the impact from foreign currency translation on earnings as well as higher foreign exchange transaction losses in the current quarter as compared to the prior year third quarter.
Consolidated Operations Review – Comparison of the First Nine Months of 2023 with the First Nine Months of 2022
Net sales were $1,486.2 million in the first nine months of 2023 compared to $1,458.8 million in the first nine months of 2022. The net sales increase of $27.4 million or 2% year-over-year reflects increases in selling price and product mix of approximately 11%, partially offset by a decline in sales volumes of approximately 9%. The increase in selling price and product mix was primarily driven by year-over-year impact of our value-based pricing initiatives. The decline in sales volumes was primarily attributable to softer end market conditions across all regions, the Company’s value-based pricing initiatives and customer order patterns, as well as the impacts of the ongoing war in Ukraine in the EMEA segment, and the wind-down of the tolling agreement for products previously divested related to the Combination, partially offset by new business wins, as mentioned above.
COGS were $951.7 million in the first nine months of 2023 compared to $1,002.4 million in the first nine months of 2022. The decrease in COGS of $50.7 million or 5% reflects lower spend on the decline in current year sales volumes, which more than offset higher costs due to inflationary pressures in the Company’s global raw material, manufacturing and supply chain and logistics costs compared to the prior year.
Gross profit in the first nine months of 2023 increased $78.1 million or 17% from the first nine months of 2022. The Company’s reported gross margin in the first nine months of 2023 was 36.0% compared to 31.3% in the first nine months of 2022. The Company’s current year improvement in gross margin was primarily driven by the year-over-year impact of our value-based pricing initiatives and, to a lesser extent, decreases in raw material and other input costs.
SG&A in the first nine months of 2023 increased $19.1 million or 6% compared to the first nine months of 2022 driven by higher labor-related costs including year-over-year inflationary increases and higher levels of incentive compensation on improved Company performance, partially offset by lower SG&A due to foreign currency translation compared to the prior year.
The Company incurred $8.0 million of Combination, integration and other acquisition related operating expenses in the first nine months of 2022, primarily due to various professional fees related to legal, financial and other advisory and consultant expenses for integration activities including internal control remediation. There were no similar costs in the first nine months of 2023. See the Non-GAAP Measures section of this Item, above.
The Company incurred Restructuring and related charges of $6.0 million and credits of $0.6 million during the first nine months of 2023 and 2022, respectively, related to reductions in headcount and site closures under the Company’s previous and current restructuring programs. See the Non-GAAP Measures section of this Item, above.
31
Quaker Chemical Corporation
Management’s Discussion and Analysis
Operating income in the first nine months of 2023 was $166.2 million compared to $105.9 million in the first nine months of 2022. Excluding non-recurring and non-core expenses that are not indicative of the future operating performance of the Company described in the Non-GAAP Measures section of this Item, above, the Company’s current year non-GAAP operating income increased to $176.9 million for the first nine months of 2023 compared to $128.9 million in the prior year’s first nine months primarily due to higher gross profit partially offset by higher SG&A, described above.
The Company had Other expense of $8.6 million in the first nine months of 2023 compared to $10.5 million in the first nine months of 2022. The first nine months of 2023 and 2022 results include $1.0 million and $1.1 million, respectively, of facility remediation recoveries, while the prior year’s first nine months of 2022 Other expense also includes a $6.8 million of loss on extinguishment of debt related to the Company’s refinancing the Original Credit Facility. See the Non-GAAP Measures section of this Item, above. Also, there was higher foreign currency transaction losses in 2023 compared to 2022.
Interest expense, net, increased $18.5 million in the first nine months of 2023 compared to the first nine months of 2022, due to an increase in interest rates in the current year partially offset by lower borrowings outstanding as compared to the prior year.
The Company’s effective tax rates for the first nine months of 2023 and 2022 were 31.1% and 19.2%, respectively. The Company’s effective tax rate for the nine months ended September 30, 2023 was primarily impacted by changes to the valuation allowance for and the usage of foreign tax credits due to an enacted law change in Brazil and additional guidance from the U.S Department of Treasury, foreign tax inclusions, withholding taxes, share-based compensation, state income taxes, and the impact of forecasted pre-tax earnings and the mix of such earnings. Comparatively, the effective tax rate for the nine months ended September 30, 2022 was impacted by foreign tax inclusions, changes in the valuation allowance for foreign tax credits, the impact of audit settlements, a reduction in reserves for uncertain tax positions, withholding taxes, and the impact of forecasted pre-tax earnings and the mix of such earnings. In addition, the effective tax rate during the nine months ended September 30, 2022 was impacted by the Company recording earnings of one of its subsidiaries at a statutory tax rate of 25% while the recertification of its concessionary 15% tax rate was pending receipt. Excluding the impact of non-core items in each period, described in the Non-GAAP Measures section of this Item, above, the Company estimates that its effective tax rates for the first nine months of 2023 and 2022 would have been approximately 28% and 26%, respectively. The Company expects continued volatility in its effective tax rates due to several factors, including the timing and scope of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, the unpredictability of the timing and amount of certain incentives in various tax jurisdictions, the treatment of certain acquisition-related costs and the timing and amount of certain share-based compensation-related tax benefits, among other factors.
Equity in net income (loss) of associated companies increased $11.3 million in the first nine months of 2023 compared to the first nine months of 2022, primarily due to higher current year income from the Company’s interest in a captive insurance company     (see the Non-GAAP Measures section of this Item, above), as well as higher current year income from the Company’s 50% interest in a joint venture in Korea.
Net income attributable to noncontrolling interest was less than $0.1 million in both the first nine months of 2023 and 2022.
Foreign exchange unfavorably impacted the Company’s first nine months of 2023 results by approximately 3% driven by the impact from foreign currency translation on earnings as well as higher foreign exchange transaction losses in the current year as compared to the prior year’s first nine months.
Reportable Segments Review - Comparison of the Third Quarter of 2023 with the Third Quarter of 2022
The Company’s reportable segments reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the chief operating decision maker of the Company assesses its performance. During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific.
The three segments are comprised of the assets and operations in each respective region, including assets and operations formerly included in the Global Specialty Businesses segment. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. All prior period information has been recast to reflect the Company’s new reportable segments.
Segment operating earnings for the Company’s reportable segments are comprised of net sales less COGS and SG&A directly related to the respective segment’s product sales. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses and Restructuring and related charges (credits), net. Other items not specifically identified with the Company’s reportable segments include Interest expense, net, and Other (expense) income, net.
32
Quaker Chemical Corporation
Management’s Discussion and Analysis
Americas
Americas represented approximately 50% of the Company’s consolidated net sales in the third quarter of 2023. The segment’s net sales were $245.9 million, a decrease of $8.8 million or 3%, compared to the third quarter of 2022. This was driven by a decrease in sales volumes of approximately 8%, partially offset by higher selling price and product mix of approximately 3% and a favorable impact of foreign currency translation of 2%. The current quarter decline in sales volumes compared to the prior year was primarily driven by softer market conditions, customer order patterns and the Company’s value-based pricing initiatives, partially offset by new business wins. The increase in selling price and product mix was primarily driven by the year-over-year impact of price increases. The favorable foreign exchange impact was primarily due to the weakening of the U.S. dollar against the Mexican peso as this exchange rate averaged 17.06 Mexican peso per U.S. dollar in the third quarter of 2023 compared to 20.23 Mexican peso per U.S. dollar in the third quarter of 2022. This segment’s operating earnings were $69.1 million, an increase of $2.4 million or 4%, compared to the third quarter of 2022 primarily driven by an improvement in the segment’s operating margins.
EMEA
EMEA represented approximately 29% of the Company’s consolidated net sales in the third quarter of 2023. The segment’s net sales were $139.6 million, an increase of $5.2 million or 4%, compared to the third quarter of 2022. This was driven by higher selling price and product mix of approximately 6% and a favorable impact from foreign currency translation of 7%, partially offset by a decrease in sales volumes of 9%. The increase in selling price and product mix was primarily driven by the year-over-year impact of price increases. The favorable foreign currency translation impact was primarily due to the weakening of the U.S. dollar against the euro as this exchange rate averaged 1.09 U.S. dollars per euro in the third quarter of 2023 compared to 1.01 U.S. dollars per euro in the third quarter of 2022. The decline in sales volumes was primarily driven by softer market conditions, the Company’s value-based pricing initiatives, customer order patterns and the impacts of the wind-down of the tolling agreement for products previously divested related to the Combination as well as the ongoing war in Ukraine, partially offset by new business wins. This segment’s operating earnings were $27.9 million, an increase of $12.4 million or 80%, compared to the third quarter of 2022 primarily driven by an increase in net sales and an improvement in operating margins.
Asia/Pacific
Asia/Pacific represented approximately 21% of the Company’s consolidated net sales in the third quarter of 2023. The segment’s net sales were $105.1 million, an increase of $1.9 million or 2%, compared to the third quarter of 2022. This was driven by higher sales volumes of 6% partially offset by an unfavorable impact from foreign currency translation of 4%. The increase in sales volumes was primarily driven by an increase in end market activity, albeit at lower levels and new business wins, partially offset by the impacts of the Company’s value-based pricing initiatives. The increase in selling price and product mix was primarily driven by year-over-year impact of price increases. The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Chinese renminbi as this exchange rate averaged 7.24 Chinese renminbi per U.S. dollar in the third quarter of 2023 compared to 6.84 Chinese renminbi per U.S. dollar in the third quarter of 2022. This segment’s operating earnings were $31.0 million, an increase of $4.2 million or 16% compared to the third quarter of 2022 primarily driven by an increase in net sales and an improvement in operating margins as well as slightly lower levels of SG&A.
Reportable Segments Review - Comparison of the First Nine Months of 2023 with the First Nine Months of 2022
Americas
Americas represented approximately 50% of the Company’s consolidated net sales in the first nine months of 2023. The segment’s net sales were $750.5 million, an increase of $48.0 million or 7% compared to the first nine months of 2022. This was driven by higher selling price and product mix of 12% and a favorable impact of foreign currency translation of 1%, partially offset by a decrease in sales volumes of 6%. The increase in selling price and product mix was primarily driven by the year-over-year impact of price increases. The favorable foreign currency impact was primarily due to the weakening of the U.S. dollar against the Mexican peso as this exchange rate averaged 17.78 Mexican peso per U.S. dollar in the first nine months of 2023 compared to 20.25 Mexican peso per U.S. dollar in the first nine months of 2022. The decline in sales volumes compared to the prior year was primarily driven by softer market conditions, the Company’s value-based pricing initiatives, customer order patterns, and the wind-down of the tolling agreement for products previously divested related to the Combination, partially offset by new business wins, as mentioned above. This segment’s operating earnings were $204.3 million, an increase of $40.2 million or 25% compared to the first nine months of 2022 primarily driven by higher net sales coupled with an improvement in operating margins, as mentioned above.
33
Quaker Chemical Corporation
Management’s Discussion and Analysis
EMEA
EMEA represented approximately 30% of the Company’s consolidated net sales in the first nine months of 2023. The segment’s net sales were $435.6 million, an increase of $8.9 million or 2% compared to the first nine months of 2022. This was a result of higher selling price and product mix of 13% and a favorable impact of foreign currency translation of approximately 1%, partially offset by a decrease in sales volumes of 12%. The increase in selling price and product mix was primarily driven by the year-over-year impact of price increases. The favorable foreign currency impact was primarily due to the weakening of the U.S. dollar against the euro as this exchange rate averaged 1.08 U.S. dollars per euro in the first nine months of 2023 compared to 1.07 U.S. dollars per euro in the first nine months of 2022. The decline in sales volumes was primarily driven by softer market conditions, the Company’s value-based pricing initiatives, customer order patterns, the impacts of the ongoing war in Ukraine and the wind-down of the tolling agreement for products previously divested related to the Combination, partially offset by new business wins. This segment’s operating earnings were $81.1 million, an increase of $22.3 million or 38% compared to the first nine months of 2022 primarily driven by higher net sales coupled with an improvement in operating margins, as mentioned above.
Asia/Pacific
Asia/Pacific represented approximately 20% of the Company’s consolidated net sales in the first nine months of 2023. The segment’s net sales were $300.1 million, a decrease of $29.4 million or 9% compared to the first nine months of 2022. This was driven by lower sales volumes of 10% and an unfavorable impact of foreign currency translation of 5%, partially offset by higher selling price and product mix of 6%. The decline in sales volumes was primarily driven by softer market conditions, customer order patterns, including the impact of COVID-19 lockdown measures, primarily in China, and the Company’s value-based pricing initiatives, partially offset by new business wins. The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Chinese renminbi as this exchange rate averaged 7.02 Chinese renminbi per U.S. dollar in the first nine months of 2023 compared to 6.59 Chinese renminbi per U.S. dollar in the first nine months of 2022. The increase in selling price and product mix was primarily driven by year-over-year impact of price increases, as mentioned above. This segment’s operating earnings were $86.6 million, an increase of $10.5 million or 14% compared to the first nine months of 2022. This was primarily driven by a recovery in operating margins as well as slightly lower levels of SG&A, which more than offset the decline in net sales, as mentioned above.
Factors That May Affect Our Future Results
(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)
Certain information included in this Report and other materials filed or to be filed by us with the SEC, as well as information included in oral statements or other written statements made or to be made by us, contain or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events, including statements regarding the potential effects of the COVID-19 pandemic, the conflict between Russia and Ukraine, inflation, bank failures, higher interest rate environment, global supply chain constraints on the Company’s business, results of operations, and financial condition, our expectation that we will maintain sufficient liquidity, remain in compliance with the terms of the Company’s credit facility, expectations about future demand and raw material costs and statements regarding the impact of increased raw material costs and pricing initiatives.
These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, including:
•the impacts on our business as a result of the COVID-19 pandemic;
•the timing and extent of the projected impacts on our business as a result of the Ukrainian and Russian conflict and actions taken by various governments and governmental organizations in response;
•the potential impacts of the automotive industry labor dispute
•inflationary pressures, cost increases and the impacts of constraints and disruptions in the global supply chain;
•the potential benefits of acquisitions;
•the potential for a variety of macroeconomic events, including the possibility of global or regional recessions, inflation generally, continued or accelerated cost increases in prices of raw materials such as oil and increasing interest rates, to impact the value of our assets or result in asset impairments or otherwise adversely affect our business;
•our current and future results and plans including our sustainability goals; and
•statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.
34
Quaker Chemical Corporation
Management’s Discussion and Analysis
Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in the Company’s other periodic reports on Forms 10-K, 10-Q and 8-K, press releases, and other materials released to, or statements made to, the public.
Any or all of the forward-looking statements in this Report, in the Company’s 2022 Form 10-K and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in the Company’s subsequent reports on Forms 10-K, 10-Q, 8-K and other related filings should be consulted. A major risk is that demand for the Company’s products and services is largely derived from the demand for our customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production slowdowns and shutdowns, including as is currently being experienced by many automotive industry companies as a result of supply chain disruptions and labor disputes.
Other major risks and uncertainties include, but are not limited to, the primary and secondary impacts of the COVID-19 pandemic, as well as inflationary pressures, including the potential for continued significant increases in raw material costs, supply chain disruptions, customer financial instability, rising interest rates and the possibility of economic recession, worldwide economic and political disruptions including the impacts of the military conflicts between Russia and Ukraine and between Israel and Hamas, the economic and other sanctions imposed by other nations on Russia, suspensions of activities in Russia by many multinational companies and the potential expansion of military activity, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence, the impact of consolidation in our industry, including loss or consolidation of a major customer and the potential occurrence of cyber-security breaches, cyber-security attacks and other security incidents.
Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automobile, aircraft, industrial equipment, and durable goods industries. Other factors could also adversely affect us, including those related to acquisitions and the integration of acquired businesses.
Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A in our 2022 Form 10-K and in our quarterly and other reports filed from time to time with the SEC. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Quaker Houghton on the Internet
Financial results, news and other information about Quaker Houghton can be accessed from the Company’s website at https://www.quakerhoughton.com. This site includes important information on the Company’s locations, products and services, financial reports, news releases and career opportunities. The Company’s periodic and current reports on Forms 10-K, 10-Q, 8-K, and other filings, including exhibits and supplemental schedules filed therewith, and amendments to those reports, filed with the SEC are available on the Company’s website, free of charge, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Information contained on, or that may be accessed through, the Company’s website is not incorporated by reference in this Report and, accordingly, you should not consider that information part of this Report.
35
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We have evaluated the information required under this Item that was disclosed in Part II, Item 7A, of our Annual Report on Form 10-K for the year ended December 31, 2022, and we believe there has been no material change to that information, except the interest rate risk noted below.
Interest Rate Risk
During June 2022, the Company entered into an amendment to its primary credit facility (the “Original Credit Facility”, or as amended, the “Credit Facility”). See Note 20 of Notes to Consolidated Financial Statements included in Item 8 of our 2022 Form 10-K and Note 14 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report. As of December 31, 2022, borrowings under the Credit Facility bear interest at either term Secured Overnight Financing Rate (“SOFR”) or a base rate, in each case, plus an applicable margin based upon the Company’s consolidated net leverage ratio, and, in the case of term SOFR, a spread adjustment equal to 0.10% per annum. As a result of the variable interest rates applicable under the Credit Facility, if interest rates rise significantly, the cost of debt to the Company will increase. This may have an adverse effect on the Company, depending on the extent of the Company’s borrowings outstanding throughout a given year. As of December 31, 2022, and September 30, 2023, the Company had outstanding borrowings under the Credit Facility of approximately $943.5 million and $814.8 million, respectively. The weighted average interest rate applicable on outstanding borrowings under the Credit Facility was approximately 4.9% and 6.3% as of December 31, 2022, and September 30, 2023, respectively. The weighted average interest rate applicable on outstanding borrowings under the Original Credit Facility and the Credit Facility during the year ended December 31, 2022 was approximately 3.0% and the nine months ended September 30, 2023 was approximately 6.1%. An interest rate change of 100 basis points would result in an approximate $9.4 million and $8.1 million increase or decrease to interest expense for the year ended December 31, 2022 and the year ended December 31, 2023, respectively.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as SOFR, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into an average fixed rate obligation of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of September 30, 2023, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. These interest rate swaps are designated and qualify as cash flow hedges. The Company has previously used derivative financial instruments primarily for the purpose of hedging exposures to fluctuations in interest rates.
Item 4. Controls and Procedures.
Evaluation of disclosure controls and procedures. As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based on that evaluation, our principal executive officer and our principal financial officer have concluded that, as of September 30, 2023, the end of the period covered by this Report, our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.
Changes in internal control over financial reporting. As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, there were no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended September 30, 2023.
36
PART II.
OTHER INFORMATION
Items 3 and 4 of Part II are inapplicable and have been omitted.
Item 1. Legal Proceedings.
Incorporated by reference is the information in Note 18 of Notes to the Condensed Consolidated Financial Statements in Part I, Item 1, of this Report.
Item 1A. Risk Factors.
The Company’s business, financial condition, results of operations and cash flows are subject to various risks that could cause actual results to vary materially from recent results or from anticipated future results. In addition to the other information set forth in this Report, you should carefully consider the risk factors previously disclosed in Part I, Item 1A of our 2022 Form 10-K. There have been no material changes to the risk factors described therein.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities.
The following table sets forth information concerning shares of the Company’s common stock acquired by the Company during the period covered by this Report:
Period(a)
Total Number
of Shares
Purchased (1)		(b)
Average
Price Paid
Per Share (2)		(c)
Total Number of
Shares Purchased as part of Publicly Announced Plans or Programs		(d)
Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (3)
July 1 - July 312,661$195.06 —$86,865,026 
August 1 - August 31130$204.79 —$86,865,026 
September 1 - September 30—$— —$86,865,026 
Total2,791$195.37 —$86,865,026 
(1)All of these shares were acquired from employees related to the surrender of Quaker Chemical Corporation shares in payment of the exercise price of employee stock options exercised or for the payment of taxes upon exercise of employee stock options or the vesting of restricted stock awards or units.
(2)The price paid for shares acquired from employees pursuant to employee benefit and share-based compensation plans is based on the closing price of the Company’s common stock on the date of exercise or vesting as specified by the plan pursuant to which the applicable option, restricted stock award, or restricted stock unit was granted.
(3)On May 6, 2015, the Board of Directors of the Company approved, and the Company announced, a share repurchase program, pursuant to which the Company is authorized to repurchase up to $100,000,000 of Quaker Chemical Corporation common stock (the “2015 Share Repurchase Program”), and it has no expiration date. There were no shares acquired by the Company pursuant to the 2015 Share Repurchase Program during the quarter ended September 30, 2023.
Limitation on the Payment of Dividends
The Credit Facility has certain limitations on the payment of dividends and other so-called restricted payment covenants. See Note 14 of Notes to Condensed Consolidated Financial Statements, in Part I, Item 1, of this Report.
Item 5. Other Information.
Insider Trading Arrangements and Policies
No director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the period covered by this Report except as follows:
On August 31, 2023, Jeewat Bijlani, Executive Vice President, Chief Strategy Officer, entered into a Rule 10b5-1 written trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Mr. Bijlani’s trading arrangement covers the sale of up to 2,900 shares of Company common stock and the exercise and sale of up to 6,338 shares of Company common stock upon the exercise of incentive and non-qualified stock options from December 1, 2023 until July 31, 2024.
37
Item 6. Exhibits.
(a) Exhibits
3.1
–
3.2
–
31.1
–
31.2
–
32.1
–
32.2
–
101.INS
–Inline XBRL Instance Document*
101.SCH
–Inline XBRL Taxonomy Schema Document*
101.CAL
–Inline XBRL Taxonomy Calculation Linkbase Document*
101.DEF
–Inline XBRL Taxonomy Definition Linkbase Document*
101.LAB
–Inline XBRL Taxonomy Label Linkbase Document*
101.PRE
–Inline XBRL Taxonomy Presentation Linkbase Document*
104
–Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
*********
38
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUAKER CHEMICAL CORPORATION
(Registrant)
/s/ Shane W. Hostetter
Date: November 2, 2023
Shane W. Hostetter, Executive Vice President, Chief Financial Officer (officer duly authorized on behalf of, and principal financial officer of, the Registrant)
39
 EX-31.1 2 kwr2023q3-exx311.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO RULE 13a 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
I, Andrew E. Tometich, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 2, 2023

/s/ Andrew E. Tometich
Andrew E. Tometich
Chief Executive Officer
1
 EX-31.2 3 kwr2023q3-exx312.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
I, Shane W. Hostetter, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 2, 2023

/s/ Shane W. Hostetter
Shane W. Hostetter
Chief Financial Officer
1
 EX-32.1 4 kwr2023q3-exx321.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 2, 2023

/s/ Andrew E. Tometich
Andrew E. Tometich
Chief Executive Officer of Quaker Chemical Corporation
1
 EX-32.2 5 kwr2023q3-exx322.htm EX-32.2 Document

EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 2, 2023

/s/ Shane W. Hostetter
Shane W. Hostetter
Chief Financial Officer of Quaker Chemical Corporation
1
 EX-101.SCH 6 kwr-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Basis of Presentation and Description of Business link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Business Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Restructuring and Related Activities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Pension and Other Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other (expense) income, net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Hedging Activities link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation and Description of Business (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Restructuring and Related Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Other (expense) income, net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Fair Value Measurements - (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Basis of Presentation and Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Business Acquisitions - (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Business Segments - Performance of Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Leases - Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Restructuring and Related Activities (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Other (expense) income, net (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Earnings Per Share - Basic (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Earnings Per Share - Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kwr-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 kwr-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 kwr-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Consolidated Entities [Axis] Consolidated Entities [Axis] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Less: Net income attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Derivative liability, notional amount Derivative Liability, Notional Amount Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Remaining lease terms (in years) Lessee, Operating Lease, Remaining Lease Term Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Cash transferred to Houghton shareholders Payments to Acquire Businesses, Gross Houghton Combination Houghton Combination [Member] Hougton, a business combination. Number of countries in which entity operates Number of Countries in which Entity Operates Service cost Defined Benefit Plan, Service Cost, Net Defined Benefit Plan, Service Cost, Net Baron Industries Baron Industries [Member] Baron Industries Deferred tax liabilities Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance stock units Performance Stock Units Performance Shares [Member] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Other (expense) income, net Total other (expense) income, net Nonoperating Income (Expense) Commitments and contingencies (Note 18) Commitments and Contingencies Previously Reported Previously Reported [Member] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Currency translation adjustments Restructuring Reserve, Foreign Currency Translation Gain (Loss) Mr. Bijlani's Trading Arrangement, Common Stock [Member] Mr. Bijlani's Trading Arrangement, Common Stock Other stock related activity Proceeds from Issuance or Sale of Equity Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Accumulated Other Comprehensive Income Equity [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Option award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Income Taxes and Uncertain Income Tax Positions Income Tax Disclosure [Text Block] Payments on revolving credit facilities, net Proceeds from (Repayments of) Lines of Credit Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Concentration Risk [Line Items] Concentration Risk [Line Items] Customer [Axis] Customer [Axis] Current liabilities Liabilities, Current [Abstract] Intersegment Sales Elimination Intersegment Eliminations [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Inventories Inventory, Net [Abstract] Dividends paid Payments of Ordinary Dividends, Common Stock Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Trademarks, formulations and product technology Trademarks Formulations And Product Technology [Member] Trademarks Formulations And Product Technology [Member] PEO Total Compensation Amount PEO Total Compensation Amount Vesting shares target upper (as a percent) Vesting Shares Target Upper Percent Vesting Shares Target Upper Percent Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Goodwill [Roll Forward] Goodwill [Roll Forward] Schedule Of Monte Carlo Option Pricing Model And The Assumptions Schedule of Monte Carlo option pricing model and the assumptions [Table Text Block] Schedule of Monte Carlo option pricing model and the assumptions Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Total Interest and Debt Expense Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Other comprehensive (loss) income before Reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Trading Symbol Trading Symbol Letters of credit outstanding amount Letters of Credit Outstanding, Amount Cumulative payments for tax settlements Cumulative Payments for Tax Settlements Cumulative Payments for Tax Settlements Restructuring Plan [Domain] Restructuring Plan [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net income attributable to Quaker Chemical Corporation Net income attributable to Quaker Chemical Corporation Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Corporate Bond Securities Corporate Bond Securities [Member] All Currencies [Domain] All Currencies [Domain] Outstanding Balance Debt and Lease Obligation LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Fair Value Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Advanced solutions Global Specialty Businesses [Member] Global Specialty Businesses. Other Other Intangible Assets [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of goods sold (excluding amortization expense - See Note 13) Cost of Goods and Services Sold Change in restructuring liabilities Increase (Decrease) in Restructuring Reserve Executive Category: Executive Category [Axis] Effect of foreign exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Credit faclity as percentage of consolidated EBITDA (as a percent) Credit facility as percentage of consolidated EBITDA Credit facility as percentage of consolidated EBITDA Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Beginning balance Ending balance Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Jeewat Bijlani [Member] Jeewat Bijlani Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Asset Acquisition [Domain] Asset Acquisition [Domain] Number of PSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business For the year ended December 31, 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Combination and other acquisition-related expenses, net of payments Combination And Other Acquisition-Related Expenses, Net Of Payments This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments. Argentina Subsidiaries [Member] Notional amount Derivative, Notional Amount Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Unrealized (loss) gain on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Product sales at a point in time Transferred at Point in Time [Member] Long-term lease liabilities Operating Lease, Liability, Noncurrent Foreign exchange losses, net Realized Gain (Loss), Foreign Currency Transaction, before Tax Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other current liabilities Accrued Liabilities [Member] Amounts reclassified from AOCI Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Financing-related debt issuance costs Payments of Debt Issuance Costs Income Statement Location [Axis] Income Statement Location [Axis] Non-current accrued pension and postretirement benefits Liability, Defined Benefit Plan, Noncurrent Reallocation of Reporting Units Revision of Prior Period, Reclassification, Adjustment [Member] Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Foreign currency forward contracts Foreign Exchange Forward [Member] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Interest expense Interest Expense, Debt Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of Lease, Cost Lease, Cost [Table Text Block] Inventories Increase (Decrease) in Inventories Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Accrued restructuring, beginning balance Accrued restructuring, ending balance Restructuring Reserve Combination, integration and other acquisition-related expenses Combination, integration and other acquisition-related expenses Business Combination, Acquisition Related Costs Antidilutive shares (in share) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Nonvested stock awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Unrecognized share-based compensation expense, nonvested stock award Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Dividends declared Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Goodwill [Line Items] Goodwill [Line Items] Property, plant and equipment, at cost Property, Plant and Equipment, Gross Leased assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability For the remainder of 2023 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Interest Income and Interest Expense Disclosure Interest Income and Interest Expense Disclosure [Table Text Block] Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Other current liabilities Operating Lease, Liability, Current Derivative term (in years) Derivative, Term of Contract Unrealized (Loss) Gain in Available-for- Sale Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Revolver Amended Revolver [Member] Amended Revolver Surrendered and liquidated life insurance policies Life Insurance, Corporate or Bank Owned, Change in Value Amortization expense Amortization of Intangible Assets ARGENTINA ARGENTINA Entity Shell Company Entity Shell Company For the year ended December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Net Book Value Finite-Lived Intangible Assets, Net Restatement Determination Date Restatement Determination Date Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization For the year ended December 31, 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Less: income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Variable lease cost Variable Lease, Cost Combination And Other Acquisition-Related Combination And Other Acquisition-Related [Member] Combination And Other Acquisition-Related [Member] Operating lease expense Operating Lease, Cost Common stock, shares issued (in shares) Common Stock, Shares, Issued Purchase price Business Combination, Consideration Transferred Gross profit Gross Profit Commitment fee percentage (as a percent) Line of Credit Facility, Commitment Fee Percentage Security Exchange Name Security Exchange Name Total Assets, Fair Value Disclosure Original Credit Facility Previous Credit Facility [Member] Syndicated multicurrency, unsecured revolving credit facility with a group of lenders. Selling, general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive loss Beginning Balance Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Share-Based Payment Arrangement, Option Employee Stock Option [Member] Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Schedule of Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Weighted average remaining life, nonvested stock awards (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Income Tax Examination [Table] Income Tax Examination [Table] Maximum Maximum [Member] Comprehensive income (loss) attributable to Quaker Chemical Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Document Type Document Type Work-in-process and finished goods Inventory, Finished Goods and Work in Process, Gross Long-term debt interest rate (as a percent) Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Geographic Concentration Risk Geographic Concentration Risk [Member] Tabular List, Table Tabular List [Table Text Block] Short-term lease expense Short-Term Lease, Cost EMEA EMEA [Member] Segment Reporting, Measurement Disclosures [Abstract] Entity Address, Address Line One Entity Address, Address Line One Retirement Benefits, Description [Abstract] Pension and other postretirement benefits Pension and Other Postretirement Benefits Cost (Reversal of Cost) Share-Based Compensation Share-Based Payment Arrangement [Text Block] For the year ended December 31, 2028 and beyond Lessee, Operating Lease, Liability, to be Paid, after Year Four Lessee, Operating Lease, Liability, to be Paid, after Year Four Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Coral Chemical Company (Coral) Coral Chemical Company (Coral) [Member] Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions. Business Acquisition [Axis] Business Acquisition [Axis] Currency conversion impacts of hyper-inflationary accounting Amount Recognized in Income Due to Inflationary Accounting Derivative [Table] Derivative [Table] Customer Concentration Risk Customer Concentration Risk [Member] Restructuring Programs Restructuring Charges [Member] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other accrued liabilities Other Liabilities, Current Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income from third party license fees Revenue from Contract with Customer, Including Assessed Tax Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Supplemental cash flow information related to leases Supplemental cash flow information related to leases Supplemental cash flow information related to leases Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Sublease income Sublease Income Business Acquisitions Business Combination Disclosure [Text Block] Industrial development revenue bond Industrial Development Revenue Bond This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility. Indefinite lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Other (expense) income, net Nonoperating Income (Expense) [Member] Operating Segments Operating Segments [Member] Dividends payable Dividends Payable, Current Income Tax Disclosure [Abstract] Derivative, fixed interest rate (as a percent) Derivative, Fixed Interest Rate Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Income Tax Examination [Line Items] Income Tax Examination [Line Items] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) Facility remediation recoveries, net Gain On Insurance Recoveries Gain On Insurance Recoveries Investments in associated companies Equity Method Investments Land Land [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Facilities Vehicles and Machinery and Equipment Facilities Vehicles and Machinery and Equipment [Member] Operating leases for certain facilities, vehicles and machinery and equipment. Other comprehensive (loss) income, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract] Entity Interactive Data Current Entity Interactive Data Current Top Five Customers Customer Concentration Risk Top Five [Member] Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. Post closing adjustment including earnouts Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Japanese Yen Japan, Yen Other Assets Other Assets [Member] Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Other Nonoperating (Expense) Income Schedule of Other Nonoperating Income (Expense) [Table Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Mexican Peso Mexico, Pesos Current assets Assets, Current [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Debt issuance costs Debt Issuance Costs, Current, Net For the year ended December 31, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows from operating leases Operating Lease, Payments Schedule of Share-Based Payment Arrangement, Cost by Plan Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Interest cost Defined Benefit Plan, Interest Cost Other Income and Expenses [Abstract] PEO PEO [Member] Loss contingency, estimate of possible loss Loss Contingency, Estimate of Possible Loss Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Pension and Other Postretirement Benefits Retirement Benefits [Text Block] Customer lists and rights to sell Customer Lists [Member] Non-income tax refunds and other related credits (expense) Proceeds From Non Income Tax Refunds The amount of cash received during the period as refunds for the overpayment of non-income taxes. Deferred compensation, deferred taxes and other, net Increase Decrease In Deferred Compensation And Other Net The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items. Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Net gain (loss) reclassified from AOCI to earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Net income available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Interest rate swaps Interest Rate Swap [Member] Expected future employer contributions, remainder of fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Total operating lease liabilities Present value of lease liabilities Operating Lease, Liability Total liabilities Liabilities Asset Acquisition [Axis] Asset Acquisition [Axis] Basis of Presentation and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Income before equity in net income of associated companies Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments All Executive Categories All Executive Categories [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Defined Benefit Pension Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Non-vested stock awards and restricted stock units Nonvested Stock Awards Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards. Debt Disclosure [Abstract] Assets and Liabilities, Lessee [Abstract] Assets and Liabilities, Lessee [Abstract] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Number of reportable segments Number of Reportable Segments Per share data: Earnings Per Share [Abstract] Hyper-inflationary economies Hyper-inflationary economies [Policy Text Block] Hyper-inflationary economies policy. Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding September 30, 2023 – 18,000,855 shares; December 31, 2022 – 17,950,264 shares Common Stock, Value, Issued Related tax amounts Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Organization, Consolidation and Presentation of Financial Statements [Abstract] Insurance Claims Insurance Claims [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Net periodic benefit cost (income) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Earnouts Business Combination, Contingent Consideration, Liability Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Assets Related To Sealing And Impregnation Of Metal Castings Assets Related To Sealing And Impregnation Of Metal Castings [Member] Assets Related To Sealing And Impregnation Of Metal Castings Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current fiscal year end date Current Fiscal Year End Date Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Recently Issued Accounting Standards Accounting Standards Update and Change in Accounting Principle [Text Block] Indefinite-lived trademarks Indefinite-Lived Trademarks Number of positions eliminated Restructuring and Related Cost, Number of Positions Eliminated Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Segment operating earnings Operating Income Loss Segment Reporting The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges. Concentration risk (as a percent) Concentration Risk, Percentage Schedule of Product Information [Table] Schedule of Product Information [Table] Asia/Pacific Asia Pacific [Member] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Company-owned life insurance Cash Surrender Value, Fair Value Disclosure Schedule of Goodwill Schedule of Goodwill [Table Text Block] Net unrealized loss deferred to AOCI Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Other Postretirement Benefits Other Postretirement Benefits Plan [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Borrowings on other debt, net Proceeds from Other Debt Italy ITALY Prior service cost (income) amortization Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Accrued compensation Accrued Salaries, Current Other non-operating income, net Other Operating Income (Expense), Net Interest Rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Services transferred over time Transferred over Time [Member] Statement of Financial Position [Abstract] Business Combination and Asset Acquisition [Abstract] Total Quaker shareholders’ equity Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Restricted Stock Restricted Stock [Member] Houghton Environmental Matters Houghton Environmental Matters [Member] Houghton environmental matters. Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Derivative Instruments Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Revision of Prior Period [Domain] Revision of Prior Period [Domain] Defined benefit plan, plan assets, liquidated assets Defined Benefit Plan, Plan Assets, Liquidated Assets Defined Benefit Plan, Invested Assets Other (expense) income, net Other Income and Other Expense Disclosure [Text Block] Restructuring and Related Activities Restructuring and Related Activities Disclosure [Text Block] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Accounting Standards Update and Change in Accounting Principle [Abstract] Accrued pension and postretirement benefits Liability, Defined Benefit Plan, Current Level 2 Fair Value, Inputs, Level 2 [Member] 2023 Grants Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Less: debt issuance costs Debt Issuance Costs, Net Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other non-current Assets Other Noncurrent Assets [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Unrecognized tax benefits, period increase Unrecognized Tax Benefits, Period Increase (Decrease) Document Period Focus Document Fiscal Period Focus For the year ended December 31, 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] For the year ended December 31, 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Share-based compensation Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Foreign Tax Authority Foreign Tax Authority [Member] Defined benefit retirement plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Earnings Per Share Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Mr. Bijlani's Trading Arrangement, Stock Options [Member] Mr. Bijlani's Trading Arrangement, Stock Options Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Property, plant and equipment, net Property, Plant and Equipment, Net Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Depreciation and amortization Results of Operations, Depreciation, Depletion, Amortization and Accretion Other comprehensive loss Amounts reported in other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax assets Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of Assets Subject to Fair Value Measurements Fair Value, Assets Measured on Recurring Basis [Table Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Business Related to Pickling and Rinsing Products and Services Business Related to Pickling and Rinsing Products and Services [Member] Business Related to Pickling and Rinsing Products and Services [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Less: income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Reallocation of reporting units Goodwill, Reallocation of Reporting Units Goodwill, Reallocation of Reporting Units Retained Earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Industrial development bonds Industrial development bonds [Member] Industrial development bonds. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Right of use lease assets Operating Lease, Right-of-Use Asset Current period change in fair value of derivatives Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Argentine and Turkish Subsidiaries Argentine and Turkish Subsidiaries [Member] Argentine and Turkish Subsidiaries Bank lines of credit and other debt obligations Bank lines of credit and other debt obligations [Member] Bank lines of credit and other debt obligations. Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Currency [Axis] Currency [Axis] For the remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Net income available to common shareholders Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Amended Credit Facility Amended Credit Facility [Member] Amended Credit Facility Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Restructuring and related charges (credits), net Restructuring and related charges (credits), net Restructuring and related (charges) credits, net Restructuring and related charges, net Restructuring Charges Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Purchase accounting adjustments Goodwill, Purchase Accounting Adjustments Interest expense, net Interest Expense [Member] Estimated future PSUs issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Estimated Future Grants Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Estimated Future Grants Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Equity in undistributed earnings of associated companies, net of dividends Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Depreciation of corporate assets and amortization Other Depreciation and Amortization Americas Americas [Member] Vesting shares target lower (as a percent) Vesting Shares Target Lower Percent Vesting Shares Target Lower Percent Less: short-term and current portion of long-term debts Short-Term Debt Assets Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Non-operating and administrative expenses Nonoperating Charges The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment. Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net income to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Maximum increase in borrowing capacity Maximum increase in borrowing capacity Maximum increase in borrowing capacity Metals Metals [Member] Metals product line. All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Tax settlement final amount due to tax authorities Tax Settlement Final Amount Due To Tax Authorities Tax Settlement Final Amount Due To Tax Authorities Less: Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Restructuring Plan [Axis] Restructuring Plan [Axis] Statement of Comprehensive Income [Abstract] (Loss) gain on disposals of property, plant, equipment and other assets, net Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Business Related To Pickling Inhibitor Technologies Business Related To Pickling Inhibitor Technologies [Member] Assets Related To Pickling Inhibitor Technologies Short-term borrowings and current portion of long-term debt Debt, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current For the year ended December 31, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Insider Trading Arrangements [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Deferred revenue Deferred Revenue Accrued restructuring Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements U.S. Term Loan Amended U.S. Term Loan [Member] Amended U.S. Term Loan Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] For the year ended December 31, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Proceeds from disposition of assets Proceeds from Sale of Property, Plant, and Equipment Noncontrolling interest Equity, Attributable to Noncontrolling Interest Cash payments Payments for Restructuring Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Debt related expenses included within Interest expense: Interest and Debt Expense [Abstract] Payments of long-term debt Repayments of Long-Term Debt Entity central index key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total share-based compensation expense Share-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Taxes on income before equity in net income of associated companies Income Tax Expense (Benefit) Income Tax Authority [Domain] Income Tax Authority [Domain] Fair Value Measurements Fair Value Disclosures [Text Block] Sales Revenue Net Revenue Benchmark [Member] Name Trading Arrangement, Individual Name Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Loss on extinguishment of debt Deferred Debt Issuance Cost, Writeoff Real estate, held-for-sale Real Estate, Held-for-Sale Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Euro Term Loan Amended EURO Term Loan [Member] Amended EURO Term Loan Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment flag Amendment Flag Actuarial loss (gain) amortization Defined Benefit Plan, Amortization of Gain (Loss) Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Payments related to acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Interest expense, net Interest Income (Expense), Net Proceeds from insurance settlement Proceeds from Insurance Settlement, Operating Activities Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Director stock ownership plan Directors Stock Ownership Plan Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan. Long-term debt term (in years) Long-Term Debt, Term Long-term debt Long-Term Debt, Excluding Current Maturities Revenue recognized under net reporting arrangements Net Reporting Amount Amount recognized as revenue under net reporting arrangements Diluted weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Assets Total Assets, Total [Member] Pension and postretirement benefit (costs) income, non-service components Pension And Postretirement Benefit Income, Non-Service Components Other income related to non-service pension cost components Share issuance and equity-based compensation plans Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture Net Sales and Revenue Recognition Revenue from Contract with Customer [Text Block] Investments in property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Capital in excess of par value Additional Paid in Capital, Common Stock Capital in Excess of Par Value Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Lease, Cost [Abstract] Lease, Cost [Abstract] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Equity in net income (loss) of associated companies Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Cover [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs Number of locations that suffered property damage Loss Contingency, Locations Damaged, Number Loss Contingency, Locations Damaged, Number Restructuring and Related Activities [Abstract] Other non-current liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Total lease payments Lessee, Operating Lease, Liability, to be Paid Raw materials and supplies Inventory, Raw Materials and Supplies, Gross Long-term debt, weighted average interest rate, over time (as a percent) Long-Term Debt, Weighted Average Interest Rate, over Time Houghton Houghton [Member] Business combination of Houghton. Pension Benefits Pension Plan [Member] Asset acquisition, consideration transferred Asset Acquisition, Consideration Transferred Business Segments Segment Reporting Disclosure [Text Block] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Derivative variable interest rate (as a percent) Derivative, Variable Interest Rate Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Income before taxes and equity in net income of associated companies Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Stock options Stock Options Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan. Largest Customers Largest customer [Member] Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues. Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating income Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenues [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Original Credit Facility and the Amended Credit Facility Original Credit Facility and the Amended Credit Facility [Member] Original Credit Facility and the Amended Credit Facility Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Product Information [Line Items] Product Information [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of Debt Schedule of Debt [Table Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Borrowings outstanding Long-Term Line of Credit Amount received from an escrow Increase (Decrease) in Deposit Assets Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Supplemental balance sheet information Supplemental balance sheet information Supplemental balance sheet information Metalworking and other Metalworking and Other [Member] Metals product line. Noncontrolling Interest Noncontrolling Interest [Member] EX-101.PRE 10 kwr-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
 9 Months Ended
Sep. 30, 2023
Oct. 31, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-12019  
Entity Registrant Name QUAKER CHEMICAL CORPORATION  
Entity Incorporation, State or Country Code PA  
Entity Tax Identification Number 23-0993790  
Entity Address, Address Line One 901 E. Hector Street  
Entity Address, City or Town Conshohocken  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19428 – 2380  
City Area Code 610  
Local Phone Number 832-4000  
Title of 12(b) Security Common Stock, $1 par value  
Trading Symbol KWR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   17,984,916
Entity central index key 0000081362  
Current fiscal year end date --12-31  
Document Fiscal Year Focus 2023  
Document Period Focus Q3  
Amendment flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 490,612 $ 492,218 $ 1,486,204 $ 1,458,777
Cost of goods sold (excluding amortization expense - See Note 13) 307,265 331,469 951,716 1,002,393
Gross profit 183,347 160,749 534,488 456,384
Selling, general and administrative expenses 122,810 115,456 362,212 343,081
Restructuring and related charges (credits), net 1,019 (1,423) 6,034 (604)
Combination, integration and other acquisition-related expenses 0 2,107 0 7,992
Operating income 59,518 44,609 166,242 105,915
Other (expense) income, net (2,713) 85 (8,558) (10,520)
Interest expense, net (12,781) (8,389) (38,744) (20,228)
Income before taxes and equity in net income of associated companies 44,024 36,305 118,940 75,167
Taxes on income before equity in net income of associated companies 13,593 10,185 36,956 14,425
Income before equity in net income of associated companies 30,431 26,120 81,984 60,742
Equity in net income (loss) of associated companies 3,279 (212) 10,660 (642)
Net income 33,710 25,908 92,644 60,100
Less: Net income attributable to noncontrolling interest 40 41 94 74
Net income attributable to Quaker Chemical Corporation $ 33,670 $ 25,867 $ 92,550 $ 60,026
Per share data:        
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 1.87 $ 1.44 $ 5.15 $ 3.35
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) 1.87 1.44 5.14 3.35
Dividends declared (in dollars per share) $ 0.455 $ 0.435 $ 1.325 $ 1.265
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income $ 33,710 $ 25,908 $ 92,644 $ 60,100
Other comprehensive (loss) income, net of tax        
Currency translation adjustments (25,504) (71,986) (24,116) (155,284)
Defined benefit retirement plans 281 497 852 2,400
Current period change in fair value of derivatives 1,241 (140) 5,804 1,535
Unrealized (loss) gain on available-for-sale securities (637) (818) 938 (2,385)
Other comprehensive loss (24,619) (72,447) (16,522) (153,734)
Comprehensive income (loss) 9,091 (46,539) 76,122 (93,634)
Less: Comprehensive loss attributable to noncontrolling interest (36) (3) (55) (5)
Comprehensive income (loss) attributable to Quaker Chemical Corporation $ 9,055 $ (46,542) $ 76,067 $ (93,639)
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 198,358 $ 180,963
Accounts receivable, net 446,459 472,888
Inventories    
Raw materials and supplies 129,204 151,105
Work-in-process and finished goods 121,566 133,743
Prepaid expenses and other current assets 70,724 55,438
Total current assets 966,311 994,137
Property, plant and equipment, at cost 431,565 428,190
Less: Accumulated depreciation (235,125) (229,595)
Property, plant and equipment, net 196,440 198,595
Right of use lease assets 38,595 43,766
Goodwill 504,457 515,008
Other intangible assets, net 890,464 942,925
Investments in associated companies 92,965 88,234
Deferred tax assets 9,569 11,218
Other non-current assets 33,705 27,739
Total assets 2,732,506 2,821,622
Current liabilities    
Short-term borrowings and current portion of long-term debt 19,246 19,245
Accounts payable 190,067 193,983
Dividends payable 8,190 7,808
Accrued compensation 43,641 39,834
Accrued restructuring 3,590 5,483
Accrued pension and postretirement benefits 1,574 1,560
Other accrued liabilities 85,799 86,873
Total current liabilities 352,107 354,786
Long-term debt 804,973 933,561
Long-term lease liabilities 22,163 26,967
Deferred tax liabilities 151,606 160,294
Non-current accrued pension and postretirement benefits 27,344 28,765
Other non-current liabilities 33,212 38,664
Total liabilities 1,391,405 1,543,037
Commitments and contingencies (Note 18)
Equity    
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding September 30, 2023 – 18,000,855 shares; December 31, 2022 – 17,950,264 shares 18,001 17,950
Capital in excess of par value 938,473 928,288
Retained earnings 538,628 469,920
Accumulated other comprehensive loss (154,724) (138,240)
Total Quaker shareholders’ equity 1,340,378 1,277,918
Noncontrolling interest 723 667
Total equity 1,341,101 1,278,585
Total liabilities and equity $ 2,732,506 $ 2,821,622
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 1 $ 1
Common stock, shares authorized (in shares) 30,000,000 30,000,000
Common stock, shares issued (in shares) 18,000,855 17,950,264
Common stock, shares outstanding (in shares) 18,000,855 17,950,264
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income $ 92,644 $ 60,100
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Amortization of debt issuance costs 1,059 2,589
Depreciation and amortization 61,434 60,692
Equity in undistributed earnings of associated companies, net of dividends (7,486) 3,612
Deferred compensation, deferred taxes and other, net (515) (8,844)
Share-based compensation 11,189 8,635
Loss on extinguishment of debt 0 5,246
Combination and other acquisition-related expenses, net of payments 0 (4,265)
Restructuring and related charges (credits), net 6,034 (604)
Pension and other postretirement benefits (2,000) (6,556)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable 22,133 (65,256)
Inventories 30,607 (72,386)
Prepaid expenses and other current assets (9,771) (11,081)
Change in restructuring liabilities (7,914) (1,234)
Accounts payable and accrued liabilities 2,046 3,059
Net cash provided by (used in) operating activities 199,460 (26,293)
Cash flows from investing activities    
Investments in property, plant and equipment (25,794) (20,230)
Payments related to acquisitions, net of cash acquired 0 (9,421)
Proceeds from disposition of assets 0 65
Net cash used in investing activities (25,794) (29,586)
Cash flows from financing activities    
Payments of long-term debt (14,075) (668,500)
Proceeds from long-term debt 0 750,000
Payments on revolving credit facilities, net (112,835) (10,418)
Borrowings on other debt, net 797 2,131
Financing-related debt issuance costs 0 (3,734)
Dividends paid (23,459) (22,302)
Other stock related activity (953) (616)
Net cash (used in) provided by financing activities (150,525) 46,561
Effect of foreign exchange rate changes on cash (5,746) (16,967)
Net increase (decrease) in cash and cash equivalents 17,395 (26,285)
Cash and cash equivalents at the beginning of the period 180,963 165,176
Cash and cash equivalents at the end of the period $ 198,358 $ 138,891
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance at Dec. 31, 2021 $ 1,387,922 $ 17,897 $ 917,053 $ 516,334 $ (63,990) $ 628
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 19,821     19,816   5
Amounts reported in other comprehensive (loss) income (6,270)       (6,271) 1
Dividends declared (7,434)     (7,434)    
Share issuance and equity-based compensation plans 1,661 15 1,646      
Ending balance at Mar. 31, 2022 1,395,700 17,912 918,699 528,716 (70,261) 634
Beginning balance at Dec. 31, 2021 1,387,922 17,897 917,053 516,334 (63,990) 628
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 60,100          
Amounts reported in other comprehensive (loss) income (153,734)          
Ending balance at Sep. 30, 2022 1,279,630 17,931 925,037 553,685 (217,655) 632
Beginning balance at Mar. 31, 2022 1,395,700 17,912 918,699 528,716 (70,261) 634
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 14,371     14,343   28
Amounts reported in other comprehensive (loss) income (75,018)       (74,985) (33)
Dividends declared (7,438)     (7,438)    
Share issuance and equity-based compensation plans 2,951 8 2,943      
Ending balance at Jun. 30, 2022 1,330,566 17,920 921,642 535,621 (145,246) 629
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 25,908     25,867   41
Amounts reported in other comprehensive (loss) income (72,447)       (72,409) (38)
Dividends declared (7,803)     (7,803)    
Share issuance and equity-based compensation plans 3,406 11 3,395      
Ending balance at Sep. 30, 2022 1,279,630 17,931 925,037 553,685 (217,655) 632
Beginning balance at Dec. 31, 2022 1,278,585 17,950 928,288 469,920 (138,240) 667
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 29,541     29,534   7
Amounts reported in other comprehensive (loss) income 15,066       15,063 3
Dividends declared (7,822)     (7,822)    
Share issuance and equity-based compensation plans 1,418 32 1,386      
Ending balance at Mar. 31, 2023 1,316,788 17,982 929,674 491,632 (123,177) 677
Beginning balance at Dec. 31, 2022 1,278,585 17,950 928,288 469,920 (138,240) 667
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 92,644          
Amounts reported in other comprehensive (loss) income (16,522)          
Ending balance at Sep. 30, 2023 1,341,101 18,001 938,473 538,628 (154,724) 723
Beginning balance at Mar. 31, 2023 1,316,788 17,982 929,674 491,632 (123,177) 677
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 29,393     29,346   47
Amounts reported in other comprehensive (loss) income (6,969)       (6,931) (38)
Dividends declared (7,830)     (7,830)    
Share issuance and equity-based compensation plans 5,284 17 5,267      
Ending balance at Jun. 30, 2023 1,336,666 17,999 934,941 513,148 (130,108) 686
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 33,710     33,670   40
Amounts reported in other comprehensive (loss) income (24,619)       (24,616) (3)
Dividends declared (8,190)     (8,190)    
Share issuance and equity-based compensation plans 3,534 2 3,532      
Ending balance at Sep. 30, 2023 $ 1,341,101 $ 18,001 $ 938,473 $ 538,628 $ (154,724) $ 723
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Equity (Parentheticals) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]                
Dividends declared (in dollars per share) $ 0.455 $ 0.435 $ 0.435 $ 0.435 $ 0.415 $ 0.415 $ 1.325 $ 1.265
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Description of Business
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Description of Business Basis of Presentation and Description of Business
As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires. The “Combination” refers to the legacy Quaker combination with Houghton International, Inc. (“Houghton”).
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments, which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company’s business structure as of January 1, 2023, including reportable segments and customer industry disaggregation. As a result of the Company’s new organizational structure effective January 1, 2023, the Company reallocated goodwill previously held by the former Global Specialty Businesses segment to the remaining business segments as of January 1, 2023. However, the Company did not recast the carrying amount of goodwill for the year ended December 31, 2022. See Notes 4, 5, and 13 of Notes to Condensed Consolidated Financial Statements.
Description of Business
The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as “FluidcareTM”, for various heavy industrial and manufacturing applications.
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three and nine months ended September 30, 2023, the Company's Argentine and Turkish subsidiaries represented a combined 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2023, the Company recorded $1.2 million and $2.9 million of remeasurement losses associated with the applicable currency conversions, respectively. Comparatively, during the three and nine months ended September 30, 2022, the Company recorded $1.0 million and $1.2 million of remeasurement losses associated with the applicable currency conversions, respectively. These losses were recorded within foreign exchange losses, net, which is a component of Other (expense) income, net, in the Company’s Condensed Consolidated Statements of Operations.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Business Acquisitions
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Acquisitions Business Acquisitions
Previous Acquisitions
In October 2022, the Company acquired a business that provides pickling and rinsing products and services, which is part of the EMEA reportable segment, for approximately 3.5 million EUR or approximately $3.5 million. This acquisition, along with the Company’s January 2022 acquisition in the Americas (described below), which had similar specializations and product offerings in pickling inhibitor technologies, strengthens Quaker Houghton’s position in pickling inhibitors and additives, enabling the Company to better support and optimize production processes for customers across the metals industry. As of September 30, 2023, the allocation of the purchase of this acquisition has been finalized.
In January 2022, the Company acquired a business that provides pickling inhibitor technologies, drawing lubricants and stamping oil, and various other lubrication, rust preventative, and cleaner applications, which is part of the Americas reportable segment, for approximately $8.0 million. This business broadens the Company’s product offerings within its existing metals and metalworking business in the Americas region. During the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company paying less than $0.1 million of additional purchase consideration. Also in January 2022, the Company acquired a business related to the sealing and impregnation of metal castings for the automotive sector, as well as impregnation resin and impregnation systems for metal parts, which is part of the EMEA reportable segment, for approximately 1.2 million EUR or approximately $1.4 million. This business broadens its product offerings and service capabilities within its existing impregnation business. The allocation of the purchase prices of both of these January 2022 acquisitions have been finalized.
In November 2021, the Company acquired Baron Industries, a privately held company that provides vacuum impregnation services of castings, powder metals and electrical components for its Americas reportable segment for $11.0 million, including an initial cash payment of $7.1 million, subject to post-closing adjustments, as well as certain earn-out provisions that are payable at various times from 2022 through 2025. The earn-out provisions could total a maximum of $4.5 million. As of September 30, 2023, the Company has remaining earn-out liabilities recorded on its Condensed Consolidated Balance Sheet of $1.1 million. Additionally, during the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company receiving a payment of less than $0.1 million.
In December 2020, the Company acquired Coral Chemical Company, LLC (“Coral”), a privately held U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. During the first nine months of 2023, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Recently Issued Accounting Standards
 9 Months Ended
Sep. 30, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]  
Recently Issued Accounting Standards Recently Issued Accounting Standards There have been no recently issued accounting standards that will have a material impact on the Company’s condensed consolidated financial statements and related footnote disclosures.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments
 9 Months Ended
Sep. 30, 2023
Segment Reporting, Measurement Disclosures [Abstract]  
Business Segments Business Segments
The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region. All prior period information has been recast to reflect the Company’s new reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.
Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”) and Selling, general and administrative expenses (“SG&A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges (credits), net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other (expense) income, net.
The following table presents information about the performance of the Company’s reportable segments:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net sales
Americas$245,899 $254,678 $750,531 $702,580 
EMEA139,620 134,386 435,602 426,739 
Asia/Pacific105,093 103,154 300,071 329,458 
Total net sales$490,612 $492,218 $1,486,204 $1,458,777 
Segment operating earnings
Americas$69,148 $66,749 $204,280 $164,065 
EMEA27,922 15,479 81,076 58,803 
Asia/Pacific30,963 26,723 86,604 76,146 
Total segment operating earnings128,033 108,951 371,960 299,014 
Combination, integration and other acquisition-related expenses— (2,107)— (7,992)
Restructuring and related (charges) credits, net(1,019)1,423 (6,034)604 
Non-operating and administrative expenses(52,280)(47,852)(154,001)(139,894)
Depreciation of corporate assets and amortization(15,216)(15,806)(45,683)(45,817)
Operating income59,518 44,609 166,242 105,915 
Other (expense) income, net(2,713)85 (8,558)(10,520)
Interest expense, net(12,781)(8,389)(38,744)(20,228)
Income before taxes and equity in net income of associated companies$44,024 $36,305 $118,940 $75,167 
The following table summarizes inter-segment revenues. All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Americas$1,772 $2,702 $6,778 $9,200 
EMEA5,161 9,448 18,718 37,259 
Asia/Pacific793 327 1,329 739 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Net Sales and Revenue Recognition
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Net Sales and Revenue Recognition Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s FluidcareTM business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $21.6 million and $63.2 million for the three and nine months ended September 30, 2023, respectively, and $21.4 million and $61.7 million for the three and nine months ended September 30, 2022, respectively.
Customer Concentration
A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2022 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 11% of consolidated net sales, with its largest customer accounting for approximately 3% of consolidated net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of September 30, 2023 or December 31, 2022.
The Company had approximately $2.8 million and $5.7 million of deferred revenue as of September 30, 2023 and December 31, 2022, respectively. For the nine months ended September 30, 2023, the Company satisfied all of the associated performance obligations and recognized into revenue the advance payments received and recorded as of December 31, 2022.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.
The following tables disaggregate the Company’s net sales by geographic region, customer industries, and timing of revenue recognized. Prior period information has been recast to reflect the Company’s current period customer industry disaggregation. See Note 1 of Notes to Condensed Consolidated Financial Statements.
Three Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,957 $32,630 $49,320 $149,907 
Metalworking and other177,942 106,990 55,773 340,705 
$245,899 $139,620 $105,093 $490,612 
Timing of Revenue Recognized
Product sales at a point in time$235,209 $128,586 $102,305 $466,100 
Services transferred over time10,690 11,034 2,788 24,512 
$245,899 $139,620 $105,093 $490,612 
Nine Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$204,834 $104,376 $144,109 $453,319 
Metalworking and other545,697 331,226 155,962 1,032,885 
$750,531 $435,602 $300,071 $1,486,204 
Timing of Revenue Recognized
Product sales at a point in time$718,187 $402,508 $291,740 $1,412,435 
Services transferred over time32,344 33,094 8,331 73,769 
$750,531 $435,602 $300,071 $1,486,204 
Three Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,943 $32,748 $51,341 $152,032 
Metalworking and other186,735 101,638 51,813 340,186 
$254,678 $134,386 $103,154 $492,218 
Timing of Revenue Recognized
Product sales at a point in time$243,699 $124,566 $99,929 $468,194 
Services transferred over time10,979 9,820 3,225 24,024 
$254,678 $134,386 $103,154 $492,218 
Nine Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$185,784 $107,163 $163,239 $456,186 
Metalworking and other516,796 319,576 166,219 1,002,591 
$702,580 $426,739 $329,458 $1,458,777 
Timing of Revenue Recognized
Product sales at a point in time$669,945 $396,944 $321,031 $1,387,920 
Services transferred over time32,635 29,795 8,427 70,857 
$702,580 $426,739 $329,458 $1,458,777 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Leases
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases Leases
The Company has operating leases for certain facilities, vehicles and machinery and equipment with remaining lease terms up to 8 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 92 years.
The Company had no material variable lease costs, sublease income, or finance leases for the three and nine months ended September 30, 2023 and 2022. The components of the Company’s lease expense are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Operating lease expense$3,886 $3,664 $11,532 $10,592 
Short-term lease expense193 201 587 625 
Supplemental cash flow information related to the Company’s leases is as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,917 $3,768 $11,547 $10,575 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities2,910 2,599 6,566 10,672 
Supplemental balance sheet information related to the Company’s leases is as follows:
September 30,
2023		December 31,
2022
Right of use lease assets$38,595 $43,766 
Other current liabilities12,113 12,024 
Long-term lease liabilities22,163 26,967 
Total operating lease liabilities$34,276 $38,991 
Weighted average remaining lease term (years)4.825.10
Weighted average discount rate4.67 %4.36 %
Maturities of operating lease liabilities were as follows:
September 30,
2023
For the remainder of 2023$3,691 
For the year ended December 31, 202412,589 
For the year ended December 31, 20258,417 
For the year ended December 31, 20266,286 
For the year ended December 31, 20273,051 
For the year ended December 31, 2028 and beyond5,614 
Total lease payments39,648 
Less: imputed interest(5,372)
Present value of lease liabilities$34,276 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring and Related Activities
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Restructuring and Related Activities
In the third quarter of 2019, the Company’s management approved a global restructuring plan (the “QH Program”) as part of its initial plan to realize certain cost synergies associated with the Combination. As of December 31, 2022, the Company substantially completed all of the initiatives under the QH Program with only an immaterial amount of remaining severance still to be paid, which has been paid as of September 30, 2023.
In the fourth quarter of 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of September 30, 2023, the program included restructuring and associated severance costs to reduce headcount by approximately 100 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to continue throughout 2023. The exact timing to complete all actions and final costs associated will depend on a number of factors that are subject to change.
Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. Restructuring costs include severance costs to reduce headcount, including customary and routine adjustments to initial estimates for employee separation costs, as well as costs to close certain facilities under the QH Program. These costs are recorded in Restructuring and related charges in the Company’s Consolidated Statements of Operations. As described in Note 4 of Notes to Consolidated Financial Statements, Restructuring and related charges are not included in the Company’s calculation of reportable segments’ measure of operating earnings and therefore these costs are not reviewed by or recorded to reportable segments.
In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. During the three months ended September 30, 2023, the Company classified certain properties with aggregate book value of approximately $6.9 million as held-for-sale that are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.
Changes in the Company’s accruals for its restructuring programs are as follows:
Restructuring Programs
Accrued restructuring as of December 31, 2022$5,483
Restructuring and related charges, net6,034 
Cash payments(7,914)
Currency translation adjustments(13)
Accrued restructuring as of September 30, 2023$3,590
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Stock options$203$533$837$1,269
Non-vested stock awards and restricted stock units2,4291,7837,1924,998
Director stock ownership plan3095653
Performance stock units1,1138753,1042,314
Total share-based compensation expense$3,775$3,200$11,189$8,634
Share-based compensation expense is recorded in SG&A, except for $0.1 million and $0.2 million for the three and nine months ended September 30, 2022, respectively, recorded within Combination, integration and other acquisition-related expenses.
Stock Options
As of September 30, 2023, unrecognized compensation expense related to unvested stock options was $0.5 million, to be recognized over a weighted average remaining period of 0.9 years.
Restricted Stock Awards and Restricted Stock Units
During the nine months ended September 30, 2023, the Company granted 38,894 non-vested restricted shares and 6,675 non-vested restricted stock units under its long-term incentive plan (“LTIP”), which are subject to time-based vesting, generally over one to three years. The fair value of these grants is based on the last sale price of the Company’s common stock on the date of grant. As of September 30, 2023, unrecognized compensation expense related to the non-vested restricted shares was $8.0 million, to be recognized over a weighted average remaining period of 1.4 years, and unrecognized compensation expense related to non-vested restricted stock units was $1.6 million, to be recognized over a weighted average remaining period of 1.5 years.
Performance Stock Units
As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”), which will be settled in a certain number of shares subject to market-based or performance-based and time-based vesting conditions. The number of fully vested shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of the Company’s peer group, the S&P Midcap 400 Materials group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service period required for the PSUs is generally three years and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.
Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. The fair value of PSUs granted with a ROIC condition is based on the trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation, which included the following assumptions set forth in the table below:
2023
Grants
Number of PSUs granted16,861
Risk-free interest rate3.85%
Dividend yield0.96%
Expected term (years)3.0
Based on the conditions of the PSUs and performance to date for each of the outstanding PSU awards as of September 30, 2023, the Company estimates that it will issue 25,613 fully vested shares as of the applicable settlement date for such outstanding PSUs awards. As of September 30, 2023, there was approximately $8.0 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.2 years.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Pension and Other Postretirement Benefits
 9 Months Ended
Sep. 30, 2023
Retirement Benefits, Description [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
The components of net periodic benefit cost (income) are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Pension BenefitsOther Postretirement BenefitsPension BenefitsOther Postretirement Benefits
20232022202320222023202220232022
Service cost$109$166$—$1 $320$520$—$1
Interest cost2,4871,272148 7,4523,9495119
Expected return on plan assets(2,033)(1,942)——(6,056)(6,038)——
Actuarial loss (gain) amortization103238(36)(23)308743(95)(70)
Prior service cost (income) amortization183(4)(8)268(12)(17)
Net periodic benefit cost (income)$684 $(263)$(26)$(22)$2,050 $(818)$(56)$(67)
In July 2023, one of the Company’s pension plans in the U.K. liquidated approximately $50 million of its invested assets and subsequently funded and entered into an insurance annuity contract, which will provide for the pension plan’s defined benefit obligations to participants.
Employer Contributions
As of September 30, 2023, $3.4 million and $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.2 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2023.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Other (expense) income, net
 9 Months Ended
Sep. 30, 2023
Other Income and Expenses [Abstract]  
Other (expense) income, net Other (expense) income, net
The components of Other (expense) income, net are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Income from third party license fees$245$253$891$906
Foreign exchange losses, net(2,498)(1,928)(10,049)(5,859)
(Loss) gain on disposals of property, plant, equipment and other assets, net(25)48 (91)33
Non-income tax refunds and other related credits (expense)911221,339 (1,617)
Pension and postretirement benefit (costs) income, non-service components(549)452(1,674)1,406
Facility remediation recoveries, net—1,1041,0141,104
Loss on extinguishment of debt——— (6,763)
Other non-operating income, net233412270
Total other (expense) income, net$(2,713)$85$(8,558)$(10,520)
Non-income tax refunds and other related credits (expense) during the nine months ended September 30, 2023 and nine months ended September 30, 2022 include adjustments to a Combination-related indemnification asset associated with the settlement of certain income tax audits for tax periods prior to August 1, 2019. See Note 11 of Notes to Condensed Consolidated Financial Statements.
Facility remediation recoveries, net, during the nine months ended September 30, 2023 and the three and nine months ended September 30, 2022, reflect gains recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage incurred during the three months ended September 30, 2021. See Note 18 of Notes to the Condensed Consolidated Financial Statements.
Loss on extinguishment of debt during the nine months ended September 30, 2022, represents a write-off of certain previously unamortized deferred financing costs as well as a portion of third party and creditor debt issuance costs incurred to execute an amendment to the Company’s primary credit facility. See Note 14 of Notes to Condensed Consolidated Financial Statements.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes and Uncertain Income Tax Positions
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes and Uncertain Income Tax Positions Income Taxes and Uncertain Income Tax PositionsThe Company’s effective tax rates for the three and nine months ended September 30, 2023 were 30.9% and 31.1%, respectively, compared to 28.1% and 19.2% for the three and nine months ended September 30, 2022, respectively. The Company’s effective tax rate for the three months ended September 30, 2023 was primarily impacted by foreign tax inclusions, withholding taxes, return to provision adjustments, the impact of U.S. Department of Treasury guidance on the usage of foreign tax credits, and the mix of earnings. The effective tax rate for the first nine months of 2023 was further impacted by various other items including changes to the valuation allowance for and the usage of foreign tax credits due to an enacted law change in Brazil, and share-based compensation. Comparatively, the prior year effective tax rates were largely impacted by foreign tax inclusions, changes in the valuation allowance for foreign tax credits, the impact of audit settlements, a reduction in reserves for uncertain tax positions, withholding taxes, and the impact of forecasted earnings and the mix of such earnings. In addition, the Company’s effective tax rates for three and nine months ended September 30, 2022 were impacted by the Company recording earnings of one of its subsidiaries at a statutory tax rate of 25% while the recertification of its concessionary 15% tax rate was pending receipt.As previously reported, Houghton Italia, S.r.l was involved in a corporate income tax audit with the Italian tax authorities covering tax years 2014 through 2018. The Company settled all years 2014 through 2018 for $3.7 million and, accordingly, released all reserves relating to this audit for the settled tax years during the first quarter of 2022. The settlement is to be paid via installments through 2026 and, through September 30, 2023, the Company has paid $1.5 million of such installments. Having received approximately $1.2 million from escrow during the quarter, the Company has a remaining indemnification receivable of $3.2 million in connection with its claim against the former owners of Houghton for any pre-Combination tax liabilities arising from this matter, as well as other audit settlements and tax matters. In the first quarter of 2023, the Company was notified by the Spanish tax authorities of audits to commence for several of its legal entities operating in Spain and spanning tax years 2018 through 2021. In addition, in July 2023, the Company was notified by the Italian tax authorities of an audit to commence for one of the Company’s Italian subsidiaries for tax year 2019. Both of these audit proceedings are ongoing and the Company has been providing documentation in response to all of their inquiries. The Company has not established any reserves for these matters at this time.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table summarizes earnings per share calculations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Basic earnings per common share$1.87 $1.44 $5.15 $3.35 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Effect of dilutive securities12,52012,56616,70915,465
Diluted weighted average common shares outstanding17,921,27417,859,87117,906,15317,851,441
Diluted earnings per common share$1.87 $1.44 $5.14 $3.35 
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 11,598 and 10,453 for the three and nine months ended September 30, 2023, respectively, and 25,896 and 24,618 for the three and nine months ended September 30, 2022, respectively.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment. The Company continually evaluates financial performance, economic conditions and other recent developments, including rising interest rates and the cost of capital among other factors, in assessing if a triggering event indicates that the carrying values of goodwill, indefinite-lived, or long-lived assets are impaired. The Company concluded that during the third quarter the ongoing financial, economic or geopolitical conditions did not represent a triggering event.
In connection with the Company’s reorganization and the associated change in reportable segments and reporting units during the first quarter of 2023, the Company performed the required impairment assessments directly before and immediately after the change in reporting units and concluded that it was not more likely than not that the fair values of any of the Company’s previous or new reporting units were less than their respective carrying amounts.
Changes in the carrying amount of goodwill were as follows. Prior period information has been recast to reflect the Company’s current period reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.
AmericasEMEAAsia/PacificGlobal
Specialty
Businesses		Total
Balance as of December 31, 2022$215,899$34,567$150,375$114,167$515,008
Reallocation of reporting units63,697 31,711 18,759 (114,167)—
Balance as of January 1, 2023279,596 66,278 169,134 — 515,008 
Currency translation adjustments2,561 (805)(12,307)— (10,551)
Balance as of September 30, 2023$282,157$65,473$156,827$—$504,457
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
September 30, 2023December 31, 2022September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Customer lists and rights to sell$824,893$831,600$226,956$191,286$597,937$640,314
Trademarks, formulations and product technology157,362158,56452,53446,281104,828112,283
Other5,8547,5765,7346,3901201,186
Total definite-lived intangible assets$988,109$997,740$285,224$243,957$702,885$753,783
The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Amortization expense$14,529 $14,102 $43,734 $43,343 
Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows:
For the remainder of 2023$13,455
For the year ended December 31, 202456,630
For the year ended December 31, 202555,942
For the year ended December 31, 202655,650
For the year ended December 31, 202755,309
As of September 30, 2023 and December 31, 2022, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $187.6 million and $189.1 million, respectively.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Debt
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Debt Debt
The following table sets forth the components of the Company’s debt:
As of September 30, 2023As of December 31, 2022
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver6.0%$82,838 5.2%$195,673 
U.S. Term Loan6.7%585,000 5.7%596,250 
Euro Term Loan5.0%146,918 3.1%151,572 
Industrial development bonds5.3%10,000 5.3%10,000 
Bank lines of credit and other debt obligationsVarious1,120 Various1,303 
Total debt$825,876 $954,798 
Less: debt issuance costs(1,657)(1,992)
Less: short-term and current portion of long-term debts(19,246)(19,245)
Total long-term debt$804,973 $933,561 
Credit facilitiesDuring June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.
As of September 30, 2023, the Company was in compliance with all of the Credit Facility covenants. See Note 20 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K.
The weighted average variable interest rates incurred on the outstanding borrowings under the Credit Facility during the three and nine months ended September 30, 2023 were approximately 6.4% and 6.1%, respectively. As of September 30, 2023, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.3%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $414 million, which is net of bank letters of credit of approximately $3 million, as of September 30, 2023.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of September 30, 2023, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of September 30, 2023, the Company had $1.7 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $3.6 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2022, the Company had $2.0 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $4.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet.
Industrial development bonds
As of September 30, 2023 and December 31, 2022, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of September 30, 2023 was approximately $34 million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of September 30, 2023 were approximately $5 million.
Interest expense, net
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest expense$12,598 $9,465 $40,863 $20,339 
Amortization of debt issuance costs353 353 1,059 2,589 
Total$12,951 $9,818 $41,922 $22,928 
Based on the variable interest rates associated with the Credit Facility, as of September 30, 2023 and as of December 31, 2022, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Income
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance at June 30, 2023$(130,738)$(4,024)$91 $4,563 $(130,108)
Other comprehensive (loss) income before Reclassifications(25,501)304 (802)1,612 (24,387)
Amounts reclassified from AOCI— 71 (4)67 
Related tax amounts— (94)169 (371)(296)
Balance at September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance at June 30, 2022$(133,110)$(11,269)$(1,170)$303 $(145,246)
Other comprehensive (loss) income before Reclassifications(71,948)453 (1,006)(182)(72,683)
Amounts reclassified from AOCI— 210 (30)— 180 
Related tax amounts— (166)218 42 94 
Balance at September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before reclassifications(24,078)915 640 7,538 (14,985)
Amounts reclassified from AOCI— 225 547 772 
Related tax amounts— (288)(249)(1,734)(2,271)
Balance as of September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance as of December 31, 2021$(49,843)$(13,172)$397 $(1,372)$(63,990)
Other comprehensive (loss) income before reclassifications(155,215)2,535 (3,326)1,993 (154,013)
Amounts reclassified from AOCI— 657 306 — 963 
Related tax amounts— (792)635 (458)(615)
Balance as of September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
All reclassifications related to unrealized (loss) gain in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other comprehensive income for noncontrolling interest are related to currency translation adjustments.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company has valued its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. The fair values of Company-owned life insurance assets are based on quotes for like instruments with similar credit ratings and terms. These assets are subject to fair value measurement as follows:
Total
Fair Value		Fair Value Measurements as of September 30, 2023
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$285 $— $285 $— 
Total$285 $— $285 $— 
Total
Fair Value		Fair Value Measurements as of December 31, 2022
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$2,114 $— $2,114 $— 
Total$2,114 $— $2,114 $— 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Hedging Activities
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Activities Hedging ActivitiesThe Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.
Foreign Exchange Forward Contracts
A significant portion of the Company’s revenues and earnings are generated by its foreign operations. These foreign operations also represent a significant portion of the Company’s assets and liabilities. Generally, all of these foreign operations use the local currency as their functional currency and many have operations in currencies other than their functional currency, which creates foreign exchange risk. The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other (expense) income, net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments.
All open foreign exchange forward contracts as of September 30, 2023 were entered into as hedges against the U.S. dollar. As of September 30, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar value of the following:
CurrencySeptember 30,
2023
Mexican Peso$41,900 
Japanese Yen4,500 
$46,400 
Open foreign exchange forward contracts as of September 30, 2023 had maturities occurring over a period of one month.
Interest Rate Swaps
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements.
These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur. Interest rate swaps are entered into with a limited number of counterparties within several tranches, each of which allows for net settlement of all contracts through a single payment to participating counterparties in a single currency in the event of a default on or termination of any one contract. As such, in accordance with the Company’s accounting policy, these derivative instruments are recorded on a net basis within the Condensed Consolidated Balance Sheets.
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Fair Value
Condensed Consolidated
Balance Sheet Location		September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsOther non-current Assets$7,538 $— 
Foreign currency forward contractsOther current liabilities(564)$— 
$6,974 $— 
The following table presents the net unrealized (gain) loss deferred to AOCI:
September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsAOCI$5,804 $— 
The following table presents the net gain (loss) reclassified from AOCI to earnings:
Location and Amount of Gain (Loss) Recognized in
Statements of Operations
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest rate swapsInterest expense, net$1,198 $134 $2,259 $(882)
Foreign exchange forward contractsOther (expense) income, net(29)— 2,107 — 
$1,169 $134 $4,366 $(882)
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and ContingenciesThe Company previously disclosed in its 2022 Form 10-K that two of the Company’s locations suffered property damage as a result of flooding and electrical fire, respectively. The Company maintains property and flood insurance for all of its locations globally. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of this previously disclosed matter, other than ongoing work with the Company’s insurance adjuster and insurance carrier regarding the insurance claims submitted. Through September 30, 2023, the Company has received cumulative payments from its insurers of $5.9 million associated with these events. During the nine months ended September 30, 2023, the Company recognized a gain on insurance recoveries of $1.0 million. See Note 10 of Notes to the Condensed Consolidated Financial Statements.As previously disclosed in its 2022 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 26 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. In addition, during the three and nine months ended September 30, 2023, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation the Company is party to, the Company believes that it has made adequate accruals for costs and liabilities associated with environmental matters or provisions for ongoing litigation for which it is aware. The Company has accrued approximately $6 million as of both September 30, 2023 and December 31, 2022, respectively, for these ongoing matters.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net income attributable to Quaker Chemical Corporation $ 33,670 $ 25,867 $ 92,550 $ 60,026
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2023
shares
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted true
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Jeewat Bijlani [Member]  
Trading Arrangements, by Individual  
Name Jeewat Bijlani
Title Executive Vice President, Chief Strategy Officer
Adoption Date August 31, 2023
Arrangement Duration 243 days
Mr. Bijlani's Trading Arrangement, Common Stock [Member] | Jeewat Bijlani [Member]  
Trading Arrangements, by Individual  
Aggregate Available 2,900
Mr. Bijlani's Trading Arrangement, Stock Options [Member] | Jeewat Bijlani [Member]  
Trading Arrangements, by Individual  
Aggregate Available 6,338
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Description of Business (Policies)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments, which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company’s business structure as of January 1, 2023, including reportable segments and customer industry disaggregation. As a result of the Company’s new organizational structure effective January 1, 2023, the Company reallocated goodwill previously held by the former Global Specialty Businesses segment to the remaining business segments as of January 1, 2023. However, the Company did not recast the carrying amount of goodwill for the year ended December 31, 2022. See Notes 4, 5, and 13 of Notes to Condensed Consolidated Financial Statements.
Hyper-inflationary economies
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three and nine months ended September 30, 2023, the Company's Argentine and Turkish subsidiaries represented a combined 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2023, the Company recorded $1.2 million and $2.9 million of remeasurement losses associated with the applicable currency conversions, respectively. Comparatively, during the three and nine months ended September 30, 2022, the Company recorded $1.0 million and $1.2 million of remeasurement losses associated with the applicable currency conversions, respectively. These losses were recorded within foreign exchange losses, net, which is a component of Other (expense) income, net, in the Company’s Condensed Consolidated Statements of Operations.
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting, Measurement Disclosures [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents information about the performance of the Company’s reportable segments:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Net sales
Americas$245,899 $254,678 $750,531 $702,580 
EMEA139,620 134,386 435,602 426,739 
Asia/Pacific105,093 103,154 300,071 329,458 
Total net sales$490,612 $492,218 $1,486,204 $1,458,777 
Segment operating earnings
Americas$69,148 $66,749 $204,280 $164,065 
EMEA27,922 15,479 81,076 58,803 
Asia/Pacific30,963 26,723 86,604 76,146 
Total segment operating earnings128,033 108,951 371,960 299,014 
Combination, integration and other acquisition-related expenses— (2,107)— (7,992)
Restructuring and related (charges) credits, net(1,019)1,423 (6,034)604 
Non-operating and administrative expenses(52,280)(47,852)(154,001)(139,894)
Depreciation of corporate assets and amortization(15,216)(15,806)(45,683)(45,817)
Operating income59,518 44,609 166,242 105,915 
Other (expense) income, net(2,713)85 (8,558)(10,520)
Interest expense, net(12,781)(8,389)(38,744)(20,228)
Income before taxes and equity in net income of associated companies$44,024 $36,305 $118,940 $75,167 
The following table summarizes inter-segment revenues. All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Americas$1,772 $2,702 $6,778 $9,200 
EMEA5,161 9,448 18,718 37,259 
Asia/Pacific793 327 1,329 739 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Net Sales and Revenue Recognition (Tables)
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following tables disaggregate the Company’s net sales by geographic region, customer industries, and timing of revenue recognized. Prior period information has been recast to reflect the Company’s current period customer industry disaggregation. See Note 1 of Notes to Condensed Consolidated Financial Statements.
Three Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,957 $32,630 $49,320 $149,907 
Metalworking and other177,942 106,990 55,773 340,705 
$245,899 $139,620 $105,093 $490,612 
Timing of Revenue Recognized
Product sales at a point in time$235,209 $128,586 $102,305 $466,100 
Services transferred over time10,690 11,034 2,788 24,512 
$245,899 $139,620 $105,093 $490,612 
Nine Months Ended September 30, 2023
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$204,834 $104,376 $144,109 $453,319 
Metalworking and other545,697 331,226 155,962 1,032,885 
$750,531 $435,602 $300,071 $1,486,204 
Timing of Revenue Recognized
Product sales at a point in time$718,187 $402,508 $291,740 $1,412,435 
Services transferred over time32,344 33,094 8,331 73,769 
$750,531 $435,602 $300,071 $1,486,204 
Three Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$67,943 $32,748 $51,341 $152,032 
Metalworking and other186,735 101,638 51,813 340,186 
$254,678 $134,386 $103,154 $492,218 
Timing of Revenue Recognized
Product sales at a point in time$243,699 $124,566 $99,929 $468,194 
Services transferred over time10,979 9,820 3,225 24,024 
$254,678 $134,386 $103,154 $492,218 
Nine Months Ended September 30, 2022
AmericasEMEAAsia/PacificConsolidated
Total
Customer Industries
Metals$185,784 $107,163 $163,239 $456,186 
Metalworking and other516,796 319,576 166,219 1,002,591 
$702,580 $426,739 $329,458 $1,458,777 
Timing of Revenue Recognized
Product sales at a point in time$669,945 $396,944 $321,031 $1,387,920 
Services transferred over time32,635 29,795 8,427 70,857 
$702,580 $426,739 $329,458 $1,458,777 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Leases (Tables)
 9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Lease, Cost The components of the Company’s lease expense are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Operating lease expense$3,886 $3,664 $11,532 $10,592 
Short-term lease expense193 201 587 625 
Supplemental cash flow information related to the Company’s leases is as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,917 $3,768 $11,547 $10,575 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities2,910 2,599 6,566 10,672 
Supplemental balance sheet information related to the Company’s leases is as follows:
September 30,
2023		December 31,
2022
Right of use lease assets$38,595 $43,766 
Other current liabilities12,113 12,024 
Long-term lease liabilities22,163 26,967 
Total operating lease liabilities$34,276 $38,991 
Weighted average remaining lease term (years)4.825.10
Weighted average discount rate4.67 %4.36 %
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities were as follows:
September 30,
2023
For the remainder of 2023$3,691 
For the year ended December 31, 202412,589 
For the year ended December 31, 20258,417 
For the year ended December 31, 20266,286 
For the year ended December 31, 20273,051 
For the year ended December 31, 2028 and beyond5,614 
Total lease payments39,648 
Less: imputed interest(5,372)
Present value of lease liabilities$34,276 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring and Related Activities (Tables)
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
Changes in the Company’s accruals for its restructuring programs are as follows:
Restructuring Programs
Accrued restructuring as of December 31, 2022$5,483
Restructuring and related charges, net6,034 
Cash payments(7,914)
Currency translation adjustments(13)
Accrued restructuring as of September 30, 2023$3,590
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Share Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Stock options$203$533$837$1,269
Non-vested stock awards and restricted stock units2,4291,7837,1924,998
Director stock ownership plan3095653
Performance stock units1,1138753,1042,314
Total share-based compensation expense$3,775$3,200$11,189$8,634
Schedule Of Monte Carlo Option Pricing Model And The Assumptions The grant-date fair value of the PSUs valued using a Monte Carlo simulation, which included the following assumptions set forth in the table below:
2023
Grants
Number of PSUs granted16,861
Risk-free interest rate3.85%
Dividend yield0.96%
Expected term (years)3.0
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Pension and Other Postretirement Benefits (Tables)
 9 Months Ended
Sep. 30, 2023
Retirement Benefits, Description [Abstract]  
Schedule of Net Benefit Costs
The components of net periodic benefit cost (income) are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Pension BenefitsOther Postretirement BenefitsPension BenefitsOther Postretirement Benefits
20232022202320222023202220232022
Service cost$109$166$—$1 $320$520$—$1
Interest cost2,4871,272148 7,4523,9495119
Expected return on plan assets(2,033)(1,942)——(6,056)(6,038)——
Actuarial loss (gain) amortization103238(36)(23)308743(95)(70)
Prior service cost (income) amortization183(4)(8)268(12)(17)
Net periodic benefit cost (income)$684 $(263)$(26)$(22)$2,050 $(818)$(56)$(67)
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Other (expense) income, net (Tables)
 9 Months Ended
Sep. 30, 2023
Other Income and Expenses [Abstract]  
Schedule of Other Nonoperating (Expense) Income
The components of Other (expense) income, net are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Income from third party license fees$245$253$891$906
Foreign exchange losses, net(2,498)(1,928)(10,049)(5,859)
(Loss) gain on disposals of property, plant, equipment and other assets, net(25)48 (91)33
Non-income tax refunds and other related credits (expense)911221,339 (1,617)
Pension and postretirement benefit (costs) income, non-service components(549)452(1,674)1,406
Facility remediation recoveries, net—1,1041,0141,104
Loss on extinguishment of debt——— (6,763)
Other non-operating income, net233412270
Total other (expense) income, net$(2,713)$85$(8,558)$(10,520)
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table summarizes earnings per share calculations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Basic earnings per common share$1.87 $1.44 $5.15 $3.35 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$33,670 $25,867 $92,550 $60,026 
Less: income allocated to participating securities(164)(115)(464)(250)
Net income available to common shareholders$33,506 $25,752 $92,086 $59,776 
Basic weighted average common shares outstanding17,908,75417,847,30517,889,44417,835,976
Effect of dilutive securities12,52012,56616,70915,465
Diluted weighted average common shares outstanding17,921,27417,859,87117,906,15317,851,441
Diluted earnings per common share$1.87 $1.44 $5.14 $3.35 
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Changes in the carrying amount of goodwill were as follows. Prior period information has been recast to reflect the Company’s current period reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.
AmericasEMEAAsia/PacificGlobal
Specialty
Businesses		Total
Balance as of December 31, 2022$215,899$34,567$150,375$114,167$515,008
Reallocation of reporting units63,697 31,711 18,759 (114,167)—
Balance as of January 1, 2023279,596 66,278 169,134 — 515,008 
Currency translation adjustments2,561 (805)(12,307)— (10,551)
Balance as of September 30, 2023$282,157$65,473$156,827$—$504,457
Schedule of Finite-Lived Intangible Assets
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
September 30, 2023December 31, 2022September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Customer lists and rights to sell$824,893$831,600$226,956$191,286$597,937$640,314
Trademarks, formulations and product technology157,362158,56452,53446,281104,828112,283
Other5,8547,5765,7346,3901201,186
Total definite-lived intangible assets$988,109$997,740$285,224$243,957$702,885$753,783
Schedule of Finite-lived Intangible Assets Amortization Expense The Company recorded amortization expense as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Amortization expense$14,529 $14,102 $43,734 $43,343 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows:
For the remainder of 2023$13,455
For the year ended December 31, 202456,630
For the year ended December 31, 202555,942
For the year ended December 31, 202655,650
For the year ended December 31, 202755,309
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
The following table sets forth the components of the Company’s debt:
As of September 30, 2023As of December 31, 2022
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver6.0%$82,838 5.2%$195,673 
U.S. Term Loan6.7%585,000 5.7%596,250 
Euro Term Loan5.0%146,918 3.1%151,572 
Industrial development bonds5.3%10,000 5.3%10,000 
Bank lines of credit and other debt obligationsVarious1,120 Various1,303 
Total debt$825,876 $954,798 
Less: debt issuance costs(1,657)(1,992)
Less: short-term and current portion of long-term debts(19,246)(19,245)
Total long-term debt$804,973 $933,561 
Schedule of Interest Income and Interest Expense Disclosure
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest expense$12,598 $9,465 $40,863 $20,339 
Amortization of debt issuance costs353 353 1,059 2,589 
Total$12,951 $9,818 $41,922 $22,928 
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Income (Tables)
 9 Months Ended
Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance at June 30, 2023$(130,738)$(4,024)$91 $4,563 $(130,108)
Other comprehensive (loss) income before Reclassifications(25,501)304 (802)1,612 (24,387)
Amounts reclassified from AOCI— 71 (4)67 
Related tax amounts— (94)169 (371)(296)
Balance at September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance at June 30, 2022$(133,110)$(11,269)$(1,170)$303 $(145,246)
Other comprehensive (loss) income before Reclassifications(71,948)453 (1,006)(182)(72,683)
Amounts reclassified from AOCI— 210 (30)— 180 
Related tax amounts— (166)218 42 94 
Balance at September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before reclassifications(24,078)915 640 7,538 (14,985)
Amounts reclassified from AOCI— 225 547 772 
Related tax amounts— (288)(249)(1,734)(2,271)
Balance as of September 30, 2023$(156,239)$(3,743)$(546)$5,804 $(154,724)
Balance as of December 31, 2021$(49,843)$(13,172)$397 $(1,372)$(63,990)
Other comprehensive (loss) income before reclassifications(155,215)2,535 (3,326)1,993 (154,013)
Amounts reclassified from AOCI— 657 306 — 963 
Related tax amounts— (792)635 (458)(615)
Balance as of September 30, 2022$(205,058)$(10,772)$(1,988)$163 $(217,655)
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets Subject to Fair Value Measurements These assets are subject to fair value measurement as follows:
Total
Fair Value		Fair Value Measurements as of September 30, 2023
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$285 $— $285 $— 
Total$285 $— $285 $— 
Total
Fair Value		Fair Value Measurements as of December 31, 2022
Using Fair Value Hierarchy
AssetsLevel 1Level 2Level 3
Company-owned life insurance$2,114 $— $2,114 $— 
Total$2,114 $— $2,114 $— 
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Hedging Activities (Tables)
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts of Outstanding Derivative Positions As of September 30, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar value of the following:
CurrencySeptember 30,
2023
Mexican Peso$41,900 
Japanese Yen4,500 
$46,400 
Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Fair Value
Condensed Consolidated
Balance Sheet Location		September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsOther non-current Assets$7,538 $— 
Foreign currency forward contractsOther current liabilities(564)$— 
$6,974 $— 
The following table presents the net unrealized (gain) loss deferred to AOCI:
September 30,
2023		December 31,
2022
Derivatives designated as cash flow hedges:
Interest rate swapsAOCI$5,804 $— 
The following table presents the net gain (loss) reclassified from AOCI to earnings:
Location and Amount of Gain (Loss) Recognized in
Statements of Operations
Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
Interest rate swapsInterest expense, net$1,198 $134 $2,259 $(882)
Foreign exchange forward contractsOther (expense) income, net(29)— 2,107 — 
$1,169 $134 $4,366 $(882)
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Description of Business (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
country
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
country
Sep. 30, 2022
USD ($)
Number of reportable segments | segment     3  
Number of countries in which entity operates | country 25   25  
Argentina | Argentine and Turkish Subsidiaries        
Currency conversion impacts of hyper-inflationary accounting $ 1.2   $ 2.9  
Argentina | Argentine and Turkish Subsidiaries | Assets Total | Geographic Concentration Risk        
Concentration risk (as a percent) 1.00%   1.00%  
Argentina | Argentine and Turkish Subsidiaries | Sales Revenue Net | Geographic Concentration Risk        
Concentration risk (as a percent) 2.00%   2.00%  
Argentina | ARGENTINA        
Currency conversion impacts of hyper-inflationary accounting   $ 1.0   $ 1.2
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Business Acquisitions - (Details)
€ in Millions, $ in Millions
 1 Months Ended 3 Months Ended
Oct. 31, 2022
EUR (€)
Oct. 31, 2022
USD ($)
Jan. 31, 2022
EUR (€)
Jan. 31, 2022
USD ($)
Nov. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Business Acquisition [Line Items]              
Cash transferred to Houghton shareholders         $ 7.1    
Maximum              
Business Acquisition [Line Items]              
Earnouts         4.5    
Assets Related To Sealing And Impregnation Of Metal Castings              
Business Acquisition [Line Items]              
Asset acquisition, consideration transferred     € 1.2 $ 1.4      
Business Related to Pickling and Rinsing Products and Services              
Business Acquisition [Line Items]              
Purchase price € 3.5 $ 3.5          
Business Related To Pickling Inhibitor Technologies              
Business Acquisition [Line Items]              
Purchase price       $ 8.0      
Purchase accounting adjustments           $ 0.1  
Baron Industries              
Business Acquisition [Line Items]              
Purchase price         $ 11.0    
Earnouts             $ 1.1
Post closing adjustment including earnouts           $ 0.1  
Coral Chemical Company (Coral) | Maximum              
Business Acquisition [Line Items]              
Loss contingency, estimate of possible loss             1.5
Coral Chemical Company (Coral) | Minimum              
Business Acquisition [Line Items]              
Loss contingency, estimate of possible loss             $ 0.0
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments - Narrative (Details)
 9 Months Ended
Sep. 30, 2023
segment
Segment Reporting, Measurement Disclosures [Abstract]  
Number of reportable segments 3
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments - Performance of Reportable Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Net sales $ 490,612 $ 492,218 $ 1,486,204 $ 1,458,777
Combination, integration and other acquisition-related expenses 0 (2,107) 0 (7,992)
Restructuring and related (charges) credits, net (1,019) 1,423 (6,034) 604
Non-operating and administrative expenses (52,280) (47,852) (154,001) (139,894)
Depreciation of corporate assets and amortization (15,216) (15,806) (45,683) (45,817)
Operating income 59,518 44,609 166,242 105,915
Other (expense) income, net (2,713) 85 (8,558) (10,520)
Interest expense, net (12,781) (8,389) (38,744) (20,228)
Income before taxes and equity in net income of associated companies 44,024 36,305 118,940 75,167
Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 490,612 492,218 1,486,204 1,458,777
Segment operating earnings 128,033 108,951 371,960 299,014
Operating Segments | Americas        
Segment Reporting Information [Line Items]        
Net sales 245,899 254,678 750,531 702,580
Segment operating earnings 69,148 66,749 204,280 164,065
Operating Segments | EMEA        
Segment Reporting Information [Line Items]        
Net sales 139,620 134,386 435,602 426,739
Segment operating earnings 27,922 15,479 81,076 58,803
Operating Segments | Asia/Pacific        
Segment Reporting Information [Line Items]        
Net sales 105,093 103,154 300,071 329,458
Segment operating earnings 30,963 26,723 86,604 76,146
Intersegment Sales Elimination | Americas        
Segment Reporting Information [Line Items]        
Net sales 1,772 2,702 6,778 9,200
Intersegment Sales Elimination | EMEA        
Segment Reporting Information [Line Items]        
Net sales 5,161 9,448 18,718 37,259
Intersegment Sales Elimination | Asia/Pacific        
Segment Reporting Information [Line Items]        
Net sales $ 793 $ 327 $ 1,329 $ 739
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Net Sales and Revenue Recognition - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Concentration Risk [Line Items]          
Revenue recognized under net reporting arrangements $ 21.6 $ 21.4 $ 63.2 $ 61.7  
Deferred revenue $ 2.8   $ 2.8   $ 5.7
Number of reportable segments | segment     3    
Top Five Customers | Sales Revenue Net | Customer Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk (as a percent)         11.00%
Largest Customers | Sales Revenue Net | Customer Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk (as a percent)         3.00%
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Net Sales and Revenue Recognition - Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Product Information [Line Items]        
Net sales $ 490,612 $ 492,218 $ 1,486,204 $ 1,458,777
Operating Segments        
Product Information [Line Items]        
Net sales 490,612 492,218 1,486,204 1,458,777
Operating Segments | Product sales at a point in time        
Product Information [Line Items]        
Net sales 466,100 468,194 1,412,435 1,387,920
Operating Segments | Services transferred over time        
Product Information [Line Items]        
Net sales 24,512 24,024 73,769 70,857
Operating Segments | Americas        
Product Information [Line Items]        
Net sales 245,899 254,678 750,531 702,580
Operating Segments | Americas | Product sales at a point in time        
Product Information [Line Items]        
Net sales 235,209 243,699 718,187 669,945
Operating Segments | Americas | Services transferred over time        
Product Information [Line Items]        
Net sales 10,690 10,979 32,344 32,635
Operating Segments | EMEA        
Product Information [Line Items]        
Net sales 139,620 134,386 435,602 426,739
Operating Segments | EMEA | Product sales at a point in time        
Product Information [Line Items]        
Net sales 128,586 124,566 402,508 396,944
Operating Segments | EMEA | Services transferred over time        
Product Information [Line Items]        
Net sales 11,034 9,820 33,094 29,795
Operating Segments | Asia/Pacific        
Product Information [Line Items]        
Net sales 105,093 103,154 300,071 329,458
Operating Segments | Asia/Pacific | Product sales at a point in time        
Product Information [Line Items]        
Net sales 102,305 99,929 291,740 321,031
Operating Segments | Asia/Pacific | Services transferred over time        
Product Information [Line Items]        
Net sales 2,788 3,225 8,331 8,427
Operating Segments | Metals        
Product Information [Line Items]        
Net sales 149,907 152,032 453,319 456,186
Operating Segments | Metals | Americas        
Product Information [Line Items]        
Net sales 67,957 67,943 204,834 185,784
Operating Segments | Metals | EMEA        
Product Information [Line Items]        
Net sales 32,630 32,748 104,376 107,163
Operating Segments | Metals | Asia/Pacific        
Product Information [Line Items]        
Net sales 49,320 51,341 144,109 163,239
Operating Segments | Metalworking and other        
Product Information [Line Items]        
Net sales 340,705 340,186 1,032,885 1,002,591
Operating Segments | Metalworking and other | Americas        
Product Information [Line Items]        
Net sales 177,942 186,735 545,697 516,796
Operating Segments | Metalworking and other | EMEA        
Product Information [Line Items]        
Net sales 106,990 101,638 331,226 319,576
Operating Segments | Metalworking and other | Asia/Pacific        
Product Information [Line Items]        
Net sales $ 55,773 $ 51,813 $ 155,962 $ 166,219
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Lessee, Lease, Description [Line Items]        
Variable lease cost $ 0 $ 0 $ 0 $ 0
Sublease income $ 0 $ 0 $ 0 $ 0
Facilities Vehicles and Machinery and Equipment        
Lessee, Lease, Description [Line Items]        
Remaining lease terms (in years) 8 years   8 years  
Land        
Lessee, Lease, Description [Line Items]        
Remaining lease terms (in years) 92 years   92 years  
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Supplemental Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Lease, Cost [Abstract]          
Operating lease expense $ 3,886 $ 3,664 $ 11,532 $ 10,592  
Short-term lease expense 193 201 587 625  
Supplemental cash flow information related to leases          
Operating cash flows from operating leases 3,917 3,768 11,547 10,575  
Leased assets obtained in exchange for new operating lease liabilities 2,910 $ 2,599 6,566 $ 10,672  
Supplemental balance sheet information          
Right of use lease assets 38,595   38,595   $ 43,766
Other current liabilities 12,113   12,113   12,024
Long-term lease liabilities 22,163   22,163   26,967
Total operating lease liabilities $ 34,276   $ 34,276   $ 38,991
Weighted average remaining lease term (years) 4 years 9 months 25 days   4 years 9 months 25 days   5 years 1 month 6 days
Weighted average discount rate 4.67%   4.67%   4.36%
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
For the remainder of 2023 $ 3,691  
For the year ended December 31, 2024 12,589  
For the year ended December 31, 2025 8,417  
For the year ended December 31, 2026 6,286  
For the year ended December 31, 2027 3,051  
For the year ended December 31, 2028 and beyond 5,614  
Total lease payments 39,648  
Less: imputed interest (5,372)  
Present value of lease liabilities $ 34,276 $ 38,991
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring and Related Activities (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
position
Sep. 30, 2022
USD ($)
Restructuring Cost and Reserve [Line Items]        
Number of positions eliminated | position     100  
Real estate, held-for-sale $ 6,900   $ 6,900  
Restructuring Reserve [Roll Forward]        
Restructuring and related charges, net 1,019 $ (1,423) 6,034 $ (604)
Restructuring Programs        
Restructuring Reserve [Roll Forward]        
Accrued restructuring, beginning balance     5,483  
Restructuring and related charges, net     6,034  
Cash payments     (7,914)  
Currency translation adjustments     (13)  
Accrued restructuring, ending balance $ 3,590   $ 3,590  
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation - Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 3,775 $ 3,200 $ 11,189 $ 8,634
Stock options        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 203 533 837 1,269
Non-vested stock awards and restricted stock units        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 2,429 1,783 7,192 4,998
Director stock ownership plan        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 30 9 56 53
Performance stock units        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 1,113 $ 875 $ 3,104 $ 2,314
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based compensation expense $ 3,775 $ 3,200 $ 11,189 $ 8,634
Combination And Other Acquisition-Related        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based compensation expense   100   200
Share-Based Payment Arrangement, Option        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Unrecognized compensation expense, options 500   $ 500  
Weighted average remaining life, nonvested stock awards (in years)     10 months 24 days  
Restricted Stock        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Weighted average remaining life, nonvested stock awards (in years)     1 year 4 months 24 days  
Nonvested stock awards granted (in shares)     38,894  
Unrecognized share-based compensation expense, nonvested stock award 8,000   $ 8,000  
Restricted Stock | Minimum        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Option award vesting period (in years)     1 year  
Restricted Stock | Maximum        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Option award vesting period (in years)     3 years  
Restricted Stock Units (RSUs)        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Weighted average remaining life, nonvested stock awards (in years)     1 year 6 months  
Nonvested stock awards granted (in shares)     6,675  
Unrecognized share-based compensation expense, nonvested stock award 1,600   $ 1,600  
Performance Stock Units        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Share-based compensation expense 1,113 $ 875 3,104 $ 2,314
Unrecognized compensation expense, options $ 8,000   $ 8,000  
Weighted average remaining life, nonvested stock awards (in years)     2 years 2 months 12 days  
Vesting shares target lower (as a percent)     0.00%  
Vesting shares target upper (as a percent)     200.00%  
Estimated future PSUs issued (in shares) 25,613   25,613  
Performance Stock Units | Maximum        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Option award vesting period (in years)     3 years  
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) - Performance Stock Units
 9 Months Ended
Sep. 30, 2023
shares
2023 Grants  
Number of PSUs granted (in shares) 16,861
Risk-free interest rate 3.85%
Dividend yield 0.96%
Expected term (years) 3 years
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pension Benefits        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]        
Service cost $ 109 $ 166 $ 320 $ 520
Interest cost 2,487 1,272 7,452 3,949
Expected return on plan assets (2,033) (1,942) (6,056) (6,038)
Actuarial loss (gain) amortization 103 238 308 743
Prior service cost (income) amortization 18 3 26 8
Net periodic benefit cost (income) 684 (263) 2,050 (818)
Other Postretirement Benefits        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]        
Service cost 0 1 0 1
Interest cost 14 8 51 19
Expected return on plan assets 0 0 0 0
Actuarial loss (gain) amortization (36) (23) (95) (70)
Prior service cost (income) amortization (4) (8) (12) (17)
Net periodic benefit cost (income) $ (26) $ (22) $ (56) $ (67)
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.3
Pension and Other Postretirement Benefits - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 9 Months Ended
Jul. 31, 2023
Sep. 30, 2023
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Defined benefit plan, plan assets, liquidated assets $ 50.0  
Employer contributions   $ 3.4
Expected future employer contributions, remainder of fiscal year   5.2
Other Postretirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Employer contributions   0.1
Expected future employer contributions, remainder of fiscal year   $ 0.2
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Other (expense) income, net (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Other Income and Expenses [Abstract]        
Income from third party license fees $ 245 $ 253 $ 891 $ 906
Foreign exchange losses, net (2,498) (1,928) (10,049) (5,859)
(Loss) gain on disposals of property, plant, equipment and other assets, net (25) 48 (91) 33
Non-income tax refunds and other related credits (expense) 91 122 1,339 (1,617)
Pension and postretirement benefit (costs) income, non-service components (549) 452 (1,674) 1,406
Facility remediation recoveries, net 0 1,104 1,014 1,104
Loss on extinguishment of debt 0 0 0 (6,763)
Other non-operating income, net 23 34 12 270
Total other (expense) income, net $ (2,713) $ 85 $ (8,558) $ (10,520)
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes and Uncertain Income Tax Positions - (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Mar. 31, 2022
Income Tax Examination [Line Items]          
Effective tax rate (as a percent) 30.90% 28.10% 31.10% 19.20%  
Italy | Houghton | Foreign Tax Authority          
Income Tax Examination [Line Items]          
Tax settlement final amount due to tax authorities         $ 3.7
Cumulative payments for tax settlements $ 1.5   $ 1.5    
Amount received from an escrow $ 1.2        
Unrecognized tax benefits, period increase     $ 3.2    
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share - Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Net income attributable to Quaker Chemical Corporation $ 33,670 $ 25,867 $ 92,550 $ 60,026
Less: income allocated to participating securities (164) (115) (464) (250)
Net income available to common shareholders $ 33,506 $ 25,752 $ 92,086 $ 59,776
Basic weighted average common shares outstanding (in shares) 17,908,754 17,847,305 17,889,444 17,835,976
Basic earnings per common share (in dollars per share) $ 1.87 $ 1.44 $ 5.15 $ 3.35
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share - Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Net income attributable to Quaker Chemical Corporation $ 33,670 $ 25,867 $ 92,550 $ 60,026
Less: income allocated to participating securities (164) (115) (464) (250)
Net income available to common shareholders $ 33,506 $ 25,752 $ 92,086 $ 59,776
Basic weighted average common shares outstanding (in shares) 17,908,754 17,847,305 17,889,444 17,835,976
Effect of dilutive securities (in shares) 12,520 12,566 16,709 15,465
Diluted weighted average common shares outstanding (in shares) 17,921,274 17,859,871 17,906,153 17,851,441
Diluted earnings per common share (in dollars per share) $ 1.87 $ 1.44 $ 5.14 $ 3.35
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share - Antidilutive Shares (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Antidilutive shares (in share) 11,598 25,896 10,453 24,618
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2022
Sep. 30, 2023
Goodwill [Roll Forward]    
Beginning balance   $ 515,008
Currency translation adjustments   (10,551)
Ending balance $ 515,008 504,457
Previously Reported    
Goodwill [Roll Forward]    
Beginning balance   515,008
Ending balance 515,008  
Reallocation of Reporting Units    
Goodwill [Roll Forward]    
Reallocation of reporting units 0  
Operating Segments | Advanced solutions    
Goodwill [Roll Forward]    
Beginning balance   0
Currency translation adjustments   0
Ending balance 0 0
Operating Segments | Americas    
Goodwill [Roll Forward]    
Beginning balance   279,596
Currency translation adjustments   2,561
Ending balance 279,596 282,157
Operating Segments | EMEA    
Goodwill [Roll Forward]    
Beginning balance   66,278
Currency translation adjustments   (805)
Ending balance 66,278 65,473
Operating Segments | Asia/Pacific    
Goodwill [Roll Forward]    
Beginning balance   169,134
Currency translation adjustments   (12,307)
Ending balance 169,134 156,827
Operating Segments | Previously Reported | Advanced solutions    
Goodwill [Roll Forward]    
Beginning balance   114,167
Ending balance 114,167  
Operating Segments | Previously Reported | Americas    
Goodwill [Roll Forward]    
Beginning balance   215,899
Ending balance 215,899  
Operating Segments | Previously Reported | EMEA    
Goodwill [Roll Forward]    
Beginning balance   34,567
Ending balance 34,567  
Operating Segments | Previously Reported | Asia/Pacific    
Goodwill [Roll Forward]    
Beginning balance   $ 150,375
Ending balance 150,375  
Operating Segments | Reallocation of Reporting Units | Advanced solutions    
Goodwill [Roll Forward]    
Reallocation of reporting units (114,167)  
Operating Segments | Reallocation of Reporting Units | Americas    
Goodwill [Roll Forward]    
Reallocation of reporting units 63,697  
Operating Segments | Reallocation of Reporting Units | EMEA    
Goodwill [Roll Forward]    
Reallocation of reporting units 31,711  
Operating Segments | Reallocation of Reporting Units | Asia/Pacific    
Goodwill [Roll Forward]    
Reallocation of reporting units $ 18,759  
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 988,109 $ 997,740
Accumulated Amortization 285,224 243,957
Net Book Value 702,885 753,783
Customer lists and rights to sell    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 824,893 831,600
Accumulated Amortization 226,956 191,286
Net Book Value 597,937 640,314
Trademarks, formulations and product technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 157,362 158,564
Accumulated Amortization 52,534 46,281
Net Book Value 104,828 112,283
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 5,854 7,576
Accumulated Amortization 5,734 6,390
Net Book Value $ 120 $ 1,186
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets - Amortization Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 14,529 $ 14,102 $ 43,734 $ 43,343
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
For the remainder of 2023 $ 13,455
For the year ended December 31, 2024 56,630
For the year ended December 31, 2025 55,942
For the year ended December 31, 2026 55,650
For the year ended December 31, 2027 $ 55,309
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.23.3
Goodwill and Other Intangible Assets - Indefinite Lived (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Indefinite lived intangible assets $ 187.6  
Houghton Combination    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived trademarks   $ 189.1
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Outstanding Balance $ 825,876 $ 954,798
Less: debt issuance costs (1,657) (1,992)
Less: short-term and current portion of long-term debts (19,246) (19,245)
Long-term debt $ 804,973 $ 933,561
Revolver    
Debt Instrument [Line Items]    
Interest Rate 6.00% 5.20%
Outstanding Balance $ 82,838 $ 195,673
U.S. Term Loan    
Debt Instrument [Line Items]    
Interest Rate 6.70% 5.70%
Outstanding Balance $ 585,000 $ 596,250
Euro Term Loan    
Debt Instrument [Line Items]    
Interest Rate 5.00% 3.10%
Outstanding Balance $ 146,918 $ 151,572
Industrial development bonds    
Debt Instrument [Line Items]    
Interest Rate 5.30% 5.30%
Outstanding Balance $ 10,000 $ 10,000
Bank lines of credit and other debt obligations    
Debt Instrument [Line Items]    
Outstanding Balance $ 1,120 $ 1,303
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Interest rate swaps          
Debt Instrument [Line Items]          
Derivative liability, notional amount   $ 300,000,000      
Derivative term (in years)   3 years      
Derivative, fixed interest rate (as a percent)   3.64%      
Derivative variable interest rate (as a percent) 5.30%   5.30%    
Other Assets          
Debt Instrument [Line Items]          
Debt issuance costs $ 3,600,000   $ 3,600,000 $ 4,300,000  
Euro Term Loan          
Debt Instrument [Line Items]          
Maximum borrowing capacity         $ 150,000,000
Debt issuance costs         700,000
U.S. Term Loan          
Debt Instrument [Line Items]          
Maximum borrowing capacity         600,000,000
Debt issuance costs         700,000
Revolver          
Debt Instrument [Line Items]          
Maximum borrowing capacity         $ 500,000,000
Credit faclity as percentage of consolidated EBITDA (as a percent)         100.00%
Borrowings outstanding 414,000,000   414,000,000    
Letters of credit outstanding amount 3,000,000   3,000,000    
Debt issuance costs $ 1,700,000   $ 1,700,000 2,000,000  
Revolver | Other Assets          
Debt Instrument [Line Items]          
Debt issuance costs         $ 1,500,000
Amended Credit Facility          
Debt Instrument [Line Items]          
Maximum increase in borrowing capacity         300,000,000
Debt issuance costs         $ 2,200,000
Long-term debt term (in years)         5 years
Amended Credit Facility | Maximum          
Debt Instrument [Line Items]          
Commitment fee percentage (as a percent)     0.275%    
Amended Credit Facility | Minimum          
Debt Instrument [Line Items]          
Commitment fee percentage (as a percent)     0.15%    
Original Credit Facility and the Amended Credit Facility          
Debt Instrument [Line Items]          
Long-term debt, weighted average interest rate, over time (as a percent) 6.40%   6.10%    
Original Credit Facility          
Debt Instrument [Line Items]          
Long-term debt interest rate (as a percent) 6.30%   6.30%    
Corporate Bond Securities          
Debt Instrument [Line Items]          
Industrial development revenue bond $ 10,000,000   $ 10,000,000 $ 10,000,000  
Bank lines of credit and other debt obligations          
Debt Instrument [Line Items]          
Letters of credit outstanding amount 5,000,000   5,000,000    
Remaining borrowing capacity $ 34,000,000   $ 34,000,000    
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.23.3
Debt - Debt Related Expenses Included within Interest Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Debt related expenses included within Interest expense:        
Interest expense $ 12,598 $ 9,465 $ 40,863 $ 20,339
Amortization of debt issuance costs 353 353 1,059 2,589
Total $ 12,951 $ 9,818 $ 41,922 $ 22,928
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance     $ (138,240)  
Other comprehensive (loss) income before Reclassifications $ (24,387) $ (72,683) (14,985) $ (154,013)
Amounts reclassified from AOCI 67 180 772 963
Related tax amounts (296) 94 (2,271) (615)
Ending Balance (154,724)   (154,724)  
Currency Translation Adjustments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance (130,738) (133,110) (132,161) (49,843)
Other comprehensive (loss) income before Reclassifications (25,501) (71,948) (24,078) (155,215)
Amounts reclassified from AOCI 0 0 0 0
Related tax amounts 0 0 0 0
Ending Balance (156,239) (205,058) (156,239) (205,058)
Defined Benefit Pension Plans        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance (4,024) (11,269) (4,595) (13,172)
Other comprehensive (loss) income before Reclassifications 304 453 915 2,535
Amounts reclassified from AOCI 71 210 225 657
Related tax amounts (94) (166) (288) (792)
Ending Balance (3,743) (10,772) (3,743) (10,772)
Unrealized (Loss) Gain in Available-for- Sale Securities        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance 91 (1,170) (1,484) 397
Other comprehensive (loss) income before Reclassifications (802) (1,006) 640 (3,326)
Amounts reclassified from AOCI (4) (30) 547 306
Related tax amounts 169 218 (249) 635
Ending Balance (546) (1,988) (546) (1,988)
Derivative Instruments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance 4,563 303 0 (1,372)
Other comprehensive (loss) income before Reclassifications 1,612 (182) 7,538 1,993
Amounts reclassified from AOCI 0 0
Related tax amounts (371) 42 (1,734) (458)
Ending Balance 5,804 163 5,804 163
Accumulated Other Comprehensive Loss        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning Balance (130,108) (145,246) (138,240) (63,990)
Ending Balance $ (154,724) $ (217,655) $ (154,724) $ (217,655)
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Narrative (Details)
$ in Millions
 1 Months Ended
Jun. 30, 2023
USD ($)
Fair Value Disclosures [Abstract]  
Surrendered and liquidated life insurance policies $ 1.9
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets    
Company-owned life insurance $ 285 $ 2,114
Total 285 2,114
Level 1    
Assets    
Company-owned life insurance 0 0
Total 0 0
Level 2    
Assets    
Company-owned life insurance 285 2,114
Total 285 2,114
Level 3    
Assets    
Company-owned life insurance 0 0
Total $ 0 $ 0
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.23.3
Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Derivative [Line Items]  
Notional amount $ 46,400
Mexican Peso  
Derivative [Line Items]  
Notional amount 41,900
Japanese Yen  
Derivative [Line Items]  
Notional amount $ 4,500
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.23.3
Hedging Activities - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Sep. 30, 2023
Foreign currency forward contracts    
Derivative [Line Items]    
Derivative term (in years)   1 month
Interest rate swaps    
Derivative [Line Items]    
Derivative term (in years) 3 years  
Derivative liability, notional amount $ 300.0  
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.23.3
Hedging Activities - Balance Sheet Classification and Fair Values (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]            
Fair Value       $ 6,974   $ 0
Net gain (loss) reclassified from AOCI to earnings $ 1,169   $ 134 4,366 $ (882)  
Interest expense, net            
Derivative Instruments, Gain (Loss) [Line Items]            
Net gain (loss) reclassified from AOCI to earnings 1,198   134 2,259 (882)  
Other (expense) income, net            
Derivative Instruments, Gain (Loss) [Line Items]            
Net gain (loss) reclassified from AOCI to earnings $ (29)   $ 0 2,107 $ 0  
Interest rate swaps            
Derivative Instruments, Gain (Loss) [Line Items]            
Net unrealized loss deferred to AOCI       5,804   0
Other non-current Assets | Interest rate swaps            
Derivative Instruments, Gain (Loss) [Line Items]            
Fair Value       7,538   $ 0
Other current liabilities | Foreign currency forward contracts            
Derivative Instruments, Gain (Loss) [Line Items]            
Fair Value   $ 0   $ (564)    
XML 87 R77.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies (Details)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
location
Loss Contingencies [Line Items]          
Facility remediation recoveries, net $ 0 $ 1,104 $ 1,014 $ 1,104  
Insurance Claims          
Loss Contingencies [Line Items]          
Number of locations that suffered property damage | location         2
Proceeds from insurance settlement     5,900    
Facility remediation recoveries, net     1,000    
Houghton Environmental Matters          
Loss Contingencies [Line Items]          
Loss contingency, estimate of possible loss $ 6,000   $ 6,000   $ 6,000
XML 88 kwr-20230930_htm.xml IDEA: XBRL DOCUMENT 0000081362 2023-01-01 2023-09-30 0000081362 2023-10-31 0000081362 2023-07-01 2023-09-30 0000081362 2022-07-01 2022-09-30 0000081362 2022-01-01 2022-09-30 0000081362 2023-09-30 0000081362 2022-12-31 0000081362 2021-12-31 0000081362 2022-09-30 0000081362 us-gaap:CommonStockMember 2021-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2021-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2021-12-31 0000081362 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000081362 2022-01-01 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000081362 us-gaap:CommonStockMember 2022-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-03-31 0000081362 2022-03-31 0000081362 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0000081362 2022-04-01 2022-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000081362 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000081362 us-gaap:CommonStockMember 2022-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000081362 us-gaap:RetainedEarningsMember 2022-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-06-30 0000081362 2022-06-30 0000081362 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000081362 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000081362 us-gaap:CommonStockMember 2022-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000081362 us-gaap:RetainedEarningsMember 2022-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-09-30 0000081362 us-gaap:CommonStockMember 2022-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000081362 us-gaap:RetainedEarningsMember 2022-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-12-31 0000081362 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000081362 2023-01-01 2023-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000081362 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000081362 us-gaap:CommonStockMember 2023-03-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000081362 us-gaap:RetainedEarningsMember 2023-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000081362 us-gaap:NoncontrollingInterestMember 2023-03-31 0000081362 2023-03-31 0000081362 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0000081362 2023-04-01 2023-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000081362 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000081362 us-gaap:CommonStockMember 2023-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000081362 us-gaap:RetainedEarningsMember 2023-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-06-30 0000081362 2023-06-30 0000081362 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000081362 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000081362 us-gaap:CommonStockMember 2023-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000081362 us-gaap:RetainedEarningsMember 2023-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember 2023-07-01 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember 2023-01-01 2023-09-30 0000081362 srt:SubsidiariesMember country:AR 2022-07-01 2022-09-30 0000081362 srt:SubsidiariesMember country:AR 2022-01-01 2022-09-30 0000081362 kwr:BusinessRelatedToPicklingAndRinsingProductsAndServicesMember 2022-10-01 2022-10-31 0000081362 kwr:BusinessProvidingPicklingInhibitorTechnologiesMember 2022-01-01 2022-01-31 0000081362 kwr:BusinessProvidingPicklingInhibitorTechnologiesMember 2022-07-01 2022-09-30 0000081362 kwr:AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember 2022-01-01 2022-01-31 0000081362 kwr:BaronIndustriesMember 2021-11-01 2021-11-30 0000081362 2021-11-01 2021-11-30 0000081362 srt:MaximumMember 2021-11-30 0000081362 kwr:BaronIndustriesMember 2023-09-30 0000081362 kwr:BaronIndustriesMember 2022-07-01 2022-09-30 0000081362 srt:MinimumMember kwr:CoralChemicalCompanyMember 2023-09-30 0000081362 srt:MaximumMember kwr:CoralChemicalCompanyMember 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2023-07-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2022-07-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2023-01-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2022-01-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2023-07-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2022-07-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2023-01-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2022-01-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2023-07-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2022-07-01 2022-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2023-01-01 2023-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2022-01-01 2022-09-30 0000081362 kwr:TopFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000081362 kwr:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2023-07-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0000081362 kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2023-09-30 0000081362 us-gaap:LandMember 2023-09-30 0000081362 us-gaap:RestructuringChargesMember 2022-12-31 0000081362 us-gaap:RestructuringChargesMember 2023-01-01 2023-09-30 0000081362 us-gaap:RestructuringChargesMember 2023-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2023-07-01 2023-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2022-07-01 2022-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2023-01-01 2023-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2022-01-01 2022-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2023-07-01 2023-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2022-07-01 2022-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2023-01-01 2023-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2022-01-01 2022-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2023-07-01 2023-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2022-07-01 2022-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2023-01-01 2023-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2022-01-01 2022-09-30 0000081362 us-gaap:PerformanceSharesMember 2023-07-01 2023-09-30 0000081362 us-gaap:PerformanceSharesMember 2022-07-01 2022-09-30 0000081362 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0000081362 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2022-07-01 2022-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2022-01-01 2022-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2023-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0000081362 us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0000081362 srt:MinimumMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0000081362 srt:MaximumMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0000081362 us-gaap:RestrictedStockMember 2023-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0000081362 srt:MaximumMember us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0000081362 us-gaap:PerformanceSharesMember 2023-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-07-01 2023-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-07-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2023-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-09-30 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2022-03-31 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2023-09-30 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2023-07-01 2023-09-30 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember srt:AmericasMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember us-gaap:EMEAMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember srt:AsiaPacificMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember kwr:GlobalSpecialtyBusinessesMember 2022-12-31 0000081362 srt:ScenarioPreviouslyReportedMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:RevisionOfPriorPeriodReclassificationAdjustmentMember srt:AmericasMember 2022-12-31 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:EMEAMember 2022-12-31 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:RevisionOfPriorPeriodReclassificationAdjustmentMember srt:AsiaPacificMember 2022-12-31 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:RevisionOfPriorPeriodReclassificationAdjustmentMember kwr:GlobalSpecialtyBusinessesMember 2022-12-31 2022-12-31 0000081362 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2022-12-31 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2022-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2023-01-01 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2023-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2023-09-30 0000081362 us-gaap:CustomerListsMember 2023-09-30 0000081362 us-gaap:CustomerListsMember 2022-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2023-09-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2022-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2023-09-30 0000081362 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000081362 kwr:HoughtonCombinationMember 2022-12-31 0000081362 kwr:AmendedRevolverMember 2023-09-30 0000081362 kwr:AmendedRevolverMember 2022-12-31 0000081362 kwr:AmendedUsTermLoanMember 2023-09-30 0000081362 kwr:AmendedUsTermLoanMember 2022-12-31 0000081362 kwr:AmendedEuroTermLoanMember 2023-09-30 0000081362 kwr:AmendedEuroTermLoanMember 2022-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2023-09-30 0000081362 kwr:IndustrialDevelopmentBondsMember 2022-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2023-09-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2022-12-31 0000081362 kwr:AmendedEuroTermLoanMember 2022-06-30 0000081362 kwr:AmendedUsTermLoanMember 2022-06-30 0000081362 kwr:AmendedRevolverMember 2022-06-30 0000081362 kwr:AmendedCreditFacilityMember 2022-06-30 0000081362 kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember 2023-07-01 2023-09-30 0000081362 kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember 2023-01-01 2023-09-30 0000081362 kwr:OldCreditFacilityMember 2023-09-30 0000081362 srt:MinimumMember kwr:AmendedCreditFacilityMember 2023-01-01 2023-09-30 0000081362 srt:MaximumMember kwr:AmendedCreditFacilityMember 2023-01-01 2023-09-30 0000081362 us-gaap:InterestRateSwapMember 2023-03-31 0000081362 us-gaap:InterestRateSwapMember 2023-01-01 2023-03-31 0000081362 us-gaap:InterestRateSwapMember 2023-09-30 0000081362 us-gaap:OtherAssetsMember kwr:AmendedRevolverMember 2022-06-30 0000081362 us-gaap:OtherAssetsMember 2023-09-30 0000081362 us-gaap:OtherAssetsMember 2022-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2023-09-30 0000081362 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-06-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-06-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-09-30 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0000081362 2023-06-01 2023-06-30 0000081362 us-gaap:FairValueInputsLevel1Member 2023-09-30 0000081362 us-gaap:FairValueInputsLevel2Member 2023-09-30 0000081362 us-gaap:FairValueInputsLevel3Member 2023-09-30 0000081362 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000081362 currency:MXN 2023-09-30 0000081362 currency:JPY 2023-09-30 0000081362 us-gaap:ForeignExchangeForwardMember 2023-01-01 2023-09-30 0000081362 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2023-01-01 2023-09-30 0000081362 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2022-01-01 2022-12-31 0000081362 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2023-01-01 2023-03-31 0000081362 2022-01-01 2022-12-31 0000081362 us-gaap:InterestRateSwapMember 2023-01-01 2023-09-30 0000081362 us-gaap:InterestRateSwapMember 2022-01-01 2022-12-31 0000081362 us-gaap:InterestExpenseMember 2023-07-01 2023-09-30 0000081362 us-gaap:InterestExpenseMember 2022-07-01 2022-09-30 0000081362 us-gaap:InterestExpenseMember 2023-01-01 2023-09-30 0000081362 us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2023-07-01 2023-09-30 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2023-01-01 2023-09-30 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0000081362 us-gaap:InsuranceClaimsMember 2022-01-01 2022-12-31 0000081362 us-gaap:InsuranceClaimsMember 2023-01-01 2023-09-30 0000081362 kwr:HoughtonEnvironmentalMattersMember 2022-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2023-09-30 0000081362 kwr:JeewatBijlaniMember 2023-07-01 2023-09-30 0000081362 kwr:JeewatBijlaniMember kwr:MrBijlanisTradingArrangementCommonStockMember 2023-09-30 0000081362 kwr:JeewatBijlaniMember kwr:MrBijlanisTradingArrangementStockOptionsMember 2023-09-30 shares iso4217:USD iso4217:USD shares kwr:segment kwr:country pure iso4217:EUR kwr:position kwr:location 0000081362 --12-31 2023 Q3 false P1Y P243D 10-Q true 2023-09-30 false 001-12019 QUAKER CHEMICAL CORPORATION PA 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer false false false 17984916 490612000 492218000 1486204000 1458777000 307265000 331469000 951716000 1002393000 183347000 160749000 534488000 456384000 122810000 115456000 362212000 343081000 1019000 -1423000 6034000 -604000 0 2107000 0 7992000 59518000 44609000 166242000 105915000 -2713000 85000 -8558000 -10520000 -12781000 -8389000 -38744000 -20228000 44024000 36305000 118940000 75167000 13593000 10185000 36956000 14425000 30431000 26120000 81984000 60742000 3279000 -212000 10660000 -642000 33710000 25908000 92644000 60100000 40000 41000 94000 74000 33670000 25867000 92550000 60026000 1.87 1.44 5.15 3.35 1.87 1.44 5.14 3.35 0.455 0.435 1.325 1.265 33710000 25908000 92644000 60100000 -25504000 -71986000 -24116000 -155284000 -281000 -497000 -852000 -2400000 1241000 -140000 5804000 1535000 -637000 -818000 938000 -2385000 -24619000 -72447000 -16522000 -153734000 9091000 -46539000 76122000 -93634000 36000 3000 55000 5000 9055000 -46542000 76067000 -93639000 198358000 180963000 446459000 472888000 129204000 151105000 121566000 133743000 70724000 55438000 966311000 994137000 431565000 428190000 235125000 229595000 196440000 198595000 38595000 43766000 504457000 515008000 890464000 942925000 92965000 88234000 9569000 11218000 33705000 27739000 2732506000 2821622000 19246000 19245000 190067000 193983000 8190000 7808000 43641000 39834000 3590000 5483000 1574000 1560000 85799000 86873000 352107000 354786000 804973000 933561000 22163000 26967000 151606000 160294000 27344000 28765000 33212000 38664000 1391405000 1543037000 1 1 30000000 30000000 18000855 18000855 17950264 17950264 18001000 17950000 938473000 928288000 538628000 469920000 -154724000 -138240000 1340378000 1277918000 723000 667000 1341101000 1278585000 2732506000 2821622000 92644000 60100000 1059000 2589000 61434000 60692000 7486000 -3612000 -515000 -8844000 11189000 8635000 0 5246000 0 -4265000 6034000 -604000 -2000000 -6556000 -22133000 65256000 -30607000 72386000 9771000 11081000 -7914000 -1234000 2046000 3059000 199460000 -26293000 25794000 20230000 0 9421000 0 65000 -25794000 -29586000 14075000 668500000 0 750000000 -112835000 -10418000 797000 2131000 0 3734000 23459000 22302000 -953000 -616000 -150525000 46561000 -5746000 -16967000 17395000 -26285000 180963000 165176000 198358000 138891000 17897000 917053000 516334000 -63990000 628000 1387922000 19816000 5000 19821000 -6271000 1000 -6270000 0.415 7434000 7434000 15000 1646000 1661000 17912000 918699000 528716000 -70261000 634000 1395700000 14343000 28000 14371000 -74985000 -33000 -75018000 0.415 7438000 7438000 8000 2943000 2951000 17920000 921642000 535621000 -145246000 629000 1330566000 25867000 41000 25908000 -72409000 -38000 -72447000 0.435 7803000 7803000 11000 3395000 3406000 17931000 925037000 553685000 -217655000 632000 1279630000 17950000 928288000 469920000 -138240000 667000 1278585000 29534000 7000 29541000 15063000 3000 15066000 0.435 7822000 7822000 32000 1386000 1418000 17982000 929674000 491632000 -123177000 677000 1316788000 29346000 47000 29393000 -6931000 -38000 -6969000 0.435 7830000 7830000 17000 5267000 5284000 17999000 934941000 513148000 -130108000 686000 1336666000 33670000 40000 33710000 -24616000 -3000 -24619000 0.455 8190000 8190000 2000 3532000 3534000 18001000 938473000 538628000 -154724000 723000 1341101000 Basis of Presentation and Description of Business<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires. The “Combination” refers to the legacy Quaker combination with Houghton International, Inc. (“Houghton”).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments, which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company’s business structure as of January 1, 2023, including reportable segments and customer industry disaggregation. As a result of the Company’s new organizational structure effective January 1, 2023, the Company reallocated goodwill previously held by the former Global Specialty Businesses segment to the remaining business segments as of January 1, 2023. However, the Company did not recast the carrying amount of goodwill for the year ended December 31, 2022. See Notes 4, 5, and 13 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as “Fluidcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”, for various heavy industrial and manufacturing applications.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hyper-inflationary economies</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three and nine months ended September 30, 2023, the Company's Argentine and Turkish subsidiaries represented a combined 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2023, the Company recorded $1.2 million and $2.9 million of remeasurement losses associated with the applicable currency conversions, respectively. Comparatively, during the three and nine months ended September 30, 2022, the Company recorded $1.0 million and $1.2 million of remeasurement losses associated with the applicable currency conversions, respectively. These losses were recorded within foreign exchange losses, net, which is a component of Other (expense) income, net, in the Company’s Condensed Consolidated Statements of Operations.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting only of normal recurring adjustments, which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company’s new structure includes three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific. Prior to the Company’s reorganization, the Company’s historical reportable segments were: (i) Americas; (ii) EMEA; (iii) Asia/Pacific; and (iv) Global Specialty Businesses. Prior period information has been recast to align with the Company’s business structure as of January 1, 2023, including reportable segments and customer industry disaggregation. As a result of the Company’s new organizational structure effective January 1, 2023, the Company reallocated goodwill previously held by the former Global Specialty Businesses segment to the remaining business segments as of January 1, 2023. However, the Company did not recast the carrying amount of goodwill for the year ended December 31, 2022. See Notes 4, 5, and 13 of Notes to Condensed Consolidated Financial Statements.</span></div> 3 25 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hyper-inflationary economies</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three and nine months ended September 30, 2023, the Company's Argentine and Turkish subsidiaries represented a combined 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three and nine months ended September 30, 2023, the Company recorded $1.2 million and $2.9 million of remeasurement losses associated with the applicable currency conversions, respectively. Comparatively, during the three and nine months ended September 30, 2022, the Company recorded $1.0 million and $1.2 million of remeasurement losses associated with the applicable currency conversions, respectively. These losses were recorded within foreign exchange losses, net, which is a component of Other (expense) income, net, in the Company’s Condensed Consolidated Statements of Operations.</span></div> 0.01 0.01 0.02 0.02 1200000 2900000 1000000 1200000 Business Acquisitions<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Previous Acquisitions</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Company acquired a business that provides pickling and rinsing products and services, which is part of the EMEA reportable segment, for approximately 3.5 million EUR or approximately $3.5 million. This acquisition, along with the Company’s January 2022 acquisition in the Americas (described below), which had similar specializations and product offerings in pickling inhibitor technologies, strengthens Quaker Houghton’s position in pickling inhibitors and additives, enabling the Company to better support and optimize production processes for customers across the metals industry. As of September 30, 2023, the allocation of the purchase of this acquisition has been finalized.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company acquired a business that provides pickling inhibitor technologies, drawing lubricants and stamping oil, and various other lubrication, rust preventative, and cleaner applications, which is part of the Americas reportable segment, for approximately $8.0 million. This business broadens the Company’s product offerings within its existing metals and metalworking business in the Americas region. During the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company paying less than $0.1 million of additional purchase consideration. Also in January 2022, the Company acquired a business related to the sealing and impregnation of metal castings for the automotive sector, as well as impregnation resin and impregnation systems for metal parts, which is part of the EMEA reportable segment, for approximately 1.2 million EUR or approximately $1.4 million. This business broadens its product offerings and service capabilities within its existing impregnation business. The allocation of the purchase prices of both of these January 2022 acquisitions have been finalized.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company acquired Baron Industries, a privately held company that provides vacuum impregnation services of castings, powder metals and electrical components for its Americas reportable segment for $11.0 million, including an initial cash payment of $7.1 million, subject to post-closing adjustments, as well as certain earn-out provisions that are payable at various times from 2022 through 2025. The earn-out provisions could total a maximum of $4.5 million. As of September 30, 2023, the Company has remaining earn-out liabilities recorded on its Condensed Consolidated Balance Sheet of $1.1 million. Additionally, during the third quarter of 2022 the Company finalized post-closing adjustments that resulted in the Company receiving a payment of less than $0.1 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company acquired Coral Chemical Company, LLC (“Coral”), a privately held U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. During the first nine months of 2023, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.</span></div> 3500000 3500000 8000000 100000 1200000 1400000 11000000 7100000 4500000 1100000 100000 0 1500000 Recently Issued Accounting Standards There have been no recently issued accounting standards that will have a material impact on the Company’s condensed consolidated financial statements and related footnote disclosures. Business Segments<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region. All prior period information has been recast to reflect the Company’s new reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”) and Selling, general and administrative expenses (“SG&amp;A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges (credits), net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other (expense) income, net.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the performance of the Company’s reportable segments:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204,280 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,723 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment operating earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,033 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,951 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">371,960 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combination, integration and other acquisition-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related (charges) credits, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-operating and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(47,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,001)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(139,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of corporate assets and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,518 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,609 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166,242 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,915 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,389)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes and equity in net income of associated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,024 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,305 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,940 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,167 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes inter-segment revenues. All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,772 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3 3 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the performance of the Company’s reportable segments:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204,280 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,076 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,803 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,723 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment operating earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,033 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,951 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">371,960 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combination, integration and other acquisition-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related (charges) credits, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-operating and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52,280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(47,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,001)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(139,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of corporate assets and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(45,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,518 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,609 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166,242 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,915 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,389)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before taxes and equity in net income of associated companies</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,024 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,305 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118,940 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,167 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes inter-segment revenues. All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,772 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,702 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,778 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,718 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,259 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 245899000 254678000 750531000 702580000 139620000 134386000 435602000 426739000 105093000 103154000 300071000 329458000 490612000 492218000 1486204000 1458777000 69148000 66749000 204280000 164065000 27922000 15479000 81076000 58803000 30963000 26723000 86604000 76146000 128033000 108951000 371960000 299014000 0 2107000 0 7992000 1019000 -1423000 6034000 -604000 52280000 47852000 154001000 139894000 15216000 15806000 45683000 45817000 59518000 44609000 166242000 105915000 -2713000 85000 -8558000 -10520000 -12781000 -8389000 -38744000 -20228000 44024000 36305000 118940000 75167000 1772000 2702000 6778000 9200000 5161000 9448000 18718000 37259000 793000 327000 1329000 739000 Net Sales and Revenue Recognition<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements Resulting in Net Reporting</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company’s Fluidcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $21.6 million and $63.2 million for the three and nine months ended September 30, 2023, respectively, and $21.4 million and $61.7 million for the three and nine months ended September 30, 2022, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Concentration</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2022 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 11% of consolidated net sales, with its largest customer accounting for approximately 3% of consolidated net sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of September 30, 2023 or December 31, 2022.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had approximately $2.8 million and $5.7 million of deferred revenue as of September 30, 2023 and December 31, 2022, respectively. For the nine months ended September 30, 2023, the Company satisfied all of the associated performance obligations and recognized into revenue the advance payments received and recorded as of December 31, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company’s net sales by geographic region, customer industries, and timing of revenue recognized. Prior period information has been recast to reflect the Company’s current period customer industry disaggregation. See Note 1 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">466,100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144,109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">453,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">545,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,032,885 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">718,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291,740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,412,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">468,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,239 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">456,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,002,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">669,945 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">396,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">321,031 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,387,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 21600000 63200000 21400000 61700000 0.11 0.03 2800000 5700000 3 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company’s net sales by geographic region, customer industries, and timing of revenue recognized. Prior period information has been recast to reflect the Company’s current period customer industry disaggregation. See Note 1 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">466,100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245,899 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,620 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,093 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490,612 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144,109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">453,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">545,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,032,885 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">718,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">402,508 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291,740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,412,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,344 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73,769 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">750,531 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">435,602 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">300,071 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486,204 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">340,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124,566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99,929 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">468,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,820 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,678 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,386 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103,154 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">492,218 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185,784 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,239 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">456,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,002,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Revenue Recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales at a point in time</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">669,945 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">396,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">321,031 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,387,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services transferred over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,580 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,739 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">329,458 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,458,777 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 67957000 32630000 49320000 149907000 177942000 106990000 55773000 340705000 245899000 139620000 105093000 490612000 235209000 128586000 102305000 466100000 10690000 11034000 2788000 24512000 245899000 139620000 105093000 490612000 204834000 104376000 144109000 453319000 545697000 331226000 155962000 1032885000 750531000 435602000 300071000 1486204000 718187000 402508000 291740000 1412435000 32344000 33094000 8331000 73769000 750531000 435602000 300071000 1486204000 67943000 32748000 51341000 152032000 186735000 101638000 51813000 340186000 254678000 134386000 103154000 492218000 243699000 124566000 99929000 468194000 10979000 9820000 3225000 24024000 254678000 134386000 103154000 492218000 185784000 107163000 163239000 456186000 516796000 319576000 166219000 1002591000 702580000 426739000 329458000 1458777000 669945000 396944000 321031000 1387920000 32635000 29795000 8427000 70857000 702580000 426739000 329458000 1458777000 Leases<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for certain facilities, vehicles and machinery and equipment with remaining lease terms up to 8 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 92 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material variable lease costs, sublease income, or finance leases for the three and nine months ended September 30, 2023 and 2022. The components of the Company’s lease expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,886 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,664 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,547 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash lease liabilities activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:73.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,766 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,024 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,991 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:86.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,691 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028 and beyond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,372)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,276 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P8Y P92Y 0 0 0 0 0 0 0 0 The components of the Company’s lease expense are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,886 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,664 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,547 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash lease liabilities activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:73.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,595 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,766 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,024 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,991 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div> 3886000 3664000 11532000 10592000 193000 201000 587000 625000 3917000 3768000 11547000 10575000 2910000 2599000 6566000 10672000 38595000 43766000 12113000 12024000 22163000 26967000 34276000 38991000 P4Y9M25D P5Y1M6D 0.0467 0.0436 <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:86.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,691 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,051 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028 and beyond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,648 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,372)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,276 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3691000 12589000 8417000 6286000 3051000 5614000 39648000 5372000 34276000 Restructuring and Related Activities<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2019, the Company’s management approved a global restructuring plan (the “QH Program”) as part of its initial plan to realize certain cost synergies associated with the Combination. As of December 31, 2022, the Company substantially completed all of the initiatives under the QH Program with only an immaterial amount of remaining severance still to be paid, which has been paid as of September 30, 2023.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of September 30, 2023, the program included restructuring and associated severance costs to reduce headcount by approximately 100 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to continue throughout 2023. The exact timing to complete all actions and final costs associated will depend on a number of factors that are subject to change.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. Restructuring costs include severance costs to reduce headcount, including customary and routine adjustments to initial estimates for employee separation costs, as well as costs to close certain facilities under the QH Program. These costs are recorded in Restructuring and related charges in the Company’s Consolidated Statements of Operations. As described in Note 4 of Notes to Consolidated Financial Statements, Restructuring and related charges are not included in the Company’s calculation of reportable segments’ measure of operating earnings and therefore these costs are not reviewed by or recorded to reportable segments.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. During the three months ended September 30, 2023, the Company classified certain properties with aggregate book value of approximately $6.9 million as held-for-sale that are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company’s accruals for its restructuring programs are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:85.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued restructuring as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.62pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,483</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued restructuring as of September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,590</span></td></tr></table></div> 100 6900000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company’s accruals for its restructuring programs are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:85.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued restructuring as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.62pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,483</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued restructuring as of September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,590</span></td></tr></table></div> 5483000 6034000 7914000 13000 3590000 Share-Based Compensation<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">203</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">533</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">837</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,269</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested stock awards and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,429</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,783</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,192</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,998</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director stock ownership plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,113</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,314</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,775</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,200</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,189</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,634</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded in SG&amp;A, except for $0.1 million and $0.2 million for the three and nine months ended September 30, 2022, respectively, recorded within Combination, integration and other acquisition-related expenses. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, unrecognized compensation expense related to unvested stock options was $0.5 million, to be recognized over a weighted average remaining period of 0.9 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards and Restricted Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, the Company granted 38,894 non-vested restricted shares and 6,675 non-vested restricted stock units under its long-term incentive plan (“LTIP”)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which are subject to time-based vesting, generally over <span style="-sec-ix-hidden:f-714">one</span> to three years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of these grants is based on the last sale price of the Company’s common stock on the date of grant. As of September 30, 2023, unrecognized compensation expense related to the non-vested restricted shares was $8.0 million, to be recognized over a weighted average remaining period of 1.4 years, and unrecognized compensation expense related to non-vested restricted stock units was $1.6 million, to be recognized over a weighted average remaining period of 1.5 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”), which will be settled in a certain number of shares subject to market-based or performance-based and time-based vesting conditions. The number of fully vested shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of the Company’s peer group, the S&amp;P Midcap 400 Materials group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service period required for the PSUs is generally </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. The fair value of PSUs granted with a ROIC condition is based on the trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation, which included the following assumptions set forth in the table below: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023<br/>Grants </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of PSUs granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,861</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the conditions of the PSUs and performance to date for each of the outstanding PSU awards as of September 30, 2023, the Company estimates that it will issue 25,613 fully vested shares as of the applicable settlement date for such outstanding PSUs awards. As of September 30, 2023, there was approximately $8.0 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.2 years.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">203</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">533</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">837</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,269</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested stock awards and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,429</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,783</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,192</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,998</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director stock ownership plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,113</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">875</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,314</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,775</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,200</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,189</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,634</span></td></tr></table></div> 203000 533000 837000 1269000 2429000 1783000 7192000 4998000 30000 9000 56000 53000 1113000 875000 3104000 2314000 3775000 3200000 11189000 8634000 100000 200000 500000 P0Y10M24D 38894 6675 P3Y 8000000 P1Y4M24D 1600000 P1Y6M 0 2 P3Y The grant-date fair value of the PSUs valued using a Monte Carlo simulation, which included the following assumptions set forth in the table below: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023<br/>Grants </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of PSUs granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,861</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.85%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0</span></td></tr></table> 16861 0.0385 0.0096 P3Y 25613 8000000 P2Y2M12D Pension and Other Postretirement Benefits<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:23.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,487</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,272</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,452</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,949</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial loss (gain) amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">308</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">743</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service cost (income) amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">684 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(263)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(818)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, one of the Company’s pension plans in the U.K. liquidated approximately $50 million of its invested assets and subsequently funded and entered into an insurance annuity contract, which will provide for the pension plan’s defined benefit obligations to participants. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, $3.4 million and $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.2 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2023.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:23.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,487</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,272</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,452</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,949</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial loss (gain) amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">308</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">743</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service cost (income) amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">684 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(263)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(818)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 109000 166000 0 1000 320000 520000 0 1000 2487000 1272000 14000 8000 7452000 3949000 51000 19000 2033000 1942000 0 0 6056000 6038000 0 0 -103000 -238000 36000 23000 -308000 -743000 95000 70000 18000 3000 -4000 -8000 26000 8000 -12000 -17000 684000 -263000 -26000 -22000 2050000 -818000 -56000 -67000 50000000 3400000 100000 5200000 200000 Other (expense) income, net<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other (expense) income, net are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from third party license fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">891</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">906</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,928)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loss) gain on disposals of property, plant, equipment and other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(91)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-income tax refunds and other related credits (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,339 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,617)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit (costs) income, non-service components</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(549)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">452</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,674)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,406</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility remediation recoveries, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,104</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,763)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">270</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other (expense) income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,713)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,558)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,520)</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-income tax refunds and other related credits (expense) during the nine months ended September 30, 2023 and nine months ended September 30, 2022 include adjustments to a Combination-related indemnification asset associated with the settlement of certain income tax audits for tax periods prior to August 1, 2019. See Note 11 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility remediation recoveries, net, during the nine months ended September 30, 2023 and the three and nine months ended September 30, 2022, reflect gains recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage incurred during the three months ended September 30, 2021. See Note 18 of Notes to the Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt during the nine months ended September 30, 2022, represents a write-off of certain previously unamortized deferred financing costs as well as a portion of third party and creditor debt issuance costs incurred to execute an amendment to the Company’s primary credit facility. See Note 14 of Notes to Condensed Consolidated Financial Statements.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other (expense) income, net are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from third party license fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">891</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">906</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,928)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loss) gain on disposals of property, plant, equipment and other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(91)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-income tax refunds and other related credits (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,339 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,617)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit (costs) income, non-service components</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(549)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">452</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,674)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,406</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility remediation recoveries, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,104</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,763)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">270</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other (expense) income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,713)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,558)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,520)</span></td></tr></table></div> 245000 253000 891000 906000 -2498000 -1928000 -10049000 -5859000 -25000 48000 -91000 33000 91000 122000 1339000 -1617000 -549000 452000 -1674000 1406000 0 1104000 1014000 1104000 0 0 0 -6763000 23000 34000 12000 270000 -2713000 85000 -8558000 -10520000 Income Taxes and Uncertain Income Tax PositionsThe Company’s effective tax rates for the three and nine months ended September 30, 2023 were 30.9% and 31.1%, respectively, compared to 28.1% and 19.2% for the three and nine months ended September 30, 2022, respectively. The Company’s effective tax rate for the three months ended September 30, 2023 was primarily impacted by foreign tax inclusions, withholding taxes, return to provision adjustments, the impact of U.S. Department of Treasury guidance on the usage of foreign tax credits, and the mix of earnings. The effective tax rate for the first nine months of 2023 was further impacted by various other items including changes to the valuation allowance for and the usage of foreign tax credits due to an enacted law change in Brazil, and share-based compensation. Comparatively, the prior year effective tax rates were largely impacted by foreign tax inclusions, changes in the valuation allowance for foreign tax credits, the impact of audit settlements, a reduction in reserves for uncertain tax positions, withholding taxes, and the impact of forecasted earnings and the mix of such earnings. In addition, the Company’s effective tax rates for three and nine months ended September 30, 2022 were impacted by the Company recording earnings of one of its subsidiaries at a statutory tax rate of 25% while the recertification of its concessionary 15% tax rate was pending receipt.As previously reported, Houghton Italia, S.r.l was involved in a corporate income tax audit with the Italian tax authorities covering tax years 2014 through 2018. The Company settled all years 2014 through 2018 for $3.7 million and, accordingly, released all reserves relating to this audit for the settled tax years during the first quarter of 2022. The settlement is to be paid via installments through 2026 and, through September 30, 2023, the Company has paid $1.5 million of such installments. Having received approximately $1.2 million from escrow during the quarter, the Company has a remaining indemnification receivable of $3.2 million in connection with its claim against the former owners of Houghton for any pre-Combination tax liabilities arising from this matter, as well as other audit settlements and tax matters. In the first quarter of 2023, the Company was notified by the Spanish tax authorities of audits to commence for several of its legal entities operating in Spain and spanning tax years 2018 through 2021. In addition, in July 2023, the Company was notified by the Italian tax authorities of an audit to commence for one of the Company’s Italian subsidiaries for tax year 2019. Both of these audit proceedings are ongoing and the Company has been providing documentation in response to all of their inquiries. The Company has not established any reserves for these matters at this time. 0.309 0.311 0.281 0.192 3700000 1500000 -1200000 3200000 Earnings Per Share<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings per share calculations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,752 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,086 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,776 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,754</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,847,305</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,889,444</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,835,976</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,506 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,752 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,086 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,847,305</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,889,444</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,835,976</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,566</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,709</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,465</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,921,274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,859,871</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,906,153</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,851,441</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 11,598 and 10,453 for the three and nine months ended September 30, 2023, respectively, and 25,896 and 24,618 for the three and nine months ended September 30, 2022, respectively.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings per share calculations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,670 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,506 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,752 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,086 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,776 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,754</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,847,305</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,889,444</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,835,976</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,506 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,752 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,086 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,847,305</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,889,444</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,835,976</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,566</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,709</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,465</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,921,274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,859,871</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,906,153</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,851,441</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 33670000 25867000 92550000 60026000 164000 115000 464000 250000 33506000 25752000 92086000 59776000 17908754 17847305 17889444 17835976 1.87 1.44 5.15 3.35 33670000 25867000 92550000 60026000 164000 115000 464000 250000 33506000 25752000 92086000 59776000 17908754 17847305 17889444 17835976 12520 12566 16709 15465 17921274 17859871 17906153 17851441 1.87 1.44 5.14 3.35 11598 10453 25896 24618 Goodwill and Other Intangible Assets<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment. The Company continually evaluates financial performance, economic conditions and other recent developments, including rising interest rates and the cost of capital among other factor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, in assessing if a triggering event indicates that the carrying values of goodwill, indefinite-lived, or long-lived assets are impaired. The Company concluded that during the third quarter the ongoing financial, economic or geopolitical conditions did not represent a triggering event.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company’s reorganization and the associated change in reportable segments and reporting units during the first quarter of 2023, the Company performed the required impairment assessments directly before and immediately after the change in reporting units and concluded that it was not more likely than not that the fair values of any of the Company’s previous or new reporting units were less than their respective carrying amounts.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows. Prior period information has been recast to reflect the Company’s current period reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global<br/>Specialty<br/>Businesses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215,899</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,567</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114,167</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reallocation of reporting units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,711 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(114,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,551)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">282,157</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,473</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,827</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">504,457</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Book Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer lists and rights to sell</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">824,893</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">831,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226,956</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597,937</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">640,314</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks, formulations and product technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157,362</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,534</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,281</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,828</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112,283</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,854</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,576</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,734</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,390</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,186</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">988,109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">997,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,957</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,885</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">753,783</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,343 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,455</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,630</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,942</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,650</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,309</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023 and December 31, 2022, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $187.6 million and $189.1 million, respectively.</span></div> <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows. Prior period information has been recast to reflect the Company’s current period reportable segments. See Note 1 of Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global<br/>Specialty<br/>Businesses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215,899</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,567</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114,167</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reallocation of reporting units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,711 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(114,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279,596 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515,008 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,551)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of September 30, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">282,157</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,473</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,827</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">504,457</span></td></tr></table></div> 215899000 34567000 150375000 114167000 515008000 63697000 31711000 18759000 -114167000 0 279596000 66278000 169134000 0 515008000 2561000 -805000 -12307000 0 -10551000 282157000 65473000 156827000 0 504457000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Book Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer lists and rights to sell</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">824,893</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">831,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226,956</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597,937</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">640,314</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks, formulations and product technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157,362</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,534</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,281</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,828</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112,283</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,854</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,576</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,734</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,390</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,186</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">988,109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">997,740</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,957</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">702,885</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">753,783</span></td></tr></table></div> 824893000 831600000 226956000 191286000 597937000 640314000 157362000 158564000 52534000 46281000 104828000 112283000 5854000 7576000 5734000 6390000 120000 1186000 988109000 997740000 285224000 243957000 702885000 753783000 The Company recorded amortization expense as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,734 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,343 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 14529000 14102000 43734000 43343000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,455</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,630</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,942</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,650</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,309</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 13455000 56630000 55942000 55650000 55309000 187600000 189100000 Debt<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the Company’s debt:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Term Loan</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">585,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.7%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596,250 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Euro Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146,918 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151,572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industrial development bonds</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">825,876 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">954,798 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: short-term and current portion of long-term debts</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,246)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,245)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">804,973 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">933,561 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Credit facilitiesDuring June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, the Company was in compliance with all of the Credit Facility covenants. See Note 20 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average variable interest rates incurred on the outstanding borrowings under the Credit Facility during the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> three and nine months </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended September 30, 2023 were approximately 6.4% and 6.1%, respectively. As of September 30, 2023, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.3%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $414 million, which is net of bank letters of credit of approximately $3 million, as of September 30, 2023.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of September 30, 2023, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of September 30, 2023, the Company had $1.7 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $3.6 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2022, the Company had $2.0 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheet and $4.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Industrial development bonds</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023 and December 31, 2022, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of September 30, 2023 was approximately $34 million.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of September 30, 2023 were approximately $5 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense, net</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,598 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,465 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,863 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,339 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,951 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,818 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,922 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,928 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the variable interest rates associated with the Credit Facility, as of September 30, 2023 and as of December 31, 2022, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the Company’s debt:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Term Loan</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">585,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.7%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596,250 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Euro Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146,918 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151,572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industrial development bonds</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,303 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">825,876 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">954,798 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,992)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: short-term and current portion of long-term debts</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,246)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,245)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">804,973 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">933,561 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.060 82838000 0.052 195673000 0.067 585000000 0.057 596250000 0.050 146918000 0.031 151572000 0.053 10000000 0.053 10000000 1120000 1303000 825876000 954798000 1657000 1992000 19246000 19245000 804973000 933561000 150000000 600000000 500000000 300000000 1 0.064 0.061 0.063 0.00150 0.00275 414000000 3000000 300000000 P3Y 0.0364 0.053 2200000 700000 700000 1500000 P5Y 1700000 3600000 2000000 4300000 10000000 10000000 34000000 5000000 <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:48.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,598 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,465 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,863 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,339 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,589 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,951 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,818 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,922 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,928 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 12598000 9465000 40863000 20339000 353000 353000 1059000 2589000 12951000 9818000 41922000 22928000 Accumulated Other Comprehensive Income<div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130,738)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,024)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,563 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130,108)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(156,239)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,743)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(546)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,724)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(133,110)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,269)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,170)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145,246)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(71,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at September 30, 2022</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(205,058)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,772)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,988)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217,655)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(132,161)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,595)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,484)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(138,240)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">547 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">772 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(156,239)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,743)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(546)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,724)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2021</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,843)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,172)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,372)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63,990)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">657 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">963 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of September 30, 2022</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(205,058)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,772)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,988)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217,655)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All reclassifications related to unrealized (loss) gain in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other comprehensive income for noncontrolling interest are related to currency translation adjustments.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130,738)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,024)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,563 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130,108)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,387)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at September 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(156,239)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,743)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(546)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,724)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at June 30, 2022</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(133,110)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,269)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,170)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">303 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145,246)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(71,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at September 30, 2022</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(205,058)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,772)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,988)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217,655)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:36.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(132,161)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,595)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,484)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(138,240)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">915 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">547 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">772 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(156,239)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,743)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(546)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,724)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2021</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,843)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,172)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,372)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(63,990)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155,215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(154,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">657 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">963 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">635 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of September 30, 2022</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(205,058)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,772)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,988)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(217,655)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> -130738000 -4024000 91000 4563000 -130108000 -25501000 304000 -802000 1612000 -24387000 0 71000 -4000 67000 0 -94000 169000 -371000 -296000 -156239000 -3743000 -546000 5804000 -154724000 -133110000 -11269000 -1170000 303000 -145246000 -71948000 453000 -1006000 -182000 -72683000 0 210000 -30000 0 180000 0 -166000 218000 42000 94000 -205058000 -10772000 -1988000 163000 -217655000 -132161000 -4595000 -1484000 0 -138240000 -24078000 915000 640000 7538000 -14985000 0 225000 547000 772000 0 -288000 -249000 -1734000 -2271000 -156239000 -3743000 -546000 5804000 -154724000 -49843000 -13172000 397000 -1372000 -63990000 -155215000 2535000 -3326000 1993000 -154013000 0 657000 306000 0 963000 0 -792000 635000 -458000 -615000 -205058000 -10772000 -1988000 163000 -217655000 Fair Value Measurements<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has valued its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. The fair values of Company-owned life insurance assets are based on quotes for like instruments with similar credit ratings and terms. These assets are subject to fair value measurement as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:48.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value Measurements as of September 30, 2023<br/>Using Fair Value Hierarchy</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company-owned life insurance</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:48.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value Measurements as of December 31, 2022<br/>Using Fair Value Hierarchy</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company-owned life insurance</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1900000 These assets are subject to fair value measurement as follows:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:48.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value Measurements as of September 30, 2023<br/>Using Fair Value Hierarchy</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company-owned life insurance</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:48.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value Measurements as of December 31, 2022<br/>Using Fair Value Hierarchy</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company-owned life insurance</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,114 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 285000 0 285000 0 285000 0 285000 0 2114000 0 2114000 0 2114000 0 2114000 0 Hedging ActivitiesThe Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the Company’s revenues and earnings are generated by its foreign operations. These foreign operations also represent a significant portion of the Company’s assets and liabilities. Generally, all of these foreign operations use the local currency as their functional currency and many have operations in currencies other than their functional currency, which creates foreign exchange risk. The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other (expense) income, net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All open foreign exchange forward contracts as of September 30, 2023 were entered into as hedges against the U.S. dollar. As of September 30, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar value of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:85.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mexican Peso</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,900 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,400 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open foreign exchange forward contracts as of September 30, 2023 had maturities occurring over a period of one month.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swaps</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur. Interest rate swaps are entered into with a limited number of counterparties within several tranches, each of which allows for net settlement of all contracts through a single payment to participating counterparties in a single currency in the event of a default on or termination of any one contract. As such, in accordance with the Company’s accounting policy, these derivative instruments are recorded on a net basis within the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:35.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.789%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated<br/>Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current Assets</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,538 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,974 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net unrealized (gain) loss deferred to AOCI:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"></td><td style="width:36.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net gain (loss) reclassified from AOCI to earnings:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:28.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Location and Amount of Gain (Loss) Recognized in<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(882)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,169 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,366 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(882)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> As of September 30, 2023, the Company had open foreign exchange forward contracts with a notional U.S. dollar value of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:85.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mexican Peso</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,900 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,400 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 41900000 4500000 46400000 P1M 300000000 P3Y <div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:35.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.789%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated<br/>Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current Assets</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,538 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,974 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net unrealized (gain) loss deferred to AOCI:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"></td><td style="width:36.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,804 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net gain (loss) reclassified from AOCI to earnings:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:28.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Location and Amount of Gain (Loss) Recognized in<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(882)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,169 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,366 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(882)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7538000 0 -564000 0 6974000 0 5804000 0 1198000 134000 2259000 -882000 -29000 0 2107000 0 1169000 134000 4366000 -882000 Commitments and ContingenciesThe Company previously disclosed in its 2022 Form 10-K that two of the Company’s locations suffered property damage as a result of flooding and electrical fire, respectively. The Company maintains property and flood insurance for all of its locations globally. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of this previously disclosed matter, other than ongoing work with the Company’s insurance adjuster and insurance carrier regarding the insurance claims submitted. Through September 30, 2023, the Company has received cumulative payments from its insurers of $5.9 million associated with these events. During the nine months ended September 30, 2023, the Company recognized a gain on insurance recoveries of $1.0 million. See Note 10 of Notes to the Condensed Consolidated Financial Statements.As previously disclosed in its 2022 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 26 of Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K. During the three and nine months ended September 30, 2023, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. In addition, during the three and nine months ended September 30, 2023, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation the Company is party to, the Company believes that it has made adequate accruals for costs and liabilities associated with environmental matters or provisions for ongoing litigation for which it is aware. The Company has accrued approximately $6 million as of both September 30, 2023 and December 31, 2022, respectively, for these ongoing matters. 2 5900000 1000000 6000000 6000000 false false false August 31, 2023 Jeewat Bijlani Executive Vice President, Chief Strategy Officer true 2900 6338 EXCEL 89 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,V%8E<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #-A6)7.M)?[.X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$Y&!R;-I:.G#@8K;.QF;+4UBQ-C:R1]^SE>FS*V!]C1TN]/ MGT"-]E(/ 9_#X#&0Q7@WN:Z/4OLU.Q%Y"1#U"9V*94KTJ7D8@E.4GN$(7ND/ M=42H.%^!0U)&D8(96/B%R-K&:*D#*AK"!6_T@O>?H_"V@68J[^BQ'.N<2SL(>'O:O>1U"]M' M4KW&]"M:26>/:W:=_%IO'O=;UE:\J@LA"E[M*R[O5Y(_O,^N/_QNPFXP]F#_ ML?%5L&W@UUVT7U!+ P04 " #-A6)7F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M ,V%8E>) !ARV 4 ,D> 8 >&PO=V]R:W-H965T&UL MM9GO;^(V',;_%8N;3IM42NQ0"CV*1'-T5UVOI=#;J9OVPB2&1$UBYCA0_OM] MG4#2=HYAT=$7)2%Y'OR)?SVQ^VLNGA.?,8E>HC!.+AN^E,N+5BMQ?1;1Y)0O M60Q7YEQ$5,*I6+22I6#4RT11V"*6U6E%-(@;@W[VW5@,^CR581"SL4!)&D54 M;*Y8R->7#=S8?3$)%KY47[0&_25=L"F3WY=C 6>MPL4+(A8G 8^18//+QA!? M.#91@NR./P*V3EX=(X4RX_Q9G=QXEPU+E8B%S)7*@L+'BCDL#)43E..?K6FC M^$TE?'V\<[_.X %F1A/F\/!'X$G_LM%M((_-:1K*"5]_85N@,^7G\C#)_J-U M?F^[W4!NFD@>;<50@BB(\T_ZLGT0KP2D6R$@6P%Y)\!5OV!O!78&FIX&-W60/9M,#31!K*IQ*@5<#4 G!PY?,8&:*/&I8$F_)<%376FY M6_U5KB<5^A[ZQF/I)V@4>\Q[JV]!68H"D5V!KHC1<,J6I\BV3A"QB*TICV.6 MW[L2Y%@G?U,3S)[ ]LN8-LF]\%G[J;0125ZW"R9CM0LQU;S08=D5-5$ M.BN0S@Y#>DBID$R$&S1A2RZD#L]L)46J>RB.4543KU/@=0[#&S,1<$_U0@3C M@+;RS$Y%OZOL>$9]3<[S@O/\P)8I*$PAV0Q078]FKSD-$VU%&F4U ;L%8-=8 MJ%$L [E!UT'(T%T:S9C0@9D]+ LW,;%P3P=GE-:$ZQ5PO4/@)FP1J&$4JO&. M1MHV:O9Y^#[\.IH@Y\OHVXTSO$7._61\/QD^WMS?Z9"-9C61L55.K-8AT#>Q MRP4T5*K:[ F:2NB=B OD\#268@.?GO9)['$?#W7$9E%=Y%=9 A^"_$A?T(T' MO368!V[&;6C2>RR)W;1Z/?N\9VEYC>*ZO*3D)8?P#CT/W).3W0&ZA?O0?:RO M5[-ES\)H=(J^0,J%1@)7(-AIR8TV=0_Y(XZ@P(_\G6LI3;;.3Q. M?.YS]YGIY(Y97I>VC$78'&S>TQ:=>"SX*HA=?46;/2LZ\#&R$B[#$C9'G/>@ M8YY(&J(_@V7U.&5VQ+TVZ:*/'[H$XT^(V%U]/SY&AL)EB,+F[).UWB&\!5=3 MF@TZ6(]UC,B$R\R$S4'GEKM0>6.?QZ9,L<>D:Y-FV[+T?,=(3+B,3-B<=QX# M"6F)SQ$FO\Y^0U/FI@)J4@MI=G)X%,$L-94P IV@7S!:4H%6--0'?K-97>PR M3&%S"H(([ 7Q DTWT8R'6EJSP=:7?6AT8OKTWC!*D/B M'J.[I^E(NW!PC'!$RG!$#@I'3BJ$>I')WUZR>H39)-4NO>QQ?-(NV#AF55W. M,A21@T+130QOV_DBG7HCI3MP+:?9L8KS&!&(E!&('!2!U!L;I'D(! LNM&// M'I];*J"M#UV7@1'8>+FEEO@8,8B4,8@<%(.F$0U#=)4F<#G1MUNS3^4+N%E7 MEZ],/^2@]#.*F%BHCOD[.$@?,D&TI+&^:LV&U:#'R#NDS#O$'%=V%>DSJ$@3 MGMFF&N\8N8>4N8>8(\MNI'TSJ4^S!6YTGTJ(M+&:0+7$/RG1;)]#[G:6N:D- ME=4 G_>Z[1[N]%LK'6.9?^P%/3-]->Y;-H*_+K8[1,MP MC+!#RK!#S%EE-UW.@T2%V0V#8,9B#WD5BYQ[[)I-3)HVUH(>(_[89?RQS:FE M6.&\SDF?%.DU?*D=8?>852WAFF5U&;A6JFR_90$^2J]=':!/=A=')*7#Z+Z)%>< M*_18Y*6\&JR46E^,1G*QXD4BAV+-2_CG3E1%HN"R6H[DNN))6AL5^8AB'(R* M)"L'X\OZWDTUOA0;E6$TN9I1I@QKQ9\8?Y,$YTJ',A?BD+Z[3 MJP'6,^(Y7RCM(H'#/9_P/->>8!Z?6Z>#W9C:\/!\Z_WG.G@(9IY(/A'Y7UFJ M5E>#:(!2?I=L//S*VX!\[6\A!U&+#6@'WK"%YKX'WK"'YK4(<^:F*OB9LF*AE?5N(!51H- MWO1)S7YM#7QEI4Z46U7!OQG8J?%$E"DL.T\1G$F19VFBX.)6P0'R04DD[M#O M:UXE>ETE.DH&R$GU8B8U,RE1>CA3,1OL<+=J1WS0CTXZ1&7HK M2K62: 8S2!WVTW[[N,=^!"SLJ*!;*M[07H>W?#U$#)\ABBESS&?R[>;4%SV3,Y.UH1;[I M-:9!;:KWAONQ%^. 0";<'S+K@E%*HF/8U(81+PHH]HYQ,Q?.C\(PW.&.(O5W MD?J]D4Z$5+KM+(5()8*FE*(3_KC(-VE6+E%2B$IE_];]"/''M>Y>T)9N.4?O MA.*(L%,70\V0_L%<&0YIX!L,.6",>$%L,&3#8I^$)# (LF$$0WG'S$U0L",H MZ"7HETI(B=:5N,N4*]; 'C9BS N-6!VP (>>&:L-\YGG14;2S&R8YP0Q'Q$U%M*,BZJ7B/8>(-PNUJ>HR !XJGM>[]6*5 M5$LNT.* >5Z S9[@ M@)$@H)Y9"2X<]F/B=X1\(%M)?\CU.I^TBWK:!MZ9]ZVWHT2D(6%F]#8L\LW0 M':XBWS?;H0L&H5/<$3G=1TY[([^&C =UH;8)W1TS=B9--HP%#%OI8<,(B6+/[ 0.7.B3H$,Z MD;U*)/TR\4/-"W3#[(BN'R;)L\-B?FP5D .&B5U#-HP%L;G=SES>/(]V-8^] MOB3] O/Z>:EQ24N/665FPR@H=&Q28\,B$D=6E=DPK=VZMI*]LB3]TG+F(N,D M![UY^B1.;#7(:&@*#0?JW%)34P>*X""P"LKA+.@D9*\_2;\ ?;>CP1FG0^JQ MT)*7#ACU8VP^=SE@,0WL#FO# @P/%AVA[O4EZ1>8OW$I+] ^8)0H567SC4KF M.31<@4H!]TM5B5J3U]I+[T1.8FSE9[; B0M#3$IL3&SQ86/"#HU)]B*3]*O, M'AK^V"2?0'Q,5KS(%O!(,A'56C0:U$E%;#TF,Q:$%ALVC/I18&I,!RRFOF]5 M@PT+X-$S<--"]U*3XM[W0C<0N(3'#8[21"47KGAIKUA]ZLN@9_4V?59OL^?R M=KP6>PU,^S7P]Z6H;MP%'.I57(D\Y95$+W^**"&O]#OW;(%.H/VG4.0)_+/> M+KCSK4H[P_"P-P\C\T6#$V6VM:D#Y0^)(1UF#A0;L@Y)0/>JFO:KZO^!RS3+ M-WJC? *;S1RCK[#I0MELVBA@TVR=#E0/FWNI3ONE^C2[SU)>IA*E? &!/XV% MQG=\^!@]]'SS39T;QDRIZ8"1(:-66KE@AZ\'&R9&!U]:"EXMZT]<$M)@4ZKF MY?KN[NXSVNOZXY%Q_PVYF!#'_2FYF#4?R?;NFV]V;Y-JF942Y?P.AL+#$/:[ MJOD,UEPHL:Z_\\R%4J*H3U<\@934 /C_3@BUO= #[#Y&CO\#4$L#!!0 ( M ,V%8E&PO=V]R:W-H965T&UL MK5A=CZ,V%/TK%EU5N])FP'PSS42:25)UI6X[W>FT#U4?'' "'<"I[22S_?6] M!H9)C(-&;5X2,.<>^YQ[_0'3 ^-/(J=4HN>JK,6-E4NYO;9MD>:T(N**;6D- M3]:,5T3"+=_88LLIR9J@JK1=QPGMBA2U-9LV;?=\-F4[618UO>=([*J*\*]W MM&2'&PM;+PU?BDTN58,]FV[)ACY0^;B]YW!G]RQ94=%:%*Q&G*YOK%M\O<2> M"F@0OQ7T((ZND9*R8NQ)W7S*;BQ'C8B6-)6*@L#?GLYI62HF&,??':G5]ZD" MCZ]?V+]OQ(.8%1%TSLK?BTSF-U9LH8RNR:Z47]CA!]H)"A1?RDK1_*)#AW4L ME.Z$9%47#".HBKK])\^=$4. M$C[0[17RG(_(=5S/,)[YV\-=DYS_U_OR/_=^8H;75XC7\'GG^%Y*X6PE_'&[ M$I+#E/_3E/N6W3>SJW7P6FQ)2F\L(!:4[ZDU^_8;'#K?F8R_)-GBDF3+"Y&= MI,CO4^2/L<]^@@VE:')A2D ;&S:Q:M_8SSPOPL[4WA\[.T2Y0>+$IZC%$)6X MH>^?HI9#5.A@Y[7'$Y%!+S(8K<.?94XY2D\*\'W)A/C0:?^(:MH4J23/)A^" M2Q;B)(&@:/5U-P BW 2AUJ!FMA\C#78T@##0>#&OKE&HUY_-*I_0=?0DJ$5 MK>%*PDE*%KQ=/++S[B!G=>3I3/J MAVG!5KX8#XB.:=Z&.-$TFW"1Z_OZ9##A)LI)] E@0$W\,/ 27?X0%X5XJ-Y EWCA6?'NJWAW5/R/5(AK M[;"HI",B)2]6.ZDF Y(,U0R,J25G)5!LP"9)85>21H? L=J8N#,+SOR!--GGM.J2$D)9O(MX\V.:G3'&Y[,'%W5 MW(!2]>.[ND5#7!0Z8:2;9*!3]9-H1ME'[Z<5Y9OFPX" I6%7R_9%I&_M/S[< M-J_<6OL=OIYC0_M"?:QHWH=?Z=LO'9\)WQ2U0"5=0U?.5009Y>W'@_9&LFWS M=KQB$MZUF\N<$MBM% ">KQF3+S>J@_X3SNQ?4$L#!!0 ( ,V%8E=&+U[% M! @ )PB 8 >&PO=V]R:W-H965T&ULK9IM<]LV$L>_ M"D;-=-H9.R(>^!3;FFGL>^A,V\O%[?4U1,$6)A3!D*#LW*?O@J1%B7A0E55[L]AJ7;];+MMB*W:\?:MJ4<$G#ZK9 M<0TOF\=E6S>";_I!NW))HBA9[KBL%JOK_KT/S>I:=;J4E?C0H+;;[7CSY;TH MU=/- B]>WO@H'[?:O+%<7=?\4=P+_4?]H8%7RX.7C=R)JI6J0HUXN%G\A-_= M,F8&]!;_D>*I/;I&)I2U4I_,BY\W-XO(*!*E*+1QP>'/7MR*LC2>0,?GT>GB M\)UFX/'UB_>_]\%#,&O>BEM5_BDW>GNSR!9H(QYX5^J/ZNF?8@PH-OX*5;;] M_^AIM(T6J.A:K7;C8%"PD]7PES^/$W$T #// #(.(%\[@(X#:!_HH*P/ZXYK MOKINU!-JC#5X,Q?]W/2C(1I9F=MXKQOX5,(XO;I5U09NBM@@N&I5*3=5[>\ MW2*X::@P%^)S)_>\A-B=40^NDMZ5R03[%C [4JZ](2= M6'.-24XB-KLE#K,8XRAVWY+T(#4-2OT3H'$IJ\NZ485H![$/LI*0(3?H42EW MSDH=DG&<)#/)#C-*4^99[ME!>,DM2 M&J5D/M>V51PSZEG]^4%W'M3]N]*\_ J)N?7E>9)0C&<:'68YPS1UB\31!+CH MS/1"S=/H+Q>H!J;I?G9-]JNA&-$7B&M4J-:96T;')UF#PK*(9\I==B3#>>21 M?L1F')3^"ZS@=PC28;?KRI[+&P';NY#(C#@/R'Y#'GF19.J79J(LCQN)TKLUAA^,H\B0% M/#$1!U&T^E>?N62E>?4H =WC-/KO?&P)R?(((#X7;-OE#,#BN_,3W'"8;H;B MK3:KLS7%+)+@,,X(3TZ^X))*)9"3ZJF:EE'PM2ZD]"Y,$ M>?C-+3N->4(@"2/P?JL:?0FEYPZM50/#9?4X5$@O*ZH& W,@ *F[5-7C M8+L1:V>R(3;V<$[8_!YZS#RIAAQUFV$V'CJ;FG\Q;8U3HHMP493,$[C3CD*7 MYA$YD9"$27@G]W(CH+L/JK31=E+QC!IMJS3S(89,_"-G&\2F&_,SE,S>:H@X MVCZ:L'GEZ3 S\^A)T60B(0F3\$4F[ O==(7N&EB\3ITVVFAL3Z9M%3/O[9[P M1\+X>U%9CV=S9F_54!$W0LM&&"RBM:C$@_2)Q:2, M/VZ5S6ATPC F.K"3@LF-IYBDQ MR81#$L;A+^=3J0T3#(3NJUR2B.2>S$4G3M$PIWX[KMC^ MO_Q ;4Q!W<3F"<)EEJ6)A[CTZ- S##.[ CTW]X[6CA),YGI='6"2^&9^0AL- MHVW($N]4A4YLHV&VW:K=3HY-4U^-J4H#W415@&;T MPV]*"X2S'YWJ_X>C3.0J35_!T6GT$S-I$JS$__:YD_J+,[@@;+^U^'XM;Z=A M3GBE8;R:FPP[OM6J^(3>8*@'&[3G92>N$.\T5.;ROY 8:'011?T_U&XYZ+A" MLFU-RN@/,CO=:KB Q8'N1:W%;BV:0>/+8R#T_7?0(.$K6#"]IRR.#Y[N1'$\ M8GSR,XU(+_(XNB )&T;PU@8)WE2FXW*JM,$> M0PXDUD,BVXXE>4X\$\NF H"%"X#C@]'QO!P:@D9L#:GV4!"HUBF&80[H4P8I M?3[O+D.2IKGO6(=-Y0$[6QZ8?-^HLC3;6E90A0GW&3JSN9Z2^3IV&"6^BHM- MZ&=A] ]S')A(&^$PD1A;B<%E2-(LSCS5"3MZT/F-M#^/,JJA9+Z 49&;U.(NAE^"C&\T*KN?TVP5EJK77^Y%1R6 MKC& SQ\4H']\87Z@&PO=V]R:W-H965T&ULK55=;],P%/TK5D!HD\;RU61C MI)&V3A,\(%6K@ ?$@YO<-M8<.]A.._CU7#M9U(YT'Q)]:&SGGN-SKF^NLZU4 M=[H",.2^YD)/O%,P%P1W=8U5;^O@,OMU N]AX5;MJZ,7?#SK*%K6(#YVLP5 MSOR!I60U",VD( I64^\RO)BE-MX%?&.PU3MC8ITLI;RSD\_EU NL(.!0&,M M\;&!&7!NB5#&KY[3&[:TP-WQ _N-\XY>EE3#3/+OK#35U#OW2 DKVG)S*[>? MH/>36+Y"]WG8 823 X"H!T0O!<0]('9& M.V7.UC4U-,^4W!)EHY'-#EQN'!K=,&%/<6$4OF6(,_E,BA+/!$J"(RTY*ZG! MR17E5!1 %I98DZ,Y52!,!885E.MC\IZ\)3[1%2[KS#[<-]M#_D(!IR$#F^^) <@YZQ,@V1*W+# M!#IGE).YU,R5VH_+I38*"^[GF-6.>S+.;3_""]W0 J8>?F4:U :\_-V;, T^ MCAG_3V1[:8B'-,1/L6,IU#6ZQ9(K[DY(0Q794-X".6*"E))SJC1I0'6G?CR6 MBHX_=?RV?6SR,/,WN_Z>BM@3/1E$3UXANBM(0EM32<7^8"%;\=WJJ.*./-G1 M$P?=[Y'P%P3NZ4\&_U)_]("L]1SWF2/-(^$GCV(0FB=#*N/1VT MIZ_7CC>%-E243*R?,Y"^U,!(X+@!?Z<1VDOH"U5K)C3AL$)H<'J&'*IK[-W$ MR,;UQJ4TV&G=L,*[$)0-P/LMFQAHW!97X'8W:';O/LLR'7,KBUZ*=I+[]3>D9$D623D! M\J61Y"'US.LS0_7Z4<@?U98QA9YV15G=3+9*[:]FLRK?LEU6?11[5L(O&R%W MF8);^3"K]I)E:[-H5\Q($$2S7<;+R>+:/+N3BVMQ4 4OV9U$U6&WR^3S+2O$ MX\T$3TX/OO.'K=(/9HOK??; [IGZ:W\GX6[6[K+F.U967)1(LLW-Y!.^6M)4 M+S 2_^'LL>I=(ZW*2H@?^N;;^F82:$2L8+G26V3PY\B6K"CT3H#CGV;32?M. MO;!_?=K]JU$>E%EE%5N*XK]\K;8WDV2"UFR3'0KU73S^BS4*A7J_7!25^1<] M-K+!!.6'2HE=LQ@0['A9_\V>&D/T%L ^[@6D64"&"^:>!;190(VB-3*CUN=, M98MK*1Z1U-*PF[XPMC&K01M>:C?>*PF_(G^W(I#E97KZGJF (W>VS MG-U,(&TK)H]LLOCE)QP%O[I4?J/-S@PP;PTP']M]\3L4(5[F8L=<:M9K([-6 MUYKC(B71?'X]._;QVU)1@(.@E3H#%K; PE'/?%K_#8E51[<24(QR4>:\8*AL M$>OG^B[73MQ+<>00HVCUC-X==*[P\KW3GU()1$-/4A[ M9(Y'D?Y;5! I)6)/NC =>+755>Z4JTZ\V (2#+':(B&91QZLI,-*1K$NQ6[% MRRXYC?^AED(B5%P_G4I6F&!G3]KDO5C?9\^F>CL5(I<5LD6F:ZJ]]XX;UYQ7EVL$N20FD:!+] [ MPL;CC'W7M.>=._90U"537)IF$*U8R3;<8_BYC0F&"7S7!QT:P3?$[R#K],XQD/P#C&,@P1[P'>VE216>*/"MIO>1PPG;P;YQB MJW@YQ#"AGNI%.IHFXS3=!B[0@X[:NN7+,?:9)RU?W_]H.'4P>9IG*;S:%B!'7)3$I&4>O3H&)V05TV\'%*T>@GPT4;A MM>7SK78[-T+7!)#Q)N";4;H>+B&!P*7@/O7\ >V+3"<]Q"0#.MEK":WS2JV%1OQ:*C M&TCGQ%/!2-<-D%&2A/(K.@5V>TN.32T,=SI*-A$K\JYS?0TI?Y"X"/LONK<_Z-=CLW0D?V MY +9GU(&@JL0Y<-4,;GSCES$1=OS(!Y.LRZY*$I"W_$7Z?B=C//[>7:\ +'- MV%9:V"(Q(/5AI1VKTW%6[VRKNY&C*(XZN.HY"FVRO-^L.X]3;Z3B]WPH):^I#G++I ;6E_9!M@H[38>?J$(+VVU,X:< MZCD$HQVITG%2_<-XO5(B_]'R:E,@GYV 7;P8#H#&-K,'")X2B-8H\*';W2\2FW^8;B/=DP1Q?Z0O>4 MQZSPG8I1>\[%,4TM3SC&81@-$D^#0SN&I.,,N?2!19E"D!MHQ1YXJ4^ZM;OT M ^B:N7 GL\V+. G2R,H.AUP4XMB7'QU]T@OC\25EF)[U+ZJ16M^V< JTE S5 M<,C1)$F'Z3'K?03>,?E@OHU7R,S$]4?4]FG[_?V3^>H\>'Z+KY;U5_1NF_JC M_F^9!"]5J& ;V#+X&(-M9?V=O+Y18F\^-:^$4F)G+K#WC1#J=*-? MT/YOA<7_ 5!+ P04 " #-A6)7:M5RVN(* "R70 & 'AL+W=O/5;UYV8K M1.M\V15ESFZN^K]]J&^NJD-;Y*7X4#O-8;?+ZC_>B:)ZO)Z1V=<_?,SOMVWW MA\7-U3Z[%[>B_77_H9;?%B>63;X399-7I5.+N^O96_(F]?H"/>*W7#PV9Y^= MKBF?JNIS]^7]YGKF=E1W?NBJ:_J?S>,2Z,V=] M:-IJ=RPLKV"7ET^_LR_'CC@K0-A( 7HL0"\MP(X%F%: D9$"_%B ZS6$(P6\ M8P%/KR$8*> ?"_A: [4.SRMKLYJJN'IVZ0TNV[D,?W[ZT MC$A>=D/QMJWE?W-9KKU95N5&#BRQ<>2GIBKR3=;*+[>M_"5'7-LXU9VSW&;E MO6B^> M+H".7, O59L50+&EO=BRVNWD2+YMJ_5GH/3JF=+9/I?5]@WZLA9-W\H/6>W\ MEA4' ?#%=KZ/HI6S7O9;G-5E7MY#_9#8*=ZNUX?=H>A[_U_M5M0R(#NYNFR[ M:?\@G']6#<2:VEE_KLIU5;9U5!0T\#A_;,?(3Y MG;C/RZZM+6W=K>-/ML+:YGZ=(N19(_1V5QVZ^VHM]E7=K?9RIE?]@K]6%OP?"[GBO[($TS.N M;.[30%NNEM:+F1I,3+(8DRR!.T,;V:F)(G P_5,P?6LP5_E#+O73II'R=UUD MM=A D?+-BPNX?O]96FN:&BE,LOBBZT\PJTR1R)2@!J>@!M:@WFYE()V\:0Y/ MNJ;<.**_^P-SK/F^OM0"($\3.1 /UY:\V-J@ MJ7,)DRQ%(E,"&9X"&5H#&9<;3:#^E-4G@4JAJ(5F;[/("UQ]605P040T&;LR M41$)_2C2HF?"/!H&QGW-A,T#E^IC*C5A_ME<53HR.G5D]'\0^Q'0EY#8!W" MV#=1H-@W8:#8-V&@V#=AHV*?N,.6VWU!N7^L#$GOH[*M4-EB5+8$E2W%8E.' MU)F+0[Y#]A\+*\/8)<::9J]C"YZ8,7V3>>"Y)-3#BNEVK%#98E2V!.P1'NGWU!3" M,382V,&*(78OYC*GE$ >!V=&T*QU30X:)EM\61,2U$I3+#8UN(,]1.S^$(YC M2DRWA4:>L0Z;J% 71!"1OAK&]C9-GEV8;"D6F_IH?W"HJ-6N '8*_SB4]IW" MD5$5MWKHE! PBS]@KF+"(AC0,]4XU<=R/C+U' N#FA(7RKJ)WJ@GTS_2) MVJF#54+#E]PK8!H-2U2V%2I;C,J6H+*E6&SJD!H,&FHW:)[9*X#&"]>=%WL= MDV./R1;#33!S_%%=&J#2DLYEVP1FINE(C6VDR]GKFAPQ5+OFLB8DJ)6F6&QJ M< 8/*%J.R):AL*1:;.DX&=XI- M/51U;J+"Z@@Z5<4)<76' 0*&K@Y; ;"(A3S0,SP G">5,-5S<0#L0,EIXF#)"1RQ@B4G<,AJ M3'+RP4?A+WG(BJ,>LD)E6Z&RQ:AL"2I;BL6F#JG!Q>'?<\B*F]8'C5BD/^2U MUS$Y]JCN#=P$/4,J0:TT!2KE8[-_\&3X"YV)XL"9*#_R(SVJJ&DTJ&PQ*EL" M=XC^G#.%8&/I%GQP9KC=F;G,1^502DAH/+&UUS4Y9J@Y,IV+)2K;"I4M1F5+4-E2+#9U2 VV#[?;/L^(6M/+ M82P@QJT4U[(2U$I3H-*SIP)JJ ;GA=N=%SQ1"_@=E/O$4+6H MR3ZH;#$J6S+6(_KA$ @WXO_PP?_A=O_G0E4+^"DAT=]8L[37-3EFJ$DZES4A M0:TTQ6)37_8W^%">/9\'1]5Z0%**D=VT!%"ZRP<3Z8>J[&V:.KE0V5(L-C6> M@PGDV4V@;["_CXSJ6V\A^QL" O8W /M;P 'VM\ #K:_ :!I?R_.7D;=O$/[TI:WV_?NI/U5M6^WZCUN122W; >3_[ZJJ M_?JE>^7UZ37M-_\#4$L#!!0 ( ,V%8E?FSSQ)#0, ) + 8 >&PO M=V]R:W-H965T&ULK99=;]HP%(;_BI5-6RMMY!-:&$0JWTRJ MA(JV74R[,(DA5ITXM0VT_[['24@I"RC:N$ELYWW>'#O'SNGNN'B4$2$*/< I2>#)BHL8*^B*M2E307"803$S'%WL[&Y M\+M\HQA-R%P@N8EC+%[ZA/%=S["-_< #74=*#YA^-\5KLB#J1SH7T#-+EY#& M))&4)TB05<^XLSLS3^LSP4]*=O*@C?1,EIP_ZLXL[!F6#H@P$BCM@.&V)0/" MF#:",)X*3Z-\I08/VWOW<39WF,L22S+@[!<-5=0S;@T4DA7>,/7 =U-2S*>I M_0+.9'9%NT)K&2C82,7C H8(8IKD=_Q'6!9@$TZP*M FC5!6X*X*;N*MT6P&W=-[0+H)VE0_[]LH\_Q K[7<%W2&@U MN.E&ED$9#=^<)CK7%TK 4PJ<\@<\"2%S28B@)3FC(5;062BX04HKB?@*#2*< MK(E$-$&CIPU5+^AJC@4\C8BB 6;R&GU%'Y&)9 3#LFLJB$S[FT$113^/PCD1 MA8ON.;A)-()HP@I^>IYOG^%-6)%R69S]LO2=LX8+DC:0:WU!CN6X%?$,SN/? M-\E9?'@>O\<"JW?6/K"-3')"> 7\J M2<26&/ZG#W;+^E:5=)TFQV(;-W:>V5:>V=<_>' M=$OAW \E% 8!@T,[1%=PNH><04>BE(C\++^NRNGJ82W5J)9J7*FRCU236JKIWRJ[X3I'JEF5RFF]J?)O8Q[\GF,BUEEM M)U' -XG*3Z)RM"P?[[*JZ6B\;W>V-EYV-H'B&Q)F) X"2 MM5^_IP&0HF+9E9K+BRV00%]/=Q_P=&WL9[>GIO:%TG1CA:O+ M4MK-!15F?=8;]YH'']5BZ?G!\/RTD@NZ)?^INK%8#5LIN2I).V6TL#0_ZTW' MKR^.>'_8\&]%:]?Y+=B3F3&?>?$^/^N-V" J*/,L0>+?BBZI*%@0S/B29/9: ME7RP^[N1_C;X#E]FTM&E*7Y3N5^>]5[V1$YS61?^HUF_H^3/,T<]D=7.FS(=A@6ETO&_O$]Q^)8#DW1@$NR.BH*5;Z27YZ?6K(7EW9#&/X*K MX32,4YJ3E]<&NU,H?)M)'9"@U"\55KJ3,E"W.(A M :+>B?],9\Y;@.R_^R(4#3C:;P 7WFM7R8S.>A7KLBOJG3]_-OYQ=/*$>T>M M>T=/2?]K4OP7JQ!3)VI'N5!:^"7.B'\93TYXP_'/4?1XM\T$%GN##HE^"]/S9 MR\ED=!+EA,7XY$4_G(>&TC4;H/(S#K\S-N$E;14?&I2DKJ3?MJ_1X3>T3 MCE!Z:FK;/$5?@F2$(NFX1"-6&3R_-!96Q> >Y$;IA9@U 95.?&42K%:(D:MG M3N5*6D6N'S1*YPPBR5'-@HGA3:T+EL/V9ZA7ND<4L;!KA>Q8^E(KY'8@[G;\ MFR$K;,Z.Z2&-+*>@ARD*/JA#9A'3Q20<% <2N]?+3 MX'8@?IY.;QHW V@5QT65'0=L@"5+9@L?RKNEK+;*(Z%AP]5]MI1Z04!.62H7 M)FFC\O;JLE5F:5$7(8[(\"59CVD.[7'F-Z4\-\9K5*G(EPMZW M\<3)O0%_*HBM^YV@;Y.)2)A2>7:SJJVKI?:,,%=G2V'K(OFZX\/[&&Q3*9TZ M3RDU2 :;$HMYKXV +],% 8^$S'_'^(W/&4[*A;@;#6:RC@5!Q'""VH1D X.%LL^NII)MQ1S M\"G7]K8&*K''I3IM)#2;-%J%*.,P?K0+!J.-;PU7(;DY&A#SI\;@1C3R,"-! M]Q7"QJ66-,UK1'!#T@9#W"/A=DM3%SD+8#[)P$"@?Z]UMNT1+"SU44;K^*<3 MS ZM:PA*K7ZN"L;(MN'_L[6"#4B.OH$WT<]Q\'.RT^W#@_;\MM6\J4-J8X:L M\^)+'#0#?[:]G(0 MB3KSJ*^8QJ_]Y[WMEJ;PN'-;HM0AY*P@X6@1XOQ:'*@78EH"&D#."5987M46 MJ.J+:Y7GV'LEX1UC:SKG76V7N+J^FC;QB/,*IUF:4W)X(S,U5VC6-P"=;;K^ MU^:V84D$:]\>#'%O;!AR>QP0:_3H_5[ O),])C6FKEZ(GPLS8]8 A )^?M-R M$)YFT?!$#+H-;XEY&MH0"IQ#LYNQ?2X\S![/9 #E%PFXHOXC\("9F#$&UCY? M0X$'XD\\ 7+\Q&'T7+E8H,<%\P;,GV0JPJ8D]\&D&_E0>XUI-)]3N! ]-&\7 MTFB%)@MC=&%,OE:H:W3RE3*U0V-8$M?O)E8(@@>3GXAWXV2#%$M\;=RA,=LP M[(O= )QA32NRNU;F*@\MJ\D54P%I[2:TY9)G,9<*="A=K]GK;0[08OQJ_#)J!F43^F&!P\F](:[(F2K0>P/4&K2%,60-MW],F5KQ./F-82]%N)[PV)86 M88T,!-?N(N^BNC.M(-0@76)R+ (GBB1T'UH;R+?,#+N ,?CN&H '1>V!TG#' MRE?,(B)A,.(QV^R)MRW^A ]QQ2R^,6D%VAD M;)4!E#'E)7E9\)<%]JRERP]CF@.6A:G@'4*7UUE#MDMI/Q/C6<\&51!661D7UQ MN1*""H7J72F(.%%ZB"30*NJN+78A#YJYOW$;V-;B'.4GWP+7]I!\S^V M#D<)=S5\!%GK7L*XZ\>;"^,V78OP<_Q].#+Y_K&&OG.I\<9S;M!6$T@T 0VR M8"CLNM@A,7_"-6ZNX.S8^-UX,$&)%$5S,?AN,GC5/H#M:.LD^7H0$(J; K?^ MSJ6S':$)1SS^F$6CL6S8230,OJD\<"188F5<]D7^!_V:/.[7:->OKJ-_HU^1 M(2=Y ?NM32R2+U3H4$P^J+G/Q;RH6WP@WW?IX:=SY'HZ(OPT=7% 1"_3+9/V^^ZT_@Y M<[L]?A2^EG:A,$<*FN/H:/#3<4_8^*$U+KRIPL?-F?'H[^'G,LPSWH#W?&EM M%JR@_=I]_G]02P,$% @ S85B5P7X2;#Q!@ %!( !D !X;"]W;W)K M&ULO5A;;]LV&/TKA!L4'>#ZEJ3-VB1 DG9HAW;+ MFG5[&/9 4;3%EB(5DK*3_OJ=CY1D.;'3KACVDD@4^5W/.21]O++NLR^D#.RF MU,:?#(H0JA?CL1>%++D?V4H:?)E;5_* 5[<8^\I)GL=%I1[/)I-GXY(K,S@] MCF.7[O38UD$K(R\=\W59/?4EY(K9']MZ:4'CVVN0RWUP_1DA=7+,VKO/9@P:O9#5B M^Y,AFTUF^P_8V^_RW(_V]K^6YX4M,V5X@H3)V9GW@'XO>_;76>:# US^WE:' MY.9@NQNBT M?<2%/!N"(EVXI!Z>/'TV?35X^D,1!E\3!0]:_O5G?889=.KE4 MMKXS^M:P7T6PF734B=F0A4)2#2MN;D$IS'0R9YQEKP=2- C>EOF7[HT,P1&OJX>N/']B]"7N]&2/V>P%7?)WKD'%M M$=U*A:*?Y>-'1[/I\Y>>_@O9,K$^6>E=$IPSYX@<^%4AL)DI'H_ MM+D5'/DJ1, ABY44BFOUA:="4RV:PB#W.4R9A2?370F5*52F M(*4A3&:KM0 M5#> 59H%(H"5WVK^&:UZ8VN(D35=[)5=QWK?8/+.\UR11,*D-"@V3>EW.UBD M$X(D2:^H(7&5K0(R^B+;X,D)'M%1C_Y3EY**2?(BG(T0D:R4@6O*+\=7=SL" M#ZGEH'V0):&MY7Y"'-?:BD3:!AA5[40!.4[OFZU$H3UBE8;-07746.8C0G*_ M@]^-Y%UMR!U?T7==9P0#T^([\+*B<:OT,(XLN8L\LPC M=,3 AV* 9=R"8AS MZD5:(;3D1D8XZV;N+KYT(/PVSNP=C29W*-'EGSG+ M*!\HYZ;+E$-\I!V:QCL?=ZGCY")&\JIV+?Q@U>7L&HTCZ"'-R+]^\[HF$\S# M4Z%ME!F>?T(Y*?.FEQ!D[-68UGAMUU?\-C:N:;IA>Y/1M),2>$S,L/"RAIU M#P ,%[L!^&IOR>Z_@YB3FE- H!9-]9)W8JE*X&!A.LS'^C'4*,1J4RLC,6IP MRQ)4L!I"[8 8] *G'/J_803I*W/?MK_UH%RRF)P0GOX#/9Z.9E_1X^GHX*O@ M(SS=!UMOYT!-*IXIC0[)[2C<2+?U0 X?U)7*T;9$PQF8VGS&^*YMP$-UT(4M MLO.+729-PY+I#E"<$-75IR4=?EG98V>RH% MW2)F"'*L@-<^)^/9F(BGHW%K(E>HDU2_!Z0DSMF;3M?B,03XA:[S!%^\H"8) MKP7Q*RY"-'O/U\S"SE5GGQ !P7\7 M8JAX;946.Q3M1(AS>N MMM%%K"/=DBC!SIU6:^@Z*:S#Z9G9A-\+:X@!&,"3MUKE42O.N>8&L+^*=S8* M9[JN*<+IM$K?8E/Z/W44"4BUC$OZ/=^NJY$9K["B9<9D!S,NK$,#+G 9C4!M MO@_9NW<7[ GM1[/)RS@G/D]?_K"%.A]'5Z.G='G+6^*XM:8B;>4+"GNN:P5= ML;J.A!ZQJSKS\KJF1!J)WC@P;L0+/B4-UYK..C"?(G]"HTV<5^EC&VE2#-H4 MTQ[0-J #^JX^;&R0T'T@Y6YG484YOJ0].9.D38BG2N'\PT8@/-?NBZF M8!-7P-VU@AK+:)=P442 G06L-RV8\_;N()03=8D3EA%KYT)S538IT G\MI_E ML.M3VS?4#IG6R3R.ZPJ'K[01V(!2DW]'[LF\O$%#:L29=E_L5\D9'O8FM!Y4 M7"O#M@O?N'=3A[PNXN\146I,2)?V;K3[R>,LW?37T]/O)>^Y6^!"!7K-L70R M>GXXP TK_@:17H*MXKT?VQ?."/&QD-A4'4W ][E%ALT+.>A^"#K]!U!+ P04 M " #-A6)7+YO8L8 " #!!0 &0 'AL+W=O;E/A]?(F<[(Q])!E1?X@SB:-*'&%]-@L+6MQSU+(&K631H/%S32:#6_F8V\?#+Y+W+D# M&7PF:V.>O')73*/$!X0*<_(,@G_/N$"E/!&'\;OCC'J7'G@H[]F_A-PYE[5P MN##JARRHFD;7$12X$5M%#V;W%;M\+CQ?;I0+7]BUME?C"/*M(U-W8(Z@EKK] MBY>N#@> Z^0=0-H!TA!WZRA$^4F0R";6[,!Z:V;S0D@UH#DXJ7U35F3Y5C*. ML@?,49-ZA3OGMEC +,_-5I/4):Q(Z$+8PDUB8D_>/LX[UGG+FK[#^A'NC:;* MP6==8/$W/N8(^S#3?9CS]"3A"IL!C)(/D";IZ 3?J$][%/A&[_ =2Q,>FT(0 M JNPJ(0N$:0^+,C22IW+1B'\G*T=67Y1OX[5IG4]/N[:3]F-:T2.TXC'R*%] MQB@[/QM>)KJ5:K.#G36BE4"!KKA,!#R]5" O#JGX]/[M.AU>W#G+#CTL[IF7)&25] M]PK82"VX30QG%X2\0,B%GEI4K8$QI TWNI N5\9MN0N#8Z6/#\:J1EN&Y>'] M<@KMA/6G_7Z:M6/Y9MXNMWMA2ZD=*-PP-!E<741@VX71*F2:,*1K0SSR0:QX MQZ+U!GSO@]XKWD&_M;,_4$L#!!0 ( ,V%8E=+*IO+>@8 \/ 9 M>&PO=V]R:W-H965T9GA>GC/Y;V'Y.6CL;^[ ME5*>?5IWO;L:K;S?G$^GKEVIM71G9J-Z]"R,74N/JEU.W<8J.0^3UMU4)$DY M74O=CZXO0]L'>WUIMK[3O?I@F=NNU])^OE6=>;P:I:-=PT>]7'EJF%Y?;N12 MW2O_T^:#16VZ1YGKM>J=-CVS:G$UNDG/;W,:'P;\K-6C.R@S8C(SYG>J?#^_ M&B5DD.I4ZPE!XO>@[E37$1#,^&/ '.V7I(F'Y1WZV\ =7&;2J3O3_:+G?G4U MJD=LKA9RV_F/YO$[-? I"*\UG0M?]AC'%OF(M5OGS7J8# O6NH]_^6GPP\&$ M.GEA@A@FB&!W7"A8^5IZ>7UIS2.S-!IH5 A4PVP8IWO:E'MOT:LQSU_?;AU: MG&/W:@E?>WF=ZO''O3S]7\^?PIS-G;)'8VW8J3 M@/=J<\:RA#.1B.P$7K;GF 6\[$6\0(U]5!MCO>Z7G+U3TFVM"LVOM6L[0U7' M?KV9.6\1*K\=\T-<)C^^#*7/N=O(5EV-D!].V0X"-53?O'MS<\%D/ZZ/0O8$6\'PJ15K,5RQJDY,PMT*]9# MC9SLL"$$! 6RDG+8,=TS)=L5K'$;%1(:Q26ZSMA-U[&-U<8R#-=FCK%1LRCY MB<=,*=(1F.J9-Z0H) UAO8'NJZ]JD587#NL_'B-\!B(X3C0ZI>@9'O\'8/!D=_@AR_M.F+3 MWG]6'SAPZ#T@M'-H1WL]U_"#[SX#L N6WADX!7.7QLP= P-L'TT6R<7=#]_> MAV)Z,0G;<0\)#4FT5#T8=*%1SB%.FG(G;(KZM"%_N#W*_;>OY'IS<;-#.F,_ M/-'?#>Z-?S)->F_U;!O9PL?/XP*V?AD( V>. P8=V/!6P5>(F-98N T\CUG: M@KGCY.D9=HN"A2-RO%K&D(L!B+4M#I _MMII:OUFY[>=Z3R,^Z@ NVW]UA(M M:MF-:U?2+LD=K55S[=V$$Q<>-H]8Z[[MME!/"G#W8GS :<$2C5B*WB+RE%FR M@\! MLY,K]C43><'KIJ%2D?.RJE&JBH0764JE1/"B3H*@L31K>"D2_'.>U27+LX*7 MB6"Y*'F5-<]4CJ5)P9,FPS_C:9'C*$MX4J4L$PW/BYK]:#RRYBF6OV9YD_ R M%:$DN$C)DI3G=8\*8O( M2U2\@7O2@N=5P^H4=I8,2]5)]IP3CN.FA#.!!Y_"L!*&5266*0<^+X:J#72,F)_)R/"3FA V) M&6-^#$>DS83\#K;C$M;G$T:4WV/])X8GE:\0Y/$)&^<5KPN8,48P\"1)J81X MJAM@OE9(%1P1@2Y2X4"KG%,^'H!R3?>6/^,@H"!"R@"'?:("XKBLLUBH4SC@ M25MCIK*BX06B*D>8)PU" (&5BQ"H35J<2F_R:94"NR[8N.9%4=/"R!$!9L<% M8YQB2DTL:^0*O#C.$+LYR(Y%PH6H:6*P:J:@ A!W^6DXZ14VV7\F$22@P79X M!;XPY"12TJ 3.J8-W"DH/[*29TE!P9TBPO(D)#)/R^JH.,4'B/Y3N1!L]IM= MZ%KUH/JM4^C"LH4UZ]VA]*5V'3F( ]_# M@U_2!29<7=Q./^.!0/(([7Q0T7YW]M]U\$ C4N@)*0XV*Z$_,CLH8 /-&52/ M7)BB(8>6P+$5(BBKN"B^T+L*6I>)"HA0.$9R>.R^.SUXI,"*97B*X9 VV][' M]\J^=?_:NXF/G*?A\:GX#CFK>[K++# U.:N*$;/Q^14KWFS"DV=F/!Y0H;C" MBU59&H#^A<'-;:C0 OLW\/5?4$L#!!0 ( ,V%8E=M@9PY- @ ($5 9 M >&PO=V]R:W-H965TS<+8=^*B: M]4@#B[.3033R1HZ_#M<&=XN=E5IULK=*]\S(U>GL/'Q[D=!\-^'O2M[9O6M& MD2RU_IUN?JY/9P$!DJVL1K(@\'ER?SHH9J^5*3.WX4=_])#?QI&2OTJUUO^S.STWR&:LF.^INLQ@( M.M7[?_%YP\/>@B(XLB#:+(@<;N_(H7PG1G%V8O0=,S0;UNC"A>I6 YSJ*2DW MH\%3A77CV0?D_4:TTC+1U^RCO)7])/%?Z:97Q-O)8H0;FKRH-B8OO,GHB,F2 M7>E^7%OV8U_+^O'Z!>#M,$9;C!?1BP9OY#!G<- M.<6G8;^=+Z\;_>8@ ;S\Y;)]T]-8.HI*G,PC%2G,K M9V???1-FP0\OH$]VZ).7K/]O&7O1Y&' 7_3#SHT1?2,AT='B@8405-\PU3-: M^U$.VKB!<\L&84:F5VQ<2S#>#:*__^Z;(@KS'RQ[WTZJKH21[-,56TX6X*SE MK))F1%/!$F7J[\G /1N,KB?DRCI[SN:LT\/-PQ) M[>U*&H-Y!TQ;-J%J#FH*R%-R;*)QG$&G;NGX# MUMYD\3S:C:"%.ESCVDCIGO>(E75>+9+4PE#KH^R60+ M> Y7=I"N>[7WW-N% MI^2)IW">?YVGZ+&G^8,8H)%*DDQ\VIE58&.E*M&/S+& T2/)-;YN?'ZP:[2. M1:<\FDZ)I*5@OT+6V8IJP5<H"-])H5\\3S0(E 1AL%"X/O_\8/SEF!6-8*TT@[[I5NI;LE MTE.SOTA1K>EV<)X09T>:&@#*3DNK:B6, B/(;JUN%6V,UO^I'XAP4Q@/3/"AL;DLW"\%OR5\&B;E4M:!:5 MN5,:]TX4I/ 4_=8HN7IN-7[!Z/RA]9Y;*T>?]5^40!+17Q#FOFS7 DNI$$;I MDEEMUPJ_EB1J:B]0P@G;-8X.&+C<]WXA6H%:9C>T8<*C*Z;GFB.&W\EJ,QAZ M>[U0]9#F-A9GHKYU:P9QOVN< M$FCKW4J7(A_V 7[?*2N:QLC&H=AN.?NLXSC76I?@6TB!2GU/X(^;"'?3B# \ M0X.GXRQ:5NO#H&>CK-8]#3'Y&2&#$Y<2P9I6+[T]M]M0BUNAA/3C"FAD+]%& MD'F_[WC#\A9-"?@]RGTFL2OY3<-U&2L;X@@]P=A- P*%/MWC??![C^^$Z;@YZ:-4[JK@S\7G'$:"-U8\2P5CA. MR(:*P4-&,^PTM0,;'0+WU,K)>HO,^KK3(WCV8<&4"\O;]U2# M=;PU4&]QI%EJP[L*.0ATUUZ(R&>H^2%N-^2KCOP U+:B'RI]SJY1;(:RJ30% M[5^&2-;HLFPI);V@@(.1.46LZ)WC(+QJ0@.@7=-;>HKF?C] Q\(-ID19N1@PX$1*3E-G]0_FAGG,.'! #9ES]>(Z6K,3B6E2T MS3_VL3L5_+QCD%W)D83UAF4Y+],<%W'$LSC 15+R.**+$%=ED/NY]*KF=B

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

NU.;58" ".+0 &@ @ &EG@$ >&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #-A6)75:BY9Q(" !S+ $P M @ $SH0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 50!5 + $H7 !VHP$ ! end XML 90 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 91 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 92 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 373 309 1 false 83 0 false 9 false false R1.htm 0000001 - Document - Cover Sheet http://www.quakerchem.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity Condensed Consolidated Statements of Changes in Equity Statements 7 false false R8.htm 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals Condensed Consolidated Statements of Changes in Equity (Parentheticals) Statements 8 false false R9.htm 0000009 - Disclosure - Basis of Presentation and Description of Business Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness Basis of Presentation and Description of Business Notes 9 false false R10.htm 0000010 - Disclosure - Business Acquisitions Sheet http://www.quakerchem.com/role/BusinessAcquisitions Business Acquisitions Notes 10 false false R11.htm 0000011 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 11 false false R12.htm 0000012 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 12 false false R13.htm 0000013 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognition Net Sales and Revenue Recognition Notes 13 false false R14.htm 0000014 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 14 false false R15.htm 0000015 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivities Restructuring and Related Activities Notes 15 false false R16.htm 0000016 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 16 false false R17.htm 0000017 - Disclosure - Pension and Other Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits Pension and Other Postretirement Benefits Notes 17 false false R18.htm 0000018 - Disclosure - Other (expense) income, net Sheet http://www.quakerchem.com/role/Otherexpenseincomenet Other (expense) income, net Notes 18 false false R19.htm 0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions Income Taxes and Uncertain Income Tax Positions Notes 19 false false R20.htm 0000020 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 0000021 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 21 false false R22.htm 0000022 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 22 false false R23.htm 0000023 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 23 false false R24.htm 0000024 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 24 false false R25.htm 0000025 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 25 false false R26.htm 0000026 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 26 false false R27.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 27 false false R28.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 28 false false R29.htm 9954471 - Disclosure - Basis of Presentation and Description of Business (Policies) Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies Basis of Presentation and Description of Business (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 29 false false R30.htm 9954472 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 30 false false R31.htm 9954473 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesandRevenueRecognition 31 false false R32.htm 9954474 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 32 false false R33.htm 9954475 - Disclosure - Restructuring and Related Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables Restructuring and Related Activities (Tables) Tables http://www.quakerchem.com/role/RestructuringandRelatedActivities 33 false false R34.htm 9954476 - Disclosure - Share Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables 34 false false R35.htm 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables Pension and Other Postretirement Benefits (Tables) Tables http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits 35 false false R36.htm 9954478 - Disclosure - Other (expense) income, net (Tables) Sheet http://www.quakerchem.com/role/OtherexpenseincomenetTables Other (expense) income, net (Tables) Tables http://www.quakerchem.com/role/Otherexpenseincomenet 36 false false R37.htm 9954479 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 37 false false R38.htm 9954480 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables 38 false false R39.htm 9954481 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 39 false false R40.htm 9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome 40 false false R41.htm 9954483 - Disclosure - Fair Value Measurements - (Tables) Sheet http://www.quakerchem.com/role/FairValueMeasurementsTables Fair Value Measurements - (Tables) Tables http://www.quakerchem.com/role/FairValueMeasurements 41 false false R42.htm 9954484 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 42 false false R43.htm 9954485 - Disclosure - Basis of Presentation and Description of Business (Details) Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails Basis of Presentation and Description of Business (Details) Details http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies 43 false false R44.htm 9954486 - Disclosure - Business Acquisitions - (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsDetails Business Acquisitions - (Details) Details http://www.quakerchem.com/role/BusinessAcquisitions 44 false false R45.htm 9954487 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 45 false false R46.htm 9954488 - Disclosure - Business Segments - Performance of Reportable Segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails Business Segments - Performance of Reportable Segments (Details) Details 46 false false R47.htm 9954489 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 47 false false R48.htm 9954490 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Details 48 false false R49.htm 9954491 - Disclosure - Leases - Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 49 false false R50.htm 9954492 - Disclosure - Leases - Supplemental Information (Details) Sheet http://www.quakerchem.com/role/LeasesSupplementalInformationDetails Leases - Supplemental Information (Details) Details 50 false false R51.htm 9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails Leases - Maturities of Operating Lease Liabilities (Details) Details 51 false false R52.htm 9954494 - Disclosure - Restructuring and Related Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails Restructuring and Related Activities (Details) Details http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables 52 false false R53.htm 9954495 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails Share-Based Compensation - Share-based Compensation Expense (Details) Details 53 false false R54.htm 9954496 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 54 false false R55.htm 9954497 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Details 55 false false R56.htm 9954498 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Details 56 false false R57.htm 9954499 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 57 false false R58.htm 9954500 - Disclosure - Other (expense) income, net (Details) Sheet http://www.quakerchem.com/role/OtherexpenseincomenetDetails Other (expense) income, net (Details) Details http://www.quakerchem.com/role/OtherexpenseincomenetTables 58 false false R59.htm 9954501 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails Income Taxes and Uncertain Income Tax Positions - (Details) Details http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions 59 false false R60.htm 9954502 - Disclosure - Earnings Per Share - Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareBasicDetails Earnings Per Share - Basic (Details) Details 60 false false R61.htm 9954503 - Disclosure - Earnings Per Share - Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareDilutedDetails Earnings Per Share - Diluted (Details) Details 61 false false R62.htm 9954504 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails Earnings Per Share - Antidilutive Shares (Details) Details 62 false false R63.htm 9954505 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Details 63 false false R64.htm 9954506 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Details 64 false false R65.htm 9954507 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails Goodwill and Other Intangible Assets - Amortization Expense (Details) Details 65 false false R66.htm 9954508 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Details 66 false false R67.htm 9954509 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails Goodwill and Other Intangible Assets - Indefinite Lived (Details) Details 67 false false R68.htm 9954510 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.quakerchem.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 68 false false R69.htm 9954511 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 69 false false R70.htm 9954512 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details) Sheet http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails Debt - Debt Related Expenses Included within Interest Expense (Details) Details 70 false false R71.htm 9954513 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Details 71 false false R72.htm 9954514 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 72 false false R73.htm 9954515 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Details 73 false false R74.htm 9954516 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) Details 74 false false R75.htm 9954517 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 75 false false R76.htm 9954518 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails Hedging Activities - Balance Sheet Classification and Fair Values (Details) Details 76 false false R77.htm 9954519 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.quakerchem.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.quakerchem.com/role/CommitmentsandContingencies 77 false false All Reports Book All Reports kwr-20230930.htm kwr-20230930.xsd kwr-20230930_cal.xml kwr-20230930_def.xml kwr-20230930_lab.xml kwr-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 95 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "kwr-20230930.htm": { "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20230930", "dts": { "inline": { "local": [ "kwr-20230930.htm" ] }, "schema": { "local": [ "kwr-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "kwr-20230930_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20230930_def.xml" ] }, "labelLink": { "local": [ "kwr-20230930_lab.xml" ] }, "presentationLink": { "local": [ "kwr-20230930_pre.xml" ] } }, "keyStandard": 285, "keyCustom": 24, "axisStandard": 29, "axisCustom": 0, "memberStandard": 52, "memberCustom": 31, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 1, "http://xbrl.sec.gov/ecd/2023": 1 }, "contextCount": 373, "entityCount": 1, "segmentCount": 83, "elementCount": 612, "unitCount": 9, "baseTaxonomies": { "http://xbrl.sec.gov/ecd/2023": 10, "http://fasb.org/us-gaap/2023": 1076, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://www.quakerchem.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations", "shortName": "Condensed Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R3": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R4": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows", "shortName": "Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R7": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "longName": "0000007 - Statement - Condensed Consolidated Statements of Changes in Equity", "shortName": "Condensed Consolidated Statements of Changes in Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-8", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-15", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R8": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals", "longName": "0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "shortName": "Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-68", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R9": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness", "longName": "0000009 - Disclosure - Basis of Presentation and Description of Business", "shortName": "Basis of Presentation and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.quakerchem.com/role/BusinessAcquisitions", "longName": "0000010 - Disclosure - Business Acquisitions", "shortName": "Business Acquisitions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "longName": "0000011 - Disclosure - Recently Issued Accounting Standards", "shortName": "Recently Issued Accounting Standards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.quakerchem.com/role/BusinessSegments", "longName": "0000012 - Disclosure - Business Segments", "shortName": "Business Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognition", "longName": "0000013 - Disclosure - Net Sales and Revenue Recognition", "shortName": "Net Sales and Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.quakerchem.com/role/Leases", "longName": "0000014 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivities", "longName": "0000015 - Disclosure - Restructuring and Related Activities", "shortName": "Restructuring and Related Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "longName": "0000016 - Disclosure - Share-Based Compensation", "shortName": "Share-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits", "longName": "0000017 - Disclosure - Pension and Other Postretirement Benefits", "shortName": "Pension and Other Postretirement Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.quakerchem.com/role/Otherexpenseincomenet", "longName": "0000018 - Disclosure - Other (expense) income, net", "shortName": "Other (expense) income, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions", "longName": "0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions", "shortName": "Income Taxes and Uncertain Income Tax Positions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.quakerchem.com/role/EarningsPerShare", "longName": "0000020 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets", "longName": "0000021 - Disclosure - Goodwill and Other Intangible Assets", "shortName": "Goodwill and Other Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.quakerchem.com/role/Debt", "longName": "0000022 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome", "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Income", "shortName": "Accumulated Other Comprehensive Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.quakerchem.com/role/FairValueMeasurements", "longName": "0000024 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.quakerchem.com/role/HedgingActivities", "longName": "0000025 - Disclosure - Hedging Activities", "shortName": "Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.quakerchem.com/role/CommitmentsandContingencies", "longName": "0000026 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies", "longName": "9954471 - Disclosure - Basis of Presentation and Description of Business (Policies)", "shortName": "Basis of Presentation and Description of Business (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "longName": "9954472 - Disclosure - Business Segments (Tables)", "shortName": "Business Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables", "longName": "9954473 - Disclosure - Net Sales and Revenue Recognition (Tables)", "shortName": "Net Sales and Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.quakerchem.com/role/LeasesTables", "longName": "9954474 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables", "longName": "9954475 - Disclosure - Restructuring and Related Activities (Tables)", "shortName": "Restructuring and Related Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "longName": "9954476 - Disclosure - Share Based Compensation (Tables)", "shortName": "Share Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables", "longName": "9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables)", "shortName": "Pension and Other Postretirement Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.quakerchem.com/role/OtherexpenseincomenetTables", "longName": "9954478 - Disclosure - Other (expense) income, net (Tables)", "shortName": "Other (expense) income, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "longName": "9954479 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954480 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.quakerchem.com/role/DebtTables", "longName": "9954481 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables", "longName": "9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "shortName": "Accumulated Other Comprehensive Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.quakerchem.com/role/FairValueMeasurementsTables", "longName": "9954483 - Disclosure - Fair Value Measurements - (Tables)", "shortName": "Fair Value Measurements - (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "longName": "9954484 - Disclosure - Hedging Activities (Tables)", "shortName": "Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "longName": "9954485 - Disclosure - Basis of Presentation and Description of Business (Details)", "shortName": "Basis of Presentation and Description of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "us-gaap:AmountRecognizedInIncomeDueToInflationaryAccounting", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "kwr:HyperInflationaryEconomiesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R44": { "role": "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "longName": "9954486 - Disclosure - Business Acquisitions - (Details)", "shortName": "Business Acquisitions - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-101", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-101", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "longName": "9954487 - Disclosure - Business Segments - Narrative (Details)", "shortName": "Business Segments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "longName": "9954488 - Disclosure - Business Segments - Performance of Reportable Segments (Details)", "shortName": "Business Segments - Performance of Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "kwr:NonoperatingCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R47": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails", "longName": "9954489 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-3", "name": "kwr:Netreportingamount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "kwr:Netreportingamount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails", "longName": "9954490 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "shortName": "Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-148", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R49": { "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "longName": "9954491 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:VariableLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:VariableLeaseCost", "us-gaap:VariableLeaseCost", "us-gaap:VariableLeaseCost", "us-gaap:SubleaseIncome", "us-gaap:SubleaseIncome", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:VariableLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:VariableLeaseCost", "us-gaap:VariableLeaseCost", "us-gaap:VariableLeaseCost", "us-gaap:SubleaseIncome", "us-gaap:SubleaseIncome", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails", "longName": "9954492 - Disclosure - Leases - Supplemental Information (Details)", "shortName": "Leases - Supplemental Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails", "longName": "9954493 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)", "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails", "longName": "9954494 - Disclosure - Restructuring and Related Activities (Details)", "shortName": "Restructuring and Related Activities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated", "unitRef": "position", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated", "unitRef": "position", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "longName": "9954495 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details)", "shortName": "Share-Based Compensation - Share-based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-206", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R54": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "longName": "9954496 - Disclosure - Share-Based Compensation - Narrative (Details)", "shortName": "Share-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-222", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R55": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "longName": "9954497 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "shortName": "Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-220", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-220", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails", "longName": "9954498 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "shortName": "Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-234", "name": "kwr:DefinedBenefitPlanServiceCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-234", "name": "kwr:DefinedBenefitPlanServiceCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "longName": "9954499 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-242", "name": "kwr:DefinedBenefitPlanPlanAssetsLiquidatedAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-242", "name": "kwr:DefinedBenefitPlanPlanAssetsLiquidatedAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.quakerchem.com/role/OtherexpenseincomenetDetails", "longName": "9954500 - Disclosure - Other (expense) income, net (Details)", "shortName": "Other (expense) income, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails", "longName": "9954501 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details)", "shortName": "Income Taxes and Uncertain Income Tax Positions - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "longName": "9954502 - Disclosure - Earnings Per Share - Basic (Details)", "shortName": "Earnings Per Share - Basic (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R61": { "role": "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "longName": "9954503 - Disclosure - Earnings Per Share - Diluted (Details)", "shortName": "Earnings Per Share - Diluted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R62": { "role": "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "longName": "9954504 - Disclosure - Earnings Per Share - Antidilutive Shares (Details)", "shortName": "Earnings Per Share - Antidilutive Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "longName": "9954505 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "shortName": "Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R64": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "longName": "9954506 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "shortName": "Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "longName": "9954507 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details)", "shortName": "Goodwill and Other Intangible Assets - Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails", "longName": "9954508 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "longName": "9954509 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "shortName": "Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.quakerchem.com/role/DebtScheduleofDebtDetails", "longName": "9954510 - Disclosure - Debt - Schedule of Debt (Details)", "shortName": "Debt - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtAndCapitalLeaseObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtAndCapitalLeaseObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "longName": "9954511 - Disclosure - Debt - Narrative (Details)", "shortName": "Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-294", "name": "us-gaap:DerivativeLiabilityNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-294", "name": "us-gaap:DerivativeFixedInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R70": { "role": "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails", "longName": "9954512 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details)", "shortName": "Debt - Debt Related Expenses Included within Interest Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "longName": "9954513 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "shortName": "Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } }, "R72": { "role": "http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954514 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-342", "name": "us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-342", "name": "us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails", "longName": "9954515 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "shortName": "Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails", "longName": "9954516 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)", "shortName": "Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "longName": "9954517 - Disclosure - Hedging Activities - Narrative (Details)", "shortName": "Hedging Activities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-351", "name": "us-gaap:DerivativeTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-351", "name": "us-gaap:DerivativeTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "longName": "9954518 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "shortName": "Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "longName": "9954519 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-3", "name": "kwr:GainOnInsuranceRecoveries", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-367", "name": "kwr:LossContingencyLocationsDamagedNumber", "unitRef": "location", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20230930.htm", "unique": true } } }, "tag": { "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateHeldforsale", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate, held-for-sale", "label": "Real Estate, Held-for-Sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r1041" ] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r96", "r107" ] }, "us-gaap_CorporateBondSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateBondSecuritiesMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Bond Securities", "label": "Corporate Bond Securities [Member]", "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)." } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Results of Operations, Depreciation, Depletion, Amortization and Accretion", "documentation": "Depreciation, depletion, amortization, and accretion related to oil and gas producing activities." } } }, "auth_ref": [] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intersegment Sales Elimination", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r286", "r297", "r298", "r299", "r300", "r301", "r303", "r307" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income, net of tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r34" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r62" ] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r96", "r100" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segments", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r284", "r296", "r301", "r305", "r306", "r307", "r308", "r309", "r310", "r313" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r33", "r69" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Benefit Costs", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r158" ] }, "us-gaap_ProceedsFromOtherDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromOtherDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings on other debt, net", "label": "Proceeds from Other Debt", "documentation": "Amount of cash inflow from debt classified as other." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r738", "r742", "r747", "r761", "r767", "r787", "r788", "r789", "r855" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r49", "r52", "r110", "r111", "r313", "r797" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r54", "r55", "r56", "r57" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r596", "r597", "r598" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r54", "r55", "r56", "r57" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r49", "r52", "r110", "r111", "r313", "r705", "r797" ] }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingMeasurementDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting, Measurement Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r345", "r346", "r347", "r348", "r352", "r353", "r354" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Payment Arrangement, Cost by Plan", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r78" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r24" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, at cost", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r148", "r194", "r665" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r258", "r274" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r15", "r655", "r665", "r850" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (loss) gain on available-for-sale securities", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r205", "r208", "r316" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets Subject to Fair Value Measurements", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r109", "r166" ] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Post closing adjustment including earnouts", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r82" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of goods sold (excluding amortization expense - See Note 13)", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r133", "r642" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r256", "r274" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of dilutive securities (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r260", "r261", "r262", "r274", "r506" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r233", "r286", "r297", "r298", "r299", "r300", "r301", "r303", "r307", "r365", "r366", "r367", "r368", "r370", "r371", "r373", "r375", "r376", "r997", "r998" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r135" ] }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments", "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r102" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r33" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r233", "r286", "r297", "r298", "r299", "r300", "r301", "r303", "r307", "r365", "r366", "r367", "r368", "r370", "r371", "r373", "r375", "r376", "r997", "r998" ] }, "us-gaap_InterestAndDebtExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpenseAbstract", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt related expenses included within Interest expense:", "label": "Interest and Debt Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 }, "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income, net", "totalLabel": "Total other (expense) income, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r136" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r255", "r275", "r276", "r277" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r952" ] }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions." } } }, "auth_ref": [ "r93" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current accrued pension and postretirement benefits", "label": "Liability, Defined Benefit Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r121", "r431", "r432", "r454", "r836" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_InterestAndDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Interest and Debt Expense", "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity." } } }, "auth_ref": [ "r17" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r153", "r230", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r586", "r774", "r775", "r795" ] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from disposition of assets", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r138" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r168", "r199", "r231", "r284", "r299", "r305", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r566", "r571", "r599", "r656", "r744", "r850", "r865", "r997", "r998", "r1033" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r630", "r849" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Standards", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r180", "r181", "r183", "r187", "r237", "r238", "r241", "r242", "r253", "r254", "r320", "r321", "r553", "r554", "r555", "r583", "r588", "r592", "r593", "r594", "r600", "r601", "r602", "r617", "r618", "r635", "r644", "r645", "r646", "r699", "r700", "r701", "r702", "r704" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r22", "r36", "r185", "r216", "r217", "r218", "r234", "r235", "r236", "r240", "r250", "r252", "r279", "r319", "r324", "r418", "r539", "r540", "r541", "r551", "r552", "r578", "r579", "r580", "r581", "r582", "r584", "r589", "r606", "r608", "r609", "r610", "r611", "r612", "r634", "r695", "r696", "r697", "r716", "r771" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r50", "r313" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r314", "r315" ] }, "us-gaap_ProceedsFromInsuranceSettlementOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromInsuranceSettlementOperatingActivities", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from insurance settlement", "label": "Proceeds from Insurance Settlement, Operating Activities", "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as operating activities. Excludes insurance settlement classified as investing activities." } } }, "auth_ref": [ "r226", "r811" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior service cost (income) amortization", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r433", "r472", "r493", "r836", "r837" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r31", "r192", "r231", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r567", "r571", "r572", "r599", "r850", "r997", "r1033", "r1034" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r867" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2023 Grants", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings outstanding", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r26", "r170", "r1043" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r544", "r545", "r657" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial loss (gain) amortization", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r433", "r471", "r492", "r836", "r837" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to Quaker Chemical Corporation common shareholders \u2013 diluted (in dollars per share)", "verboseLabel": "Diluted earnings per common share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r223", "r243", "r244", "r246", "r247", "r249", "r259", "r270", "r273", "r274", "r278", "r590", "r591", "r653", "r674", "r819" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r152", "r229", "r378", "r384", "r385", "r386", "r387", "r388", "r389", "r394", "r401", "r402", "r404" ] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance stock units", "verboseLabel": "Performance Stock Units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r455", "r503", "r530", "r531", "r532", "r640", "r641", "r694", "r722", "r723", "r776", "r778", "r780", "r781", "r792", "r809", "r810", "r822", "r829", "r844", "r852", "r855", "r987", "r1001", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Balance", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r173" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding amount", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Total", "label": "Assets, Total [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r503", "r641", "r694", "r722", "r723", "r776", "r778", "r780", "r781", "r792", "r809", "r810", "r822", "r829", "r844", "r852", "r1001", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency conversion impacts of hyper-inflationary accounting", "label": "Amount Recognized in Income Due to Inflationary Accounting", "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting." } } }, "auth_ref": [ "r613" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings and current portion of long-term debt", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r200" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r47" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r455", "r503", "r530", "r531", "r532", "r640", "r641", "r694", "r722", "r723", "r776", "r778", "r780", "r781", "r792", "r809", "r810", "r822", "r829", "r844", "r852", "r855", "r987", "r1001", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalariesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Accrued Salaries, Current", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30", "r816" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r448", "r458", "r496", "r834", "r835", "r836", "r837" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r503", "r641", "r694", "r722", "r723", "r776", "r778", "r780", "r781", "r792", "r809", "r810", "r822", "r829", "r844", "r852", "r1001", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued pension and postretirement benefits", "label": "Liability, Defined Benefit Plan, Current", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current." } } }, "auth_ref": [ "r120", "r431", "r432", "r454", "r836" ] }, "kwr_AmendedUsTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "AmendedUsTermLoanMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Term Loan", "label": "Amended U.S. Term Loan [Member]", "documentation": "Amended U.S. Term Loan" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerListsMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer lists and rights to sell", "label": "Customer Lists [Member]", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r83" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Investments in property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r139" ] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends declared", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r11", "r156" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r191", "r203", "r231", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r566", "r571", "r599", "r850", "r997", "r998", "r1033" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsAndLiabilitiesLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAndLiabilitiesLesseeAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets and Liabilities, Lessee [Abstract]", "label": "Assets and Liabilities, Lessee [Abstract]" } } }, "auth_ref": [] }, "kwr_SupplementalCashFlowInformationRelatedToLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "SupplementalCashFlowInformationRelatedToLeasesAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental cash flow information related to leases", "label": "Supplemental cash flow information related to leases", "documentation": "Supplemental cash flow information related to leases" } } }, "auth_ref": [] }, "kwr_AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "AssetsRelatedToSealingAndImpregnationOfMetalCastingsMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Related To Sealing And Impregnation Of Metal Castings", "label": "Assets Related To Sealing And Impregnation Of Metal Castings [Member]", "documentation": "Assets Related To Sealing And Impregnation Of Metal Castings" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "kwr_GainOnInsuranceRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "GainOnInsuranceRecoveries", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facility remediation recoveries, net", "label": "Gain On Insurance Recoveries", "documentation": "Gain On Insurance Recoveries" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option award vesting period (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r845" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r433", "r470", "r491", "r836", "r837" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends payable", "label": "Dividends Payable, Current", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30" ] }, "kwr_MetalworkingAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "MetalworkingAndOtherMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Metalworking and other", "label": "Metalworking and Other [Member]", "documentation": "Metals product line." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income before Reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r217", "r606", "r609", "r612", "r670", "r955" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts reclassified from AOCI", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r217", "r606", "r611", "r612", "r670", "r955" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected future employer contributions, remainder of fiscal year", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year", "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year." } } }, "auth_ref": [ "r496", "r837" ] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries in which entity operates", "label": "Number of Countries in which Entity Operates", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining life, nonvested stock awards (in years)", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r537" ] }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "NonvestedStockAwardsCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-vested stock awards and restricted stock units", "label": "Nonvested Stock Awards Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r433", "r437", "r469", "r490", "r836", "r837" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r224", "r243", "r244", "r246", "r247", "r256", "r257", "r269", "r274", "r284", "r298", "r304", "r307", "r821" ] }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before equity in net income of associated companies", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "documentation": "Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency [Axis]", "label": "Currency [Axis]" } } }, "auth_ref": [ "r1024" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r392", "r458", "r463", "r597", "r637", "r834", "r835", "r836" ] }, "kwr_TrademarksFormulationsandproducttechnologymemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "TrademarksFormulationsandproducttechnologymemberMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks, formulations and product technology", "label": "Trademarks Formulations And Product Technology [Member]", "documentation": "Trademarks Formulations And Product Technology [Member]" } } }, "auth_ref": [] }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank lines of credit and other debt obligations", "label": "Bank lines of credit and other debt obligations [Member]", "documentation": "Bank lines of credit and other debt obligations." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Quaker Chemical Corporation", "terseLabel": "Net income attributable to Quaker Chemical Corporation", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r130", "r142", "r175", "r190", "r211", "r214", "r218", "r231", "r239", "r243", "r244", "r246", "r247", "r251", "r252", "r267", "r284", "r298", "r304", "r307", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r591", "r599", "r669", "r753", "r769", "r770", "r821", "r863", "r997" ] }, "kwr_MetalsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "MetalsMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Metals", "label": "Metals [Member]", "documentation": "Metals product line." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic benefit cost (income)", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r467", "r488", "r836", "r837" ] }, "kwr_OldCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "OldCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original Credit Facility", "label": "Previous Credit Facility [Member]", "documentation": "Syndicated multicurrency, unsecured revolving credit facility with a group of lenders." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r392", "r458", "r463", "r597", "r638", "r825", "r826", "r834", "r835", "r836" ] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Concentration Risk", "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r51", "r797" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r905" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r132", "r231", "r284", "r298", "r304", "r307", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r599", "r821", "r997" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r233", "r566", "r567", "r571", "r572", "r636", "r808", "r996", "r999", "r1000" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r908" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r907" ] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r1004" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r870", "r940" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r906" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r60", "r62", "r643" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r905" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r309", "r642", "r688", "r689", "r690", "r691", "r692", "r693", "r813", "r830", "r851", "r946", "r994", "r995", "r1003", "r1044" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r823" ] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Share issuance and equity-based compensation plans", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r32", "r380" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r906" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r29", "r231", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r567", "r571", "r572", "r599", "r730", "r820", "r865", "r997", "r1033", "r1034" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r823" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total share-based compensation expense", "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r534", "r542" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r309", "r642", "r688", "r689", "r690", "r691", "r692", "r693", "r813", "r830", "r851", "r946", "r994", "r995", "r1003", "r1044" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationTable", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Examination [Table]", "label": "Income Tax Examination [Table]", "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued." } } }, "auth_ref": [ "r160" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r907" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of PSUs granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r515" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in net income (loss) of associated companies", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r14", "r129", "r174", "r291", "r317", "r666" ] }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities." } } }, "auth_ref": [ "r14" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonvested stock awards granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r522" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r936" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNetAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: short-term and current portion of long-term debts", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r119", "r169", "r850", "r1042" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r907" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Axis]", "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r186", "r234", "r235", "r236", "r239", "r240", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r278", "r322", "r323", "r552", "r587", "r589", "r590", "r591", "r616", "r633", "r634", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r708" ] }, "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of positions eliminated", "label": "Restructuring and Related Cost, Number of Positions Eliminated", "documentation": "The number of positions eliminated during the period as a result of restructuring activities." } } }, "auth_ref": [] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Domain]", "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r186", "r234", "r235", "r236", "r239", "r240", "r243", "r244", "r245", "r246", "r248", "r249", "r250", "r251", "r252", "r253", "r278", "r322", "r323", "r552", "r587", "r589", "r590", "r591", "r616", "r633", "r634", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r708" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r907" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r127", "r172", "r663", "r850", "r962", "r970", "r1018" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r596", "r597", "r598" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r313", "r832", "r1003", "r1044", "r1045" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r622", "r628" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r908" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLineItems", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Examination [Line Items]", "label": "Income Tax Examination [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments related to acquisitions, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r41" ] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r392", "r458", "r459", "r460", "r461", "r462", "r463", "r637", "r638", "r639", "r825", "r826", "r834", "r835", "r836" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r46", "r193", "r815" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r58", "r61" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r234", "r235", "r236", "r279", "r642", "r709", "r717", "r724", "r725", "r726", "r727", "r728", "r729", "r732", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r745", "r746", "r747", "r748", "r749", "r751", "r754", "r755", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r771", "r856" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r908" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r595" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r14", "r59", "r63" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r547" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r137", "r398", "r405", "r827", "r828" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs", "label": "Amortization of Debt Issuance Costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r131", "r400", "r614", "r960" ] }, "us-gaap_InsuranceClaimsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceClaimsMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance Claims", "label": "Insurance Claims [Member]", "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims." } } }, "auth_ref": [ "r177" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales Revenue Net", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r313", "r943" ] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Nonoperating (Expense) Income", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r908" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r233", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r615", "r824", "r825", "r826", "r827", "r828", "r961" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Book Value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r145", "r643" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r60", "r62" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to Quaker Chemical Corporation common shareholders \u2013 basic (in dollars per share)", "verboseLabel": "Basic earnings per common share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r223", "r243", "r244", "r246", "r247", "r249", "r256", "r259", "r270", "r273", "r274", "r278", "r590", "r591", "r653", "r674", "r819" ] }, "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reallocation of Reporting Units", "label": "Revision of Prior Period, Reclassification, Adjustment [Member]" } } }, "auth_ref": [ "r188" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r145", "r647" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Information [Line Items]", "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r908" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r629", "r849" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r908" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r869" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r929" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r623" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r931" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r623" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r358", "r359", "r360", "r364", "r992", "r993" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r902" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r198" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Per share data:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r234", "r235", "r236", "r279", "r642", "r709", "r717", "r724", "r725", "r726", "r727", "r728", "r729", "r732", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r745", "r746", "r747", "r748", "r749", "r751", "r754", "r755", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r771", "r856" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r227" ] }, "us-gaap_TransferredAtPointInTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransferredAtPointInTimeMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product sales at a point in time", "label": "Transferred at Point in Time [Member]", "documentation": "Contract with customer in which good or service is transferred at point in time." } } }, "auth_ref": [ "r833" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Product Information [Table]", "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r227" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in associated companies", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r294", "r317", "r950", "r969" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Quaker shareholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r122", "r125", "r126", "r143", "r734", "r750", "r772", "r773", "r850", "r865", "r962", "r970", "r1018", "r1048" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r140", "r141", "r142" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r936" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r954" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Activities", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r165", "r576", "r585" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r928" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Currencies [Domain]", "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInRestructuringReserve", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Change in restructuring liabilities", "label": "Increase (Decrease) in Restructuring Reserve", "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations." } } }, "auth_ref": [ "r959" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r934" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 18)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r35", "r116", "r658", "r731" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r927" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r941" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r928" ] }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashSurrenderValueFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company-owned life insurance", "label": "Cash Surrender Value, Fair Value Disclosure", "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r201" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r80", "r81", "r561", "r838", "r841" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r904" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r16", "r74", "r75", "r76", "r77" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense, options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1006" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use lease assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r620" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized share-based compensation expense, nonvested stock award", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r1006" ] }, "us-gaap_OtherDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation of corporate assets and amortization", "label": "Other Depreciation and Amortization", "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other." } } }, "auth_ref": [ "r14", "r64", "r134" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r561", "r838", "r841" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r585" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r431", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r500", "r501", "r502", "r504", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r216", "r217", "r606", "r608", "r609", "r610", "r611", "r612" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r13" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r930" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r78" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r23", "r91", "r92", "r94", "r95", "r98", "r101", "r105", "r106", "r108", "r585" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r431", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r500", "r501", "r502", "r504", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r146" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Defined benefit retirement plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r9", "r128" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r80", "r81", "r561" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r233", "r566", "r567", "r571", "r572", "r636", "r808", "r996", "r999", "r1000" ] }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtPercentageBearingVariableInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt interest rate (as a percent)", "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate", "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time." } } }, "auth_ref": [ "r32" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r866" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r146" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r561" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r146" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r146" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, fixed interest rate (as a percent)", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r43" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss", "terseLabel": "Amounts reported in other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r22", "r25", "r212", "r215", "r219", "r606", "r607", "r612", "r649", "r670", "r955", "r956" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk (as a percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r49", "r52", "r110", "r111", "r313" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r935" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r932" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the remainder of 2023", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r189", "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r307", "r313", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r342", "r348", "r354", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r823", "r946", "r1044" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r935" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r933" ] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "(Loss) gain on disposals of property, plant, equipment and other assets, net", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r960", "r985", "r986" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of foreign exchange rate changes on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1021" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r392", "r458", "r459", "r460", "r461", "r462", "r463", "r597", "r637", "r638", "r639", "r825", "r826", "r834", "r835", "r836" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related tax amounts", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r12", "r20", "r163" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r124", "r156", "r661", "r699", "r704", "r712", "r733", "r850" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r934" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining lease terms (in years)", "label": "Lessee, Operating Lease, Remaining Lease Term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1025" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "country_AR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AR", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ARGENTINA", "label": "ARGENTINA" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r870", "r940" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r868" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnouts", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r3", "r84", "r564" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r870", "r940" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive shares (in share)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r275" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from third party license fees", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r285", "r286", "r297", "r302", "r303", "r309", "r311", "r313", "r427", "r428", "r642" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r140" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r285", "r286", "r297", "r302", "r303", "r309", "r311", "r313", "r427", "r428", "r642" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r934" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at the beginning of the period", "periodEndLabel": "Cash and cash equivalents at the end of the period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r46", "r140", "r228" ] }, "kwr_Vestingsharestargetupperpercent": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "Vestingsharestargetupperpercent", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting shares target upper (as a percent)", "label": "Vesting Shares Target Upper Percent", "documentation": "Vesting Shares Target Upper Percent" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r176" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r33", "r72", "r73", "r112", "r113", "r115", "r117", "r154", "r155", "r233", "r379", "r380", "r381", "r382", "r383", "r385", "r390", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r615", "r824", "r825", "r826", "r827", "r828", "r961" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r358", "r359", "r360", "r364", "r992", "r993" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "kwr_HyperInflationaryEconomiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "HyperInflationaryEconomiesPolicyTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Hyper-inflationary economies", "label": "Hyper-inflationary economies [Policy Text Block]", "documentation": "Hyper-inflationary economies policy." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financing-related debt issuance costs", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r45" ] }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsAndWorkInProcess", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process and finished goods", "label": "Inventory, Finished Goods and Work in Process, Gross", "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale." } } }, "auth_ref": [ "r953" ] }, "kwr_BusinessRelatedToPicklingAndRinsingProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "BusinessRelatedToPicklingAndRinsingProductsAndServicesMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Related to Pickling and Rinsing Products and Services", "label": "Business Related to Pickling and Rinsing Products and Services [Member]", "documentation": "Business Related to Pickling and Rinsing Products and Services [Member]" } } }, "auth_ref": [] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r358", "r359", "r360", "r364", "r992", "r993" ] }, "us-gaap_RestructuringChargesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringChargesMember", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Programs", "label": "Restructuring Charges [Member]", "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included." } } }, "auth_ref": [ "r149", "r150" ] }, "kwr_GlobalSpecialtyBusinessesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "GlobalSpecialtyBusinessesMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advanced solutions", "label": "Global Specialty Businesses [Member]", "documentation": "Global Specialty Businesses." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r531" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r358", "r359", "r360", "r364", "r992", "r993" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r643" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r532" ] }, "kwr_CoralChemicalCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "CoralChemicalCompanyMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Coral Chemical Company (Coral)", "label": "Coral Chemical Company (Coral) [Member]", "documentation": "Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r343", "r344", "r346", "r349", "r355" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related charges (credits), net", "verboseLabel": "Restructuring and related charges (credits), net", "negatedLabel": "Restructuring and related (charges) credits, net", "netLabel": "Restructuring and related charges, net", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r14", "r350", "r352", "r988" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533" ] }, "kwr_HoughtonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "HoughtonMember", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Houghton", "label": "Houghton [Member]", "documentation": "Business combination of Houghton." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "kwr_Industrialdevelopmentrevenuebond": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "Industrialdevelopmentrevenuebond", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Industrial development revenue bond", "label": "Industrial Development Revenue Bond", "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility." } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Authority", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r337", "r338", "r339", "r340", "r643", "r647" ] }, "kwr_TaxSettlementFinalAmountDueToTaxAuthorities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "TaxSettlementFinalAmountDueToTaxAuthorities", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax settlement final amount due to tax authorities", "label": "Tax Settlement Final Amount Due To Tax Authorities", "documentation": "Tax Settlement Final Amount Due To Tax Authorities" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Director stock ownership plan", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension Benefits", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r431", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r500", "r501", "r504", "r836", "r837", "r841", "r842", "r843" ] }, "kwr_LargestCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "LargestCustomerMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Largest Customers", "label": "Largest customer [Member]", "documentation": "Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Domain]", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate swaps", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r812", "r860", "r861" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r60", "r62" ] }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and other postretirement benefits", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r935" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued restructuring", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r951", "r989", "r990" ] }, "currency_JPY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "JPY", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japanese Yen", "label": "Japan, Yen" } } }, "auth_ref": [] }, "kwr_MrBijlanisTradingArrangementCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "MrBijlanisTradingArrangementCommonStockMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Mr. Bijlani's Trading Arrangement, Common Stock [Member]", "documentation": "Mr. Bijlani's Trading Arrangement, Common Stock" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accrued restructuring, beginning balance", "periodEndLabel": "Accrued restructuring, ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r346", "r351" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Postretirement Benefits", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r430", "r455", "r457", "r463", "r480", "r482", "r483", "r484", "r485", "r486", "r498", "r499", "r500", "r836" ] }, "kwr_BaronIndustriesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "BaronIndustriesMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Baron Industries", "label": "Baron Industries [Member]", "documentation": "Baron Industries" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r13" ] }, "us-gaap_DeferredFinanceCostsCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsCurrentNet", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Current, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r114" ] }, "kwr_HoughtonCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "HoughtonCombinationMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Houghton Combination", "label": "Houghton Combination [Member]", "documentation": "Hougton, a business combination." } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r156" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other Postretirement Benefits", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r431", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r500", "r501", "r502", "r836", "r837", "r838", "r839", "r840" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r27", "r850" ] }, "kwr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsEstimatedFutureGrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsEstimatedFutureGrants", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated future PSUs issued (in shares)", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Estimated Future Grants", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Estimated Future Grants" } } }, "auth_ref": [] }, "kwr_CombinationAndOtherAcquisitionRelatedExpensesNetOfPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "CombinationAndOtherAcquisitionRelatedExpensesNetOfPayments", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Combination and other acquisition-related expenses, net of payments", "label": "Combination And Other Acquisition-Related Expenses, Net Of Payments", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments." } } }, "auth_ref": [] }, "kwr_OperatingIncomeLossSegmentReporting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "OperatingIncomeLossSegmentReporting", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment operating earnings", "label": "Operating Income Loss Segment Reporting", "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges." } } }, "auth_ref": [] }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyEstimateOfPossibleLoss", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, estimate of possible loss", "label": "Loss Contingency, Estimate of Possible Loss", "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date." } } }, "auth_ref": [ "r359", "r360", "r363", "r364" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r90", "r163", "r213", "r215", "r220", "r650", "r671" ] }, "kwr_NonoperatingCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "NonoperatingCharges", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Non-operating and administrative expenses", "label": "Nonoperating Charges", "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency translation adjustments", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r989", "r990" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r28" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]" } } }, "auth_ref": [] }, "kwr_IndustrialDevelopmentBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "IndustrialDevelopmentBondsMember", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Industrial development bonds", "label": "Industrial development bonds [Member]", "documentation": "Industrial development bonds." } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lease, Cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1026" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Comprehensive loss attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r12", "r87", "r90", "r213", "r215", "r221", "r651", "r672" ] }, "kwr_GoodwillReallocationOfReportingUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "GoodwillReallocationOfReportingUnits", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reallocation of reporting units", "label": "Goodwill, Reallocation of Reporting Units", "documentation": "Goodwill, Reallocation of Reporting Units" } } }, "auth_ref": [] }, "country_IT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IT", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Italy", "label": "ITALY" } } }, "auth_ref": [] }, "kwr_Vestingsharestargetlowerpercent": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "Vestingsharestargetlowerpercent", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting shares target lower (as a percent)", "label": "Vesting Shares Target Lower Percent", "documentation": "Vesting Shares Target Lower Percent" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "kwr_DefinedBenefitPlanPlanAssetsLiquidatedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "DefinedBenefitPlanPlanAssetsLiquidatedAssets", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit plan, plan assets, liquidated assets", "label": "Defined Benefit Plan, Plan Assets, Liquidated Assets", "documentation": "Defined Benefit Plan, Invested Assets" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, period increase", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r1007" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "kwr_CumulativePaymentsForTaxSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "CumulativePaymentsForTaxSettlements", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative payments for tax settlements", "label": "Cumulative Payments for Tax Settlements", "documentation": "Cumulative Payments for Tax Settlements" } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDepositOtherAssets", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amount received from an escrow", "label": "Increase (Decrease) in Deposit Assets", "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Payments on revolving credit facilities, net", "label": "Proceeds from (Repayments of) Lines of Credit", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30", "r850" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533" ] }, "kwr_StockOptionsCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "StockOptionsCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Stock Options Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining borrowing capacity", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r28" ] }, "kwr_HoughtonEnvironmentalMattersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "HoughtonEnvironmentalMattersMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Houghton Environmental Matters", "label": "Houghton Environmental Matters [Member]", "documentation": "Houghton environmental matters." } } }, "auth_ref": [] }, "kwr_MrBijlanisTradingArrangementStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "MrBijlanisTradingArrangementStockOptionsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Mr. Bijlani's Trading Arrangement, Stock Options [Member]", "documentation": "Mr. Bijlani's Trading Arrangement, Stock Options" } } }, "auth_ref": [] }, "kwr_MaximumIncreaseInBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "MaximumIncreaseInBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum increase in borrowing capacity", "label": "Maximum increase in borrowing capacity", "documentation": "Maximum increase in borrowing capacity" } } }, "auth_ref": [] }, "kwr_ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Monte Carlo Option Pricing Model And The Assumptions", "label": "Schedule of Monte Carlo option pricing model and the assumptions [Table Text Block]", "documentation": "Schedule of Monte Carlo option pricing model and the assumptions" } } }, "auth_ref": [] }, "currency_MXN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "MXN", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mexican Peso", "label": "Mexico, Pesos" } } }, "auth_ref": [] }, "kwr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2028 and beyond", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four", "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income, net", "label": "Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing nonoperating income (expense)." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "kwr_DefinedBenefitPlanServiceCostNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "DefinedBenefitPlanServiceCostNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost, Net", "documentation": "Defined Benefit Plan, Service Cost, Net" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, weighted average interest rate, over time (as a percent)", "label": "Long-Term Debt, Weighted Average Interest Rate, over Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time." } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r109" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r122" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjecttoFairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r392", "r458", "r459", "r460", "r461", "r462", "r463", "r597", "r639", "r825", "r826", "r834", "r835", "r836" ] }, "kwr_OriginalCreditFacilityAndTheAmendedCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "OriginalCreditFacilityAndTheAmendedCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original Credit Facility and the Amended Credit Facility", "label": "Original Credit Facility and the Amended Credit Facility [Member]", "documentation": "Original Credit Facility and the Amended Credit Facility" } } }, "auth_ref": [] }, "kwr_PensionAndPostretirementBenefitIncomeNonServiceComponents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "PensionAndPostretirementBenefitIncomeNonServiceComponents", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefit (costs) income, non-service components", "label": "Pension And Postretirement Benefit Income, Non-Service Components", "documentation": "Other income related to non-service pension cost components" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r632" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r967" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r85", "r418", "r963", "r964", "r965", "r1048" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r916" ] }, "kwr_ArgentineAndTurkishSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "ArgentineAndTurkishSubsidiariesMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentine and Turkish Subsidiaries", "label": "Argentine and Turkish Subsidiaries [Member]", "documentation": "Argentine and Turkish Subsidiaries" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r916" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r122" ] }, "kwr_FacilitiesVehiclesAndMachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "FacilitiesVehiclesAndMachineryAndEquipmentMember", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facilities Vehicles and Machinery and Equipment", "label": "Facilities Vehicles and Machinery and Equipment [Member]", "documentation": "Operating leases for certain facilities, vehicles and machinery and equipment." } } }, "auth_ref": [] }, "kwr_Netreportingamount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "Netreportingamount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized under net reporting arrangements", "label": "Net Reporting Amount", "documentation": "Amount recognized as revenue under net reporting arrangements" } } }, "auth_ref": [] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r939" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitions" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisitions", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r161", "r562" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r632" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r853", "r854", "r855", "r857", "r858", "r859", "r862", "r963", "r964", "r1015", "r1046", "r1048" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r307", "r313", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r348", "r354", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r823", "r946", "r1044" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r85", "r86", "r88", "r185", "r186", "r217", "r234", "r235", "r236", "r240", "r250", "r319", "r324", "r418", "r539", "r540", "r541", "r551", "r552", "r578", "r579", "r580", "r581", "r582", "r584", "r589", "r606", "r608", "r612", "r634", "r696", "r697", "r714", "r734", "r750", "r772", "r773", "r794", "r864", "r962", "r970", "r1018", "r1048" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r935" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r632" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r903" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r937" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r632" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r916" ] }, "kwr_LossContingencyLocationsDamagedNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "LossContingencyLocationsDamagedNumber", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of locations that suffered property damage", "label": "Loss Contingency, Locations Damaged, Number", "documentation": "Loss Contingency, Locations Damaged, Number" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the remainder of 2023", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r1027" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1027" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding September\u00a030, 2023 \u2013 18,000,855 shares; December\u00a031, 2022 \u2013 17,950,264 shares", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r122", "r659", "r850" ] }, "kwr_CombinationAndOtherAcquisitionRelatedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "CombinationAndOtherAcquisitionRelatedMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Combination And Other Acquisition-Related", "label": "Combination And Other Acquisition-Related [Member]", "documentation": "Combination And Other Acquisition-Related [Member]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r97", "r99", "r101", "r104", "r721", "r723", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r745", "r746", "r747", "r748", "r759", "r760", "r761", "r762", "r765", "r766", "r767", "r768", "r783", "r785", "r789", "r791", "r817", "r853", "r855" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r867" ] }, "kwr_BusinessProvidingPicklingInhibitorTechnologiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "BusinessProvidingPicklingInhibitorTechnologiesMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Related To Pickling Inhibitor Technologies", "label": "Business Related To Pickling Inhibitor Technologies [Member]", "documentation": "Assets Related To Pickling Inhibitor Technologies" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r872", "r883", "r893", "r918" ] }, "us-gaap_DerivativeLiabilityNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotionalAmount", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, notional amount", "label": "Derivative Liability, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative liability." } } }, "auth_ref": [ "r784", "r786", "r787", "r790", "r1012", "r1013", "r1014" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r7", "r128", "r603", "r604", "r605" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r544", "r545" ] }, "kwr_SupplementalBalanceSheetInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "SupplementalBalanceSheetInformationAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental balance sheet information", "label": "Supplemental balance sheet information", "documentation": "Supplemental balance sheet information" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r122", "r732" ] }, "kwr_TopFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "TopFiveMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Top Five Customers", "label": "Customer Concentration Risk Top Five [Member]", "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r916" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r22", "r122", "r732", "r750", "r1048", "r1049" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r936" ] }, "kwr_AmendedRevolverMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "AmendedRevolverMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolver", "label": "Amended Revolver [Member]", "documentation": "Amended Revolver" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r881", "r889", "r899", "r916", "r924", "r928", "r936" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1013", "r1014" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r881", "r889", "r899", "r916", "r924", "r928", "r936" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes on income before equity in net income of associated companies", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r178", "r182", "r251", "r252", "r292", "r546", "r557", "r676" ] }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "ProceedsFromNonIncomeTaxRefunds", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-income tax refunds and other related credits (expense)", "label": "Proceeds From Non Income Tax Refunds", "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current fiscal year end date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r968" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r871", "r882", "r892", "r917" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss) attributable to Quaker Chemical Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r213", "r215", "r222", "r652", "r673" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r37", "r171", "r231", "r318", "r365", "r368", "r369", "r370", "r376", "r377", "r599", "r662", "r734" ] }, "kwr_AmendedEuroTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "AmendedEuroTermLoanMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Term Loan", "label": "Amended EURO Term Loan [Member]", "documentation": "Amended EURO Term Loan" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r935" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r797" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r49", "r52", "r110", "r111", "r313", "r797" ] }, "kwr_JeewatBijlaniMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "JeewatBijlaniMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Jeewat Bijlani [Member]", "documentation": "Jeewat Bijlani" } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r873", "r884", "r894", "r919" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r297", "r298", "r299", "r300", "r301", "r307" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r49", "r52", "r110", "r111", "r313", "r797", "r944" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r871", "r882", "r892", "r917" ] }, "kwr_AmendedCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "AmendedCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended Credit Facility", "label": "Amended Credit Facility [Member]", "documentation": "Amended Credit Facility" } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas [Member]" } } }, "auth_ref": [ "r1050", "r1051", "r1052", "r1053" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r15" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r867" ] }, "us-gaap_DerivativeVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeVariableInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative variable interest rate (as a percent)", "label": "Derivative, Variable Interest Rate", "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r48", "r49", "r52", "r53", "r110", "r167", "r797" ] }, "kwr_CreditFacilityAsPercentageOfConsolidatedEBITDA": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "CreditFacilityAsPercentageOfConsolidatedEBITDA", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit faclity as percentage of consolidated EBITDA (as a percent)", "label": "Credit facility as percentage of consolidated EBITDA", "documentation": "Credit facility as percentage of consolidated EBITDA" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r148" ] }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20230930", "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation, deferred taxes and other, net", "label": "Increase Decrease In Deferred Compensation And Other Net", "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items." } } }, "auth_ref": [] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia/Pacific", "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r1050", "r1051", "r1052", "r1053" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r877", "r888", "r898", "r923" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r874", "r885", "r895", "r920" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Axis]", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r19" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r867" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r874", "r885", "r895", "r920" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r938" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r904" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r875", "r886", "r896", "r921" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r904" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r867" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r878", "r889", "r899", "r924" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity central index key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r867" ] }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r876", "r887", "r897", "r922" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r867" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before taxes and equity in net income of associated companies", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r284", "r298", "r304", "r307", "r675", "r821" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r14", "r70", "r71" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r196", "r325", "r648", "r823", "r850", "r975", "r982" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r621" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r632" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r313", "r832", "r1003", "r1044", "r1045" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r18" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease liabilities", "terseLabel": "Present value of lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r621" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r721", "r723", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r745", "r746", "r747", "r748", "r759", "r760", "r761", "r762", "r765", "r766", "r767", "r768", "r783", "r785", "r789", "r791", "r853", "r855" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r44", "r711" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r147" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r909" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r909" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r937" ] }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/Otherexpenseincomenet" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income, net", "label": "Other Income and Other Expense Disclosure [Text Block]", "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions." } } }, "auth_ref": [ "r157", "r159" ] }, "us-gaap_IndefiniteLivedTrademarks": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedTrademarks", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived trademarks", "label": "Indefinite-Lived Trademarks", "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit." } } }, "auth_ref": [ "r147" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r284", "r298", "r304", "r307", "r821" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r909" ] }, "us-gaap_AccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Accrued Liabilities [Member]", "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered." } } }, "auth_ref": [ "r30" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r621" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-lived Intangible Assets Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r575" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r909" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r224", "r258", "r263", "r264", "r265", "r266", "r269", "r274" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r23", "r97", "r101", "r104", "r107", "r108", "r575" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r910" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Net Sales and Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r184", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r429" ] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Previously Reported", "label": "Previously Reported [Member]" } } }, "auth_ref": [ "r186", "r234", "r236", "r239", "r240", "r243", "r244", "r252", "r278", "r552", "r587", "r589", "r590", "r616", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r708", "r945", "r947", "r948", "r949", "r966", "r972", "r973", "r1016", "r1028", "r1029" ] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Acquisition [Domain]", "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r1008" ] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Acquisition [Axis]", "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r1008" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current Assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r529" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r912" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r311", "r312", "r718", "r719", "r720", "r777", "r779", "r782", "r793", "r796", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r814", "r831", "r855", "r1003", "r1044" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r911" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r915" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r913" ] }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossRealized", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange losses, net", "label": "Realized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r752", "r863", "r1019", "r1020", "r1047" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r914" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r914" ] }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits, Description [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r631", "r849" ] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r1050", "r1051", "r1052", "r1053" ] }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferred", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset acquisition, consideration transferred", "label": "Asset Acquisition, Consideration Transferred", "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer." } } }, "auth_ref": [ "r846", "r1009", "r1010", "r1011" ] }, "us-gaap_InventoryRawMaterialsAndSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSupplies", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and supplies", "label": "Inventory, Raw Materials and Supplies, Gross", "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed." } } }, "auth_ref": [ "r953" ] }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Income and Interest Expense Disclosure", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Description of Business", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r118", "r162", "r706", "r707" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r311", "r312", "r718", "r719", "r720", "r777", "r779", "r782", "r793", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r814", "r831", "r855", "r1003", "r1044" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r632" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LifeInsuranceCorporateOrBankOwnedChangeInValue", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Surrendered and liquidated life insurance policies", "label": "Life Insurance, Corporate or Bank Owned, Change in Value", "documentation": "The change in cash surrender or contract value during the period which adjusted the amount of premiums paid in determining the expense or income recognized under the contract for the period." } } }, "auth_ref": [ "r971" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r823", "r974", "r975", "r976", "r977", "r978", "r979", "r980", "r981", "r982", "r983", "r984" ] }, "us-gaap_LongTermDebtTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTerm", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt term (in years)", "label": "Long-Term Debt, Term", "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1017" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1003" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Pension Plans", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r8", "r21", "r39", "r955", "r956", "r957" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r185", "r234", "r235", "r236", "r240", "r250", "r252", "r319", "r324", "r539", "r540", "r541", "r551", "r552", "r578", "r580", "r581", "r584", "r589", "r695", "r697", "r716", "r1048" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in Excess of Par Value", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r539", "r540", "r541", "r716", "r963", "r964", "r965", "r1015", "r1048" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r879", "r890", "r900", "r925" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r190", "r211", "r214", "r225", "r231", "r239", "r251", "r252", "r284", "r298", "r304", "r307", "r318", "r365", "r366", "r368", "r369", "r370", "r372", "r374", "r376", "r377", "r565", "r568", "r569", "r591", "r599", "r654", "r667", "r715", "r753", "r769", "r770", "r821", "r847", "r848", "r864", "r957", "r997" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r66", "r67", "r68" ] }, "us-gaap_DerivativeTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTermOfContract", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative term (in years)", "label": "Derivative, Term of Contract", "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (Loss) Gain in Available-for- Sale Securities", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r205", "r206", "r207", "r209", "r217", "r218", "r955" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r878", "r889", "r899", "r916", "r924" ] }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WriteOffOfDeferredDebtIssuanceCost", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "label": "Deferred Debt Issuance Cost, Writeoff", "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt." } } }, "auth_ref": [ "r137" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r114", "r1002" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes and Uncertain Income Tax Positions", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r232", "r543", "r548", "r549", "r550", "r556", "r558", "r559", "r560", "r713" ] }, "us-gaap_TransferredOverTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransferredOverTimeMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Services transferred over time", "label": "Transferred over Time [Member]", "documentation": "Contract with customer in which good or service is transferred over time." } } }, "auth_ref": [ "r833" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r345", "r346", "r347", "r348", "r352", "r353", "r354" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r151", "r356", "r357", "r798", "r991" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r6", "r21", "r39", "r217", "r218", "r608", "r609", "r610", "r611", "r612", "r955" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r878", "r889", "r899", "r924" ] }, "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized loss deferred to AOCI", "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net", "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings." } } }, "auth_ref": [ "r103" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r22", "r185", "r216", "r217", "r218", "r234", "r235", "r236", "r240", "r250", "r252", "r279", "r319", "r324", "r418", "r539", "r540", "r541", "r551", "r552", "r578", "r579", "r580", "r581", "r582", "r584", "r589", "r606", "r608", "r609", "r610", "r611", "r612", "r634", "r695", "r696", "r697", "r716", "r771" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Combination, integration and other acquisition-related expenses", "negatedLabel": "Combination, integration and other acquisition-related expenses", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r79" ] }, "srt_SubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SubsidiariesMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentina", "label": "Subsidiaries [Member]" } } }, "auth_ref": [ "r1005", "r1030", "r1031", "r1032" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r878", "r889", "r899", "r924" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r5", "r21", "r39", "r579", "r582", "r634", "r695", "r696", "r955", "r956", "r957", "r963", "r964", "r965" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net income attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r89", "r164", "r211", "r214", "r251", "r252", "r668", "r957" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r879", "r890", "r900", "r925" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r878", "r889", "r899", "r924" ] }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: income allocated to participating securities", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r268", "r271", "r272" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase accounting adjustments", "label": "Goodwill, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r0", "r981" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other stock related activity", "label": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r10", "r710" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r65", "r195", "r664" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r878", "r889", "r899", "r924" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash transferred to Houghton shareholders", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r41", "r563" ] }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: income allocated to participating securities", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted", "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r268", "r271", "r272", "r942" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r341", "r347", "r756" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r347", "r756" ] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sublease income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r627", "r849" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease, Cost [Abstract]", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r204", "r208", "r573", "r574", "r577" ] }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TimingOfTransferOfGoodOrServiceAxis", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of Transfer of Good or Service [Axis]", "label": "Timing of Transfer of Good or Service [Axis]", "documentation": "Information by timing of transfer of good or service to customer." } } }, "auth_ref": [ "r833", "r1003" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in excess of par value", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r123" ] }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TimingOfTransferOfGoodOrServiceDomain", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of Transfer of Good or Service [Domain]", "label": "Timing of Transfer of Good or Service [Domain]", "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time." } } }, "auth_ref": [ "r833", "r1003" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r880", "r891", "r901", "r926" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "periodStartLabel": "Beginning Balance", "periodEndLabel": "Ending Balance", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r128", "r202", "r660", "r700", "r704" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Current period change in fair value of derivatives", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r204", "r208" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r209", "r217", "r218", "r570", "r818", "r955" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease expense", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r625", "r849" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r505", "r507", "r535", "r536", "r538", "r845" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net gain (loss) reclassified from AOCI to earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r179", "r208", "r210" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustments", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r332" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r624", "r849" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r197", "r339" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r346", "r958" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease cost", "label": "Variable Lease, Cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r626", "r849" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r42", "r710" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r619" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment fee percentage (as a percent)", "label": "Line of Credit Facility, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r1022", "r1023" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r927" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Other Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r144" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "610", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//610/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "720", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//720/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479583/944-40-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21B" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "65", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-65" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "66", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-16" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r849": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r850": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r851": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r853": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r855": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r857": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r859": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r860": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r861": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r862": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r863": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r864": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r865": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r940": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r941": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r942": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "325", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481551/325-30-35-2" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 96 0000081362-23-000071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-23-000071-xbrl.zip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

.KYVZNS,[V2R>,)2FNJ75(WO!YSP3V.I@.TQ"X+34C7?8=% 0D(4BWF1I_2L*0O+#TM-L2R#[ M.,VV=.M>'E6/R7AU)7@\ $C8-HR9P".3X6\F]6.Q9SAS%;D1DDP&U)MH%'.@ M[@=4)F/QG%\;^<5D-)O)M:YNH66=R= R:ZRM99Q79S+.RQIKZQITU9D,NC;1 MV&.(YTQ&0#G/5PVUBLH.=!ZT9W'^A?GG].0EO+8#B/ M@M"#!?.['6P% D-,8"YJ51,F%.FR])F++^W$!**6'GQDX0GR?P7?/'\2.51U M!LBUIKYG16888G/L>H[W]#:A+ZV-H/29"Q0U@T>%RA%SX9Z]E!G=4_G^]OH( M#'-QF)HQHU#)8#+F\8$CL[C[9:%+?GT(SEPD(@7R=\]]"K$_N<"/X?)I!&=P MKX6M._SL.<]U6IJ9"PVP1>M"<E$9%/=>J MCR,T8-8K98[LA:*=6?]S,]F_(O?7=Q+'OQF=^]BRP_14,'+KS:-C/\6QFOI@ MGSF_LR9,*%02ZNN+'G"=E?3"0%]??_1@5GN!U*ZO1WH@[[] 6M?7'XU5^3=D MV@Z,NSX4KZ%/>N/;3[:+G&62PRKZ,,8'X@8+S;2,&KJW#+*NBA)1HX:>\HUS M2!U7I)-@U-!!WD48MKZV;0<[&C5TT0_&^":?BF8P&Q:X@&D\@W__C*] I?D1 M^?F='?Q:+@:X@MGX. CO@ +W+VA:MJHMK!^QP6PH@!7"[R$>:E%;B0UF PBL M<*DL2Z3QL83,+_R*G/@,2(S#[UZRA7^U(NH@=5#%N=,&LP$,=NA=J$ Q&[Y@ MA]X%AOI5J68QAUG=ON=//1^6"Y)CO,=FY-NA79^]+*I4LX!!E70O%._,A@YF MM:V7?T8PKG-O,O5J^<90DH:F55)69]^?R< M6#ZMB!Y@5$>.,.MDY^?(-0Y_NCY&COUO4K3_C&->_(YL][L7E+Y.%,<39OWO M_#Q)B0^\.4?!^)OCO?R!K2=\B_Q:B0FSSC:S2P@#V3558M959WZ]88)]S#KB M-5BX\*D4ZCPUR_JL,OE7$/J5!OG^UP;>J&-B@D$&EP;>J^->@ $,E MGE-A/JS2H+!"I9Y3<1QI4%2A8L^I.)XT*+Y0K>=4'$L:%&"H8@DIK@91:5!8 MH595&^3\5USY5@G[ M&N3[5U[Y5@D#&Q0RJ+KRK1+^-2C <'C/22[2 &E06*$ZSZE0CC0HJE"EYU0H M3QH47ZC0S3&A2OJ+QLH1(&-BAR M47790B7\*SUTL8,+J6=W(?7"",%L". ;LOW_1DZ$O[[-_OP#GHA\<_SVG9SE ML(SHV4U7[C0* WJ'7)L="!JSKGP1?%#JPP=F'?DB^*#6AP_,NN_LZZ4B,VL: MLRX[^WJI4#XPZZ>SKY<*Y0-SCC=IL7P>^6"KFV\QI<, M?T#2_[S]1QU(RJQ[FJWM[C?/Q_:3>_EJCDDO\:VIM>>&PMG6%:#4R9 PJR;SD&R"I)<0:TEVV0_D# ;0RA1ZQ<(E3/3]"-L M?;?1(SD+HY3NL4PH$V9C'!PG!>"DJ,,;U%[I,9BZ*%9F@R"LG&+!A%IC-D3" M))>JDB7F BAS^IO>!,_RI^MU?\JDR]Z\R& M>!CD444KDLYL:(=!'E54":(S&UG)Q*-KS_5@OG#%?8I_T.R5B=D0!]/DU]+/Y"F;0,!L MR(-]$%2E99F-?^1A&<'M'U[T- X]]])]MGW/)6]#S@\4@M-0GV8>?69#';5A M1Y&%*WWFHAK8M$ Q6?:S;47(F9/[/S%^0>%7^U\. M?&2!A)WY_OPE/_SD!<'\*LD_DK&?>Y.)Y]Z'GOFK/K+&7.2#6?92QMY,B97& MI"X]ME]/?!QXD6_B(/XXQLBBXP%R#K_ /Y3M-I;QR))U\Q'U# T;IJ')VF!D M/(Y4198M9/Z3*.#Y;X+PS0'V3VRW.\8VK"\GJCX-3U]L*QR?R)+TOSO+]R'_ M"6Y]],+0FYS G7 YF"(WO6YZCN>?_(6 9C0Z'<'PNR,TL9VWD__S !P*A&O\ M(MQY$^3^'S% ;M -8,+)C8'];PROA+?3CR_Q<#1).G5L%Z?#DQ7I?Y\2HG0M M;)+S@(%E8$$#*G=R40?/1]>V87Y.F@:X)/TCU/+#J8.>@.4T5'3'YTNL[ ' M4WS&?FB;R.DBQWYR3^B$XLMS'!Q),19"0%QHI6].+A_12\>AM7K-&!P9TN;+ MTI$\NW9,G^VG-Z1PI!B#W\&L"#%^ZZB==Q,/O>F)/ V%P'-L2Z ,!T9-D46$ M_$029/J(^3N.*2'62 &=>4P$$Y/8^&9TPPMV0=3@':+Z:Q#5&?Z\OGJXO!#N M'\X>+N^7,<#@:.\OSW_>73U<7=X+9]<7PN7_G/]Q=OW[I7!^\^/'U?W]U[!CC=*+Y'I_33GJ]?N9")V+?_J1K*AY^+>)62D_ ME.DKXQ!N?][=_SR[?A >;@2P&![ +!!D5;BY$^3>)^NS/CC4E@P)F:&Q-GY M [DL&ZJV1"+F5HYL]M(WSQ?",1;^3!$CQ%Z?@,%SL'984F[ISR_C2- R\"SX MICN!1XS)S[H6>NN^8>1WL9L"404##D_#V(M6)5$@3NKN*Q(K1+ZYJ^\JRG4[ M8[J=]AVSB7>_6;F/D!/,M+O6&7I-UNX/=V?7]U=4AW/UOD&]AS/0I/I]Y'L3 M(9WBP4?V4=!,^(^_R+ITNO^_E(=?K(#HMG# M:[B2HE&G_LY_7=X)YW]<_K@Z/_LNG-_=4@*;_UIXFM0\MVS[W(#?VW<\]:CD# @$Q2SQ+BJ>\]D^?, M0P_]SO 6NV[PYCPCUT;%.DPUI_ #>KU*"BWBXM%E^V?0&=)2 D/M&]*'A"O6 M7X]%=TM-0/G+5C_;LD61*8 _YI$>(<*_(M\.+-ND/AFL8_8BBNEM_A, \=_T M\[OEJSBOO5XDO#JZ.[H_$BXG4\=[ QHN@U*X]H[6$8JO2K5ACW'X7M>*M;+FI3V(= Y_WO@/ MWLML_98EXN&[P=@;>^8O[*[0)K>CG[R*ZNT;_Q8L!M#1V0T*6ICZ@$U[BAP!OV(S(LT_X&M8&7'PN2:F:\9) PP$@H//>X7G#QT!RB8? M\X .Q73_-!!"[.#IV'/3<*5(#$4G(MP2D(\1<-/")SET&]&<9_##)5E2.T-= M7A&>;O:GDDV2SBT9Y[)K(&N=X4!5NAK0;8_0$YOLNO9"X6Q*"K()[EA:>[/) MTC=8R,"*)EP4Z:H&'U"B4Y!KI5^-[ "8*Y!4/:!O),1]T,#F(\NAX* @%'R: MB3SB0;;B@FQ%%8J5*A?K:M!)"8<)SBWI5)=$9[$/<)E&?A"1,&WH"7 ']=AD MY=/C9[)^D1SEF1F>%*L3#NRF#8ZTOK(+PE3E2%5V*Z3X^)JJ:X4[?_4:K'1D MR(.FQD_7B]^#'<:;-S RQX()"CK(80(NJ9O:DR+>6R7/>=3+ENX482X M3K)E%!(X:64J@ 9^&=OPS5Q-YPG7;E^[V"=,=A,W6=7>9.612MC,Q.W%I05 M3+IQ3Q3^*@M3Y O/Y-B)/?((&0#8+@XDTAP+\XS\>F?X7W^_8Y#.FZODJHS, M%"4&:3_DN/3@?4R,J)AWX; ^:"$8ZS\\_U2'XE+&Q'9>,+E3JA)[FEPFI8R"!5=A'22W3GUL8KHJRHI J[$# MX1,\#U@H!!$L!L'8(R43::%@.$;A^[&_H.51TGHJ^N-D#I]%ZD%^4N(Y/@(0 MX/KCOV &Y'YZ*_R(C")Y#BEM#>@@Z"")5VE(@H7>@J,MA6@Y@XKQ42MA7#Q+ MU$F(PBB8P730&?X#!^\A65")X;:BX6QQA]>#5!:NQ_C&^L%KCRD:>;EB$V"GS>2EXNY5S*=Y)R$"PD.#!R+"#3!"GWR8G) M%/@^65#7?BL :KMK+P034 _P%C]=ZD!6)D"#-Y'8#_ X6'0)E9Z$)]]["MO*#?CGH+V>//]MC8=+;Z)ZS4QNFCN[BM09?E^O M)7R'F7XO7D?:TXM%HEM,Y6F=P,IGJ[,K6E.N9ZG2G6>C T@+'WFTS5 MIC W[^I("?(U"N!!0;!U"[HB[[<'O63=4OFMM9"!R_4>6%LE("7'[Y0:YS$Q MMDN"4K0D,)\5&7T0:B#EC&LC)/9H70B4!CYA774]&K>,@CA, 7R*V]6L:7/@ M^?1=SAMY^8L-KX;7"BY,S2/J_-D.Z#KM(M>TD4/L=;)YC-Q,FJ%:R+<"@11W MV]:F&B;U$_J\-N(@"-5$#IL8%0O&V'%2U B? LT-A5O]/TX\O-Y8P+I'SA@ M)X19 1^VQ7O!'']"@K27SCPFB $_4?2)[3*62!- MO'+$4ADLT^2[Z>JXF^YZ!O3[!.BD._6\[$JX602^*]R8H?=(T$X4F2JGK>0: MO8TVEX+]1H4:*$5._*'J-=8@G7 MBKRQG7S"*6G^$_08>$X4;O[))GMJ^.71/WX_[N6VZ1D;Y)-SM^+?C/TY.)]P M]]''Z%<7C0!&)\AY06]!YYAWT:]M%_V#U0-F;9D:H5^@;L_'>$+T'$QAUIR M^0;J:^@>C_C AH9QU%=VV@\R.%+4W791?/A4[4@WLO75S+7%XJC?SY: KC1P MESO$=HM(96JY5E1CWK>KZ[/K\ZNS[P+8CS=W/Y).=#FX6%@!?B7=$3)9'>7* M928[9P>Y5#:PD>O,BG6FVAE>A7@BR =3E^\>T27WGQCI,VR7-&LZZ1KGNTKJG)MW/%.:RS99LZ[29E44. ME+>(&TL-'EI2M"#HX.'>Q&?0D_KL=.L4@=$#O G3ZNEK>'%M22#\\.@NDLOX M+!*8V.QTD"2NFQX14ML9$AYMGIC"E7<-E+?.E3=7W@MX,#(J;Y*T]O&8'!7\ MC 72QGB"&Z?&#:[&N1JOA1H'I*IOJ$)'-L.C1BT+A!_)_X5"XLX-? M7-O61=L2/JM[.KMPQ=^!K2[7N(AU)P9--A[13LC"[>1;XY1T$C0<4.D)H8(Y=:A#9$J;!"Z MG/?FO<3Y(MZ$1;S7&=[04QRNW+CS,SR*ZY[:Z)X>=X*8=8(4:;!8C*!S3ZBI M2A3X?/DZMA_MD >0ZJ,[@6OJ((_NU+GN/)CNE.7.\!YHAT)2T\.%JB9"1=BF M&A\)%8.G@)RRPFZYB"-(2)MG?@9)'0V)'<\@80'/ZU<=4CXF7.4X?8R5@6_H M@/]^'AD%4NUDFOR2N:[J[^UUM803[/*$?N2-YS)N:VN]YORYC)33UU&.%9#4 M^RC#Q1V/4_SXFMK+=AX1'RPS@U4.!/BL]Z;:0I[@6,CN=2\0@!9<.1]UG MNNVBF5*$U#62,AQ-^Z)IBY)Z1.:O)]^+7*N;#-$T,1Z-=CX0K8KXU#4&CI$J MK_=HV3;);%R7A#H0X:\E37YQTCYY'U.SWG@*=118[X^@5A>/H":?XA.HHZ#[ MA-#TY X_8S?"WWQO0K?PPA/_;H?C\RB Z6'_\M5T(D*6,W+"D*2ZGCS/"@@!+>$33IDMH(D'0_TWS8$)^'5* M,F9"5Z#ARM4TZ#W& NEZ+,CJYXWA%"4?_=:JGWI+XA;OD'#D9O0[X<>9:]UC M_]DV<7 /G,DK<%IGJ$I]4=%[^XK;>F"7NKB]>^7&R!K'TQ8_IS@\D5I[%52X M;G \-1A/6RSVXO"D=X9&3Q;[LL[QU& \;;$\B\-3GQB8DJ2(JJ$RA*B"$B/T MW7W&SQP)Q-P?]^TWL*RQ3BD]+VEY,TK'0.0CH$JJEH]G*^" M@B <=/M;D'N S@#0Z9+8U_8V&3GH&@:Z+6;F[J#3I,ZPIVJB-FA5VH6#;G]; M= _0D5Q?3Q?503UR#&V(;=YC![Y\$H4G[&(?.;1U#K(FMFL'H1\?2I$$-5<* M>KC_EM4D3:C\>TQC<.'.EBA\&1,XKSB1I)VBB -98LB3X[&! UN>Y6"+)*+D MG@CJFF.KP=C:8F"6@RV2<]%)R<_>A7<<6PQC:XL=60ZV2/Y%4T5I(#.$K3:4 M?=]AX%QDAI%/D^)@1=*V#!AF/$8^.8/]D^ECRPZ#SZ+@XKTBGPT7G*VET0N4 M/H^)FU=,=)H&D(N*.-74Q:\ACC[M93D&,'[XJPQ$T<22IJPFE5;*7#B86 %3 MH36J^T-HT!GJHJ06%1SB.&)2*:V8A;F4T@IH# #-FIKE2K1.&P*&Y][DT79I MM:,HV,#8I[C]!S7Y/-HE%IE_1G;<:*N;&H$\AKBOV?]B M.I-"D7=Z=V2_8JO[;^Q[J]+3DSI#>BB\%UM8EO2=WAHHH M2WN74W!T,8RN+:9A*8I+X8JK#=#:$D,L3W&IG6%?- R6(M1MJI%,NLJY3V!B MFMX$\SK)X@W*&8VO*(F_>T%N*=$ZPYXA]MJU=YMC;W^+LP#L]3I#31-UB5=- M_Q5H ^$BF1>J)AKSWEE5>15F4N4KCGI^2 M(.?GQ&C=/<]=7^\6 MJ_,#'*U Q>@,![PG0-W DDO]K-B)):L?70),B;W>JK?,U4\S$)4UMUT8HF1B M"XH]974'0"60:D.AXQ5I,XR#,$UIM[&:L10K+R7LDD!8B%$K_!H4AZ)_XSL M\(V<)P8F8Q(D)(TE41!XIAUOEO$F,&![OT+)U@;?MV2\YS'WM(>K[49 COD9 M=E\IR^+['@C??MBNYP/34CD]MQ?26F";#F.Z3?;ZB*A451N68;@JFMV3H&<8TZ1 G#T1#*ZKG M!@=U4T"])?//,*B-SK#?$V6]J#)]Q@H*/O!K* QJY5M08 @ 17O)R2C=M:BO MWUZX P$L2!SUK]C%^?N@]2581%2QMW\'7AX#8AA+F0SWO;$49P#E_6L5.)88 MQE(F@WEO+"G483/V[_G%L<0PEC+9J7MCB320TT1-84DO\:CT 0W&MKN#&TS) M7R]^9E?P0/Y?GQZ")&IJ43W3>$RC*2#>8,.R"&*2 =5%>4TI' =QNT&\P7AF M$<1Z9SB016/_!ND9"XW"J3@F1J ":ZJ/1YP]:Z :NDPN9,$%M!D0$V\IJNZ[SHE%GXE%9548Q> M&D@T_:#K>WM='%DL*Z;LYY$'>XDW! M^)BT'9I\#$@J3A7[A1WMQ ,!38'7.90CNF^5IZ8,Z+_6M+DFZ-$ M\MC$.9U*0Z+16KU?#Z>RH#@&%R\N7KMY"WG%2Z:1Z4%-]B=S\>+B5:D?E5>\ M%!J%[_7XZL7%JZ7BE*LTX2,K>NVIYQJ$@9-R" QF,D8\%"X7H9&,B M(<.T%YBA L4M+R)^ZA(W-@9VB@@.\2$R.D0>P,D?P"&[#R;P'RJ;8\\!@@<" M/>95/A4>46";^S2U;^A:W9 5&73R/6'[AV$;Y?W"?(E\%R8?I+_^2D R6X.E MV1JL=8;RT:"!QU!S 6BZ &B%"$"/"$!A=59< +@ '$P Y$($0.\,>T?['YG( M!8 +P*$%H%>( )!NS$!IHM /C=ILP@8Q3A*7 2X"+#M*&T4 5F2J*_$98#+ M0.UD()^O]($,R,6X2ZR6!+/>E^#"?K;!;[,"PDX'6)7=J^%QCX;(\I)7LU*3 M<4X=X?O0,W_-P#*3ZP0SZP1;Z0RE(ZW'4B"$1P*Y1.1W<@J3")5*!%.A02X1 M7"+R^SR%200M%U#W/[N 2P27B$H]H,(D@M8/*#I+$D']H6.:-('_6O;S\ O\ MD[YZ@OPGV^W&/SG1@=S)-Z2"3U_&M(G)QM#R>$R?>&*'\#8S ]0C1Y@B/R3=>\,Q#C! T66';?P)1FO(/Z+5@?3 MSKXCVT6N:<,/@Q"^H)WXCF9\>T^^9$ JH=34"VS"ZQ,?.RBTG_'IBVV%8Y@@ MQ>C"KQ)J2_.?H$<8 ?C8&W^RRJ<#,N9#-BC+Q%G\EXR?2(:-93RR9-U\1#U# MPX9I:+(V&!F/(U6190N9_Y2-3OJCL9_.8(J>4%O0>=X MF3) EF1 Z*$,U-P,[U&H]+H%;,--$^2J#P!H<<^N0N&@Y@9BS#VB9K\RW;. M]JH#%+\V4.J-YZ9R#$U[3!T4#=?%DZDC=>^^BQ,ER4=GOL MQ]?4GLX'6Z_!*ID>NR7$OG4?B;%RZQH/*A;/BOR,];KH 59%+/R ^\:!< DZ MV/KRZ!\/[_$4].XCK":J)&;8)=58^ES#-WG(LR^.%AS\K)O]&*>@(BEJEGUV M6Z?;+IHI14A=(RG#T;0OFMJPTW=S>_MMLVSG_O]\DZ]O\/10??QE22^JD7\N MUC!>9\6%JTW"5=:)!;+4+^K( BY<7+C8F34+9S/(TJ"HPQFX<''A8F?6+)Q" M(4M&4<=0'$2X$E?Q77)8UJCH%%29DN<9Q3CV?(2-&F$;XADWX1C[])#F>08T M.<*Z$N7:<(HKU3)+919QE<4WSX=WNRD+'@@'XM>> MN=;#G!^_(]NE9S'X=@#TO(A\^/<6)NA9USB\&3V@U[P&DRQ15[\GK7HCV0^) M9:\.3J;@;H;"HZLY[/ MSB(ZUD+/(+O+.$1N_!7*/@XM'U::BM,'7@N/V.S M-&.:B-$M^8+*&+WKU@O".0>^QCRY)7PXFSDX9Z@9#>P9QE%7F/%; NKTSG#04SCJ&HRZ?8W:O5&7TY EU2BB5EA*C[6> M0:S;LK'S H8K=4<$_L#6$YXYC&2?ZQW98!X$]@@HDOJ6.\@9Z5(J*OL?',Y#&BR'-(JP M=/-#<15MI"&HMJK3>>2,69@56#Y7I9Y32!M.<; FX\7U7', N*7$K%( RF2A M[3'5&*Q-P=F?KH]A&/_&5EKC\P1,%DB]PS.R';)/OPL<[0:([/+'9N3;H;VC M55M?C_*@%1!SEOSA.812J=C=N/5<9-V7?TZ,6WWB<3NL26KYI)71 G"SE*DTZ(R73;V#XVQ ML3.PP)A%>R%91-1V9TCV.\.^(FK:/LX4AV33(%E$\<+.D"2Y*EWL*:N5"AR2 M[85D$94-.T.2)+1ZJMA7"ZBWK<&VXP(WWY6T99:/L,XC+,A_8]IM6VZYG)Q: M'. W-KC4T:_1ZJM/ADQ,1TMQZ/LW?+1P0_>!=>RYYD>\Y,+ZG*])I$ =A MWG5 E3I#0Y0,7D93-PR6XI!5C4:Y,]3 4%8+""=P)+*H#;=D):K&G](9]G51 M7N.H<77(-@A+\;RJAJ-*$F>B7H2/QEK9S=JS9^EGFYS^$9YTC=7C)BI%V'<< M!"?OSATAQJ^ %E@OA)[@+C&?'M5$N,\K)Z-9AE/ M6YK-EH"G'N")PZFA<-K=:MT53GIGN.9P:HZG9N!I2[EW"7CJ Y[8@%.AE2ZU M,R(_B*&NV)%9SO#+EZ%)#G)3@7R6%Y'7T(AV.]L9%TD:MG7382SQW-[M@(:> MURQSN\5:BF!DQ3$:+L9;"W$QA/HS[F5>$-8DF M0"1][TY.7(ZY'+=!C@^==\HMT7*20RJN0K\28:9A@V/J&P\W'H.>C(RAAC 9ED,PQRWTB^R/5">!_RX6N7)H^>?'#^I\B/3W08 MXP #R))3XPG +,!)_!>E.2)?CVP7N:8-/PQ"^((VQ3]:/DM^@7S)@%1"J:D7 MV 0>)SYV:(.DY&!W.3[J>^%7";6E^4_0(XP@"C?_9)5/!V3,AVQ0EXFS^"\9 M/Y$F&\MX9,FZ^8AZAH8-T]!D;3 R'D>J(LL6,O])=G$G/QK/"E:GZ EW'WV, M?G41:)1)Z LL$_N M@N$@9L8BC'VB>/^RG7-]$$0:=P,1.R;)4;(ZMC/ M9ZKK?%%U?44.J"XLW(\Q7CC)H\)9;-3HZ^?UZ6>JG4^%"\]QD!^0!G3AV(O@ M158@"OC5Q+ .@DZ/.])]7J=\5H7^H\4LCAK/-#-=BDWR\FF 3](_3BT[F#KH M[<1VZ;#ICTZ754IO-6).WQ=?3O2281SU!BI134DD/WEQHK6.J-9Z9U;$U_KJ M4=_H;;PL'6(I<8#,AB#PC2"5'N4]LRW)P150XN[^_?+C? MYTPSOO5DMZTG!V+[QUU=41#@#T[W*J(\MLIG%-K7[$A5&(\GD=9UX.3"7,D? M^,_(!FMHW?%M>]>+, ?HE5#:KN4Q,F5SQI!*I5/.$RC3MT2\ 2]GKD7^ZNMBLHX1).#NF6@[EF2;,) P$'VQJ(#0XP?3$W"+LBG?PS5*W6!L ;]'**5GO M9E2]QF%BN>7&K=89:IHN:KW5O 4KYE^36;U%5Q7*:G)T4%\1!X,MZVZ;NOY> MN<] 2L__J)/O@=S1TI[1JIYW=^A% *& 'X-(4:(ML2 M\.N4E!C$&LR+^PX7GDMH,J2WZ+&$SIEODNB*J\VT:O: MZ&HWU[<%,??B.NG-9&BBO.;0IC*L+J83?V"Y3F$X;Z(P=1!15V!LD73^E-2= MBP(*8>8?-$#*0(UV WFK$1:3GQQA'<*2?)F2_G??R^]/]$CJ125.Y):(2 4& M6+MAL-4T*Q0&)"VC#$396#WVMK5IF;@'W)EI1I/(H=7J%I[Z0,.U73EV+7_( MWO*F4NCFVOJV/7>WI?I ;WLNNQKH]0%ZBB'V#$:@=^A\+,LFZY[50.VV4W8U5Z]Q?B$B M&0]#%S5MBY7"C=6:&*N[@,"(*W?7:=(&[Y#94&A"_B;;6*, "PY&\._^T<,V M ':+UKH!N((!X#Y])S2E5+X9_0PPC2+E1:PN=89J!L#R/&T5NJE85I,S+52Q MORTEWX8X(ZFBE(RYH:ATACU)$[7>EI@U3ZU6H79V9JL*;)5[ MHB0=)H'*M(J)SY:VW1"Y3S9IB1 ;/[M[="U:%K?6K*5$C3-G8*E?OB:GH.R, M7:TS'!B2J.D%57MP2ZC8BK426-[K# U-$8TU(=?6642D)# (:7LNTB,&E)5' MXH^TG1?I",;W!^RKM4A@(7S[@<.Q9RU0.S=J=4 M@);!I&@;F+Q%3Q7%Y#ZL M1@-167/@5NL,J0L\PKX/BBA$KP5'D)0CJ=]$D&[11"E%XX:>Y#"/=$W-C5/: M.K^G%[0WEMM,1>JB ME,XMJRJ,A%^W4U-)1BOPY(T.7U^T5&M>?5V^0PH=UJ M(?LDFJV*_6U;Z+AM5$DTNQ 6RYVATA?[:]I(EUBCGZF%5:5\BLOTUZNB8HJS M6]#Z)W>BO$%-@3+M3,@MK0I(*PBK(O:DP^P$Y5CG6"]F/T9NK*L$ZP-%%O4U MQ[8WV$Y>WR#U^]79UZOO5P]7E_?"V?6%ZI;SPE]@MP#MH#*L-.M4L[,>J1.T1OI[\AK9PKIC7H;4W-7H)+> M=(:T]GQ&5HR[)C,Y8U?4/9E,.M(9JF@,V.KG5&TVVGZV+>Q:^^FC%B4%MMEY M*3WWQ.J@,\RP19PG?BJQB KBL=$9]L7!@8J+:Z&-0-'[45*CA]W@X\W_?.W, M:" 1DMXC!Y&FUSMB=2#1S3:ZQEXKIC;P>+M]5 2/YM M :82L9,(HTB68NH!Q7%H^_1<GV_=8E"M50"''H6#7G2_N!K;97'5,DITX+ZI M^!:MV5G*EA>@NNMZK7>&@Y[8-_@A8PQJL**83#9UZ>*@?T"KC/GV9\OMQ0NJ M$6IWPZLM*JL ( _ B^PIHBRQE_UK-^NW*+("6&\0UFMB?\"[" V_?UC1MF/= M: M1NTUA 9D?@,JDL&;WC4.&!*NOI(G&MN67-VAD3&D5PWZY,S14%;S"+1F9 M-I1DSQ57W)>QX-+L)H,U5W/&=+U]VP.W9 <5F%K;CDWGL:WJ&S06P6ZRB4@7 MC6UU=6TPKY8:?_"056G=/Q:\@AUZ0QA:?&ZM7M0&3QZ[*K4)R)[<)J%U71(5 M@WZVL%.,>B!W0]DB*O*4] ;?46,@R[L%G@Q[JH&]K9=S"1"-/,!XTP9@3 MN8HDD;CRW>/#<8FZNR[1>2U-%B1]BW!F>>Y.)G;3BIKTTX!

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ⓤ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end